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Abstract 
Evaluating Changes in Knowledge, Beliefs, and Behaviors Associated with HPV Following 
an Educational Intervention among Women 
Crystal Sheaves, MSN, APRN, FNP-BC 
.   
Background:  Prevalence of HPV is estimated to be 10-15% among Americans.  HPV is 
recognized as the causative agent in 99.7% of all cervical cancers.  In 2006, a vaccine was 
released to prevent specific types of HPV that cause cervical cancer.  Despite demonstrated 
vaccine safety and efficacy, vaccine rates are still low at less than 20% among women 18-26 
years old.  Vaccine uptake may be impacted by women’s HPV knowledge and beliefs.   
Aims:  The purpose of this study was to evaluate changes in women’s knowledge, beliefs, and 
behaviors associated with HPV following an educational intervention study.  Specifically, the 
study was designed to evaluate the effectiveness of a video-based HPV prevention education 
intervention as compared to the standard of care written HPV educational material on improving 
women’s knowledge, beliefs, and behaviors regarding HPV prevention. 
Methods:  This study used a quasi-experimental pre-test/post-test design with delayed 
intervention treatment for the control group.  Recruitment included women 18-26 years of age 
who had not yet had the HPV vaccine. 
Results:  Both the control and intervention group had low HPV knowledge prior to education.  
Knowledge scores increased significantly for both groups following education.  Type of 
education had no significant impact on HPV knowledge.  Women’s willingness to accept the 
vaccine for themselves and their children increased for both groups over time, while the women 
in the video-based intervention were significantly more willing to accept the vaccine for their 
adolescent sons at time 2.  Health beliefs related to HPV infection and HPV prevention also 
positively changed for both groups over time.  Furthermore, health beliefs were a significant 
predictor of participants’ willingness to accept the vaccine for themselves at time 2. 
Conclusion:  Despite the majority of women having regular contact with health care providers 
for pap testing in this study, participants had overall low HPV knowledge scores at study 
enrollment, which improved following both educational approaches.   The women in this study 
had an increased willingness to accept the vaccine for themselves and their adolescent children 
following education and women receiving the video-based intervention were significantly more 
willing to accept the vaccine for their adolescent sons at time 2.  Why this happened is unclear, 
but perhaps the video-based educational information regarding eligibility for the vaccine was 
more gender neutral than the CDC written fact sheet used in this study.  Future studies need to 
explore why women who have access to regular pap testing are not receiving the HPV 
knowledge that would facilitate their ability to make informed decisions regarding HPV primary 
prevention.  Additionally, future research should investigate the impact of gender neutral 
language in HPV educational materials as a means of increasing HPV vaccine uptake among 
adolescent males.
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Chapter 1 
Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI) 
in the United States (US), causing many serious physical and psychological health concerns for 
those infected (Weinstock, Berman, & Cates, 2004).  Recent advances in HPV screening and 
prevention have the potential to positively impact the incidence of disease.  However, lack of 
HPV knowledge is a barrier to utilization of prevention measures (Bynum Brandt, Friedman, 
Annang, & Tanner, 2011; Juraskova , Obrien, et al., 2011).  Creative, evidence based, HPV 
educational interventions are needed to correct this problem.  This study proposes to evaluate the 
effectiveness of an innovative and novel video-based HPV educational intervention on 
participants' HPV knowledge, beliefs, and behaviors. 
Background of the Problem 
Pathophysiology 
  HPV is one of many papillomaviruses found in different animal species (Gearhart, 2011).  
Each papillomavirus is species specific, and cross species infection does not occur.  Thus only 
human papillomavirus is found in the human species (Stanley, 2010).  HPV is transmitted 
between humans via skin to skin contact (Brandt et al., 2006).  Transmission of the virus was not 
well understood until the late 20th century.  In 1949, HPV genital warts were first recognized as 
being contagious and transmitted via a virus, although not until the 1970s did scientists’ 
hypothesize HPV was associated with cervical cancer (Sarid & Gao, 2011).  The first evidence to 
support this hypothesis was discovered by Harald zur Hausen in 1983 when HPV types 16 and 
18 were identified in association with cervical cancer (Oliveira, 2007; Sarid & Gau, 2011).  HPV 
is now recognized as the causative agent in 99.7% of all cervical cancers (Ault, 2006).  Research 
continues to uncover the number of types of HPV and their effect on the human body.  To date 
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science has identified over 130 subtypes of HPV.  Of these 40 are known to infect the genital 
tract of humans, 15 of which are known to be oncogenic high-risk types (Stanley, 2010).  The 
additional 25 types are non-oncogenic low-risk types of HPV, including HPV types 6 and 11 
commonly understood to cause genital warts (Stanley, 2010). 
 HPV is a genome of double stranded DNA, which infects the squamous and glandular 
epithelium.  Currently there are 8000 base pairs of the genome identified.  It is believed the HPV 
E6 and E7 oncoprotiens play a major role in cervical cell mutations.  These oncoproteins from 
high-risk HPV types activate cell oncogenesis, while simultaneously suppressing tumor 
suppressor genes found in the host cells (Ault, 2006; Oliveira, 2007).  This results in uninhibited 
replication of the HPV genes in host cells causing cell dysplasia.  These oncogenic HPV types 
have been identified as causative organisms in cervical, penile, anorectal, and head and neck 
cancers in humans (Sarid & Gao, 2011).    
 Not all persons infected with HPV will be chronic carriers of the virus or develop 
symptoms of the disease.  For most infected (90%) with HPV the immune system will clear the 
virus from their body within two years of infection (Centers for Disease Control [CDC], 2012; 
Ault, 2006).  A lack of understanding still exists as to why the immune response is not successful 
in clearing the virus from all persons infected.  There is evidence that secondary bacterial and 
viral infections, viral load, parity, oral contraceptives, and cigarette smoking all play a part in the 
lack of immune response in those who go on to develop HPV related symptoms (Ault, 2006; 
Villa et al., 2002).  Also unknown is the exact incubation period from contraction of HPV to 
either clearing of the disease or evidence of symptoms.  Originally, HPV was thought to cause 
oncogenesis slowly over a period of ten years or more, but recent research suggests oncogenic 
changes can occur in as little as three years (Ault, 2006).  An important fact is that immune 
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clearing of the virus does not appear to confer immunity to HPV.  People whose immune system 
has cleared a specific HPV type can still be infected with other HPV types, and can even be re-
infected with the same HPV type (Villa et al., 2002).  For this reason even persons previously 
diagnosed with HPV should be encouraged to utilize additional HPV prevention (condoms, 
vaccination, and pap screening). 
Incidence/prevalence  
 HPV is recognized as one of the most common STIs worldwide, but precise worldwide 
prevalence is difficult to obtain due to differences in access to screening technology and 
frequency of screening (World Health Organization [WHO], 2009).  The 2009 WHO report 
showed that only 5% of women in low-income developing countries have received screening for 
HPV, compared to 75% of women in high-income developed countries.  Therefore, worldwide 
reporting of cervical cancer incidence is the most accurate way to determine probable infection 
with high-risk HPV types.  Worldwide estimates suggest cervical cancer incidence is 16.2 per 
100,000 women (Castellsague et al., 2007), and is the second most common cancer worldwide 
(Heymann as cited in Stanhope & Lancaster, 2012).  The WHO (2009) reports that the highest 
incidence of cervical cancer is seen in the poorest and least developed countries.   
 In America, HPV is estimated to be the most common STI among adults (Weinstock et 
al., 2004).  Approximately 26-29 million Americans are infected with HPV, resulting in a 
prevalence rate of 10-15% of Americans (Tyring, 1997), consistent with WHO (2007) estimates 
of 13.1 % in the United States.  The CDC (2009) estimate there will be six million new cases of 
HPV each year and at least 50% of people will contract HPV in their lifetime.   
 Estimates from the National Health and Nutrition Examination Survey (NHANES) 
conducted by the CDC examined the prevalence of high-risk and low-risk types of HPV among 
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females aged 14-59 years.  Overall HPV prevalence was 26.8% (23.3%-30.9%) among females 
14-59 years (n=1,921) (Dunne et al., 2007).  Prevalence estimates show the total prevalence of 
HPV types 6, 11, 16, and 18 to be 18.5%.  Findings suggest both high-risk and low-risk types are 
more prevalent among 20-24 year old women (55.3% and 36.3% respectively)  with overall 
prevalence for this age group being 44.8% (95% confidence interval) (Dunne et al., 2007).  Both 
the 14-19 year olds and the 20-24 year olds had more high-risk than low-risk types of HPV and 
higher viral loads than older women.  There was a higher prevalence rate of HPV among women 
14-24 years (33.8%), compared to older women 25-59 years (25-29 years = 27.4%; 30-39 years 
= 27.5%; 40-49 years= 25.2%; 50-59 years = 19.6%) (Dunne et al., 2007).     
 Extrapolation of exact prevalence estimates of HPV by state are not possible given the 
current reporting practices in America (Weinstock et al., 2000).  HPV is currently not a 
reportable disease in most states.  However, inferences can be made based on the incidence of 
cervical cancer by state (Horner, Altekruse, Zou, Wilderoff, Katki, & Stinchcomb, 2011).  In a 
recent CDC report, the incidence of cervical cancer was the highest at 8.5-11.2% among West 
Virginia (WV), Kentucky, Maryland, Delaware, New Jersey, Arkansas, Oklahoma, Texas, 
Louisiana, Mississippi, Alabama, and Florida (CDC, 2007). 
 A study sponsored by the CDC and the WV Bureau of Public Health assessed the 
prevalence of high-risk HPV (hrHPV) among 814 women in the state using provider collected 
and self-collected samples (Reed, et al., 2004).  For women younger than 40 years of age the 
prevalence of hrHPV types was 25.5%.  While women older than 40 years of age had a 
prevalence of 12.5% for hrHPV types (Reed, et al., 2004).   
 These findings of high prevalence rates of hrHPV are consistent with high incidence rates 
of cervical cancer found in a study of Appalachian states (Hopenhayn, King, Christian, Huang, & 
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Christian, 2008).  Out of five Appalachian states, WV was noted to have the highest incidence 
rates of cervical cancer (10.9 per 100,000 women) (listed in order of incidence: West Virginia, 
Kentucky, Alabama, Pennsylvania, and Ohio).  The states with the highest incidence were also 
found to be those with the highest levels of poverty and lowest levels of education, factors that 
are relevant to WV, an entirely rural Appalachian state (Hopenhayn et al., 2008). 
Psychosocial Burden of HPV 
 Several studies have highlighted the psychological burden of HPV (Bertram & 
Magnussen, 2008; Daley et al., 2008;  Daley et al., 2010; Kahn et al., 2005; Lagro-Janssen & 
Schijf, 2005; McCaffery & Irwig, 2005; Perrin et al., 2006; Sandfort & Pleasant, 2009 ; Waller et 
al., 2007).  Women diagnosed with HPV have been shown to experience negative emotions of 
shame and stigma associated with the diagnosis.  These negative emotions are compounded by 
the lack of knowledge regarding HPV prevalence among the population.  Stigma associated with 
HPV has implications for disease prevention in the future.  Studies have identified stigma 
associated with HPV as a barrier to prevention seeking behaviors, partner notification, and social 
support (Friedman & Shepeard, 2007; Perrin et al., 2006).  Addressing the psychosocial stigma 
attached to HPV diagnosis is important to facilitate successful prevention programs. 
The lack of knowledge regarding HPV and cervical cancer screening is associated with 
increased feelings of stigma and psychological distress over subsequent positive diagnosis with 
HPV (Bertram & Magnussen, 2008; Daley et al., 2008; Daley et al., 2010; Lagro-Janssen & 
Schijf, 2005).  A study of women's knowledge and experience of stigma associated with 
diagnosis of HPV found women's HPV knowledge was low, and that lower knowledge was 
associated with higher levels of anxiety and stigma over receiving the diagnosis of HPV 
(McCaffery & Irwig, 2005).  Regular contact with health care personnel during annual pap 
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testing presents an opportunity to increase knowledge and decrease adverse emotional responses 
to subsequent diagnosis of the disease (Waller, Marlow, & Wardle, 2009). 
Prevention  
 Primary prevention.  Prevention of cervical cancer, a result of infection with HPV, 
involves primary prevention through HPV vaccination and secondary prevention through 
Papanicolaou (pap) smear screening.  Until recently, secondary prevention was the mainstay of 
cervical cancer prevention, and was cited as a major factor in the reduction of cervical cancer in 
America (Hawkins, Cooper, Saraiya, Gelb, & Polonec, 2011).  However, in 2006, the US Federal 
Drug Administration (FDA) and the European Union approved the first HPV vaccine for girls 
and young women ages 11-26 years (Wheeler, 2007).  The first vaccine approved was a 
quadrivalent vaccine, marketed as Gardasil®, which provides protection against two oncogenic 
types of HPV (types 16 and 18 and two non-oncogenic types of HPV known to cause genital 
warts, types 6 and 11).  Cervarix®, a bivalent HPV vaccine which protects against oncogenic 
types 16 and 18, was approved later that same year (Wheeler, 2007).  Most recently the Advisory 
Committee on Immunization Practices (ACIP) added the recommendation to vaccinate young 
boys ages 11-12 with the quadrivalent HPV vaccine (CDC, August 2011). 
 Studies show HPV vaccines to be safe and effective at preventing HPV infections, with 
both vaccines demonstrating efficacy of 100% for intended HPV types (Wheeler, 2007).  
Vaccine side effects appear to be minimal with the most common side effects being pain and 
irritation at the injection site (Wheeler, 2007).  Because first generation HPV vaccines do not 
include all oncogenic types, the possibility for future research to include other HPV types in 
vaccine formulations is likely. Additional research is ongoing to determine long-term immunity 
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provided by currently approved vaccines, alternate dosing schedules, and the need for and timing 
of booster immunizations (Wheeler, 2007). 
 A problem with prevention has been the low rates of current vaccination.  According to 
the CDC's National Immunization Survey data (MMWR, February 3, 2012), only 48.7% of 
adolescents aged 13-17 years in the US have received ≥ 1 dose of the HPV vaccine, and only 
32% have received the recommended ≥ 3 doses of the vaccine series.  Rates for WV from the 
National Immunization Survey are slightly lower than the national rates at 42.4% of adolescents 
receiving ≥ 1 dose of HPV vaccine, and only 25.3% receiving ≥ 3 doses of the vaccine series.  
HPV vaccination rates are also low among women 19-26 years old, with only 20.7% of women 
having received at least one dose of HPV (MMWR, February 3, 2012).  In comparison to other 
states, WV ranked in the middle on HPV immunization rates for adolescents with Idaho having 
the lowest rates of  ≥1 and ≥ 3 HPV doses (28.8% and 17.6% respectively), and Rhode Island 
having the highest rates of 73.0% and 55.1% respectively (CDC, December 2011).   
 Lack of HPV knowledge has been cited as a barrier to immunization (Bynum et al., 2011; 
Juraskova, Bari et al., 2011).  Several studies have demonstrated support for increasing vaccine 
knowledge by addressing health beliefs with educational initiatives as a way of increasing 
vaccine intentions (Brewer et al., 2011; Cates, Brewer, Fazekas, Mitchell, & Smith, 2009; 
Fazekas, Brewer, & Smith, 2008; Gerend, Cruz, & Shepherd, 2007; Gerend & Magloire, 2008; 
Kahn, Rosenthal, Hamann, & Bernstein, 2003; Kahn et al., 2008).  A review of HPV vaccine 
studies, supports using the Health Belief Model (HBM) to guide future educational endeavors for 
HPV vaccine promotion (Mishra, 2011).  Included in the model based education are promotional 
messages emphasizing efficacy, official's recommendations, and susceptibility to cancer as major 
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facilitators of intention to vaccinate.  Future HPV vaccine educational efforts should focus on 
these facilitators, while eliminating barriers to vaccination.  
  Secondary Prevention.  According to the National Cancer Institute (NCI) 2005 report 
78% of sexually active women over the age of 18 years have received a pap test within the past 3 
years.  This number is relatively high for secondary prevention of HPV related cervical cancer.  
Similarly, the CDC (2009) reported a rate of 83.6% for women 18-44 years, 80.6% for women 
45-64 years, and 54.9% for women 65 years and older with an average of 73% of women 18 
years and older having a pap smear test within the past 3 years. 
 Pap smear technology has evolved in recent years, relying on thin-prep method of 
collection, and utilizing hybrid capture technology to isolate HPV genomes for typing on 
abnormal pap smears (Roland, Larkins, Benard, Berkowitz, & Saraiya, 2010).  This has led to 
fewer false-positive and false-negative pap smear results (Agorastos, Sotiriadis, & 
Chatzigeorgiou, 2010).   
  Pap smear education of women has not kept pace with changes in pap smear technology.   
While most women have heard of and have undergone pap smear testing in the US, they do not 
fully understand the purpose of pap test screening (Hawkins et al., 2011; Panagopoulou, Giata, 
Montgomery, Dinas, & Benos, 2011; Vasconcelos, 2011).  In fact, women most often report 
other reasons (contraception, pelvic pain or symptoms) for attending clinics for pap smear 
testing, not related to HPV or cervical cancer screening (Bayer, Nussbaum, Cabrera, & Paz-
Soldan, 2011; Bertram & Magnussen, 2008; Daley et al. 2010; Friedman & Shepeard, 2007; 
Perrin et al., 2006; Vasconcelos, 2011).  Contributing to the lack of knowledge, women reported 
a lack of education by health care providers during routine pap test visits with 71.6% of them 
reporting never receiving information about HPV during the visit.   This study highlights the 
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need for more HPV and cervical cancer education of women during routine gynecologic pap 
visits (Cermak, Cottrell, & Murnan, 2010).     
Impact 
 Despite advances in HPV prevention and screening technology, there remains 
underutilization and lack of knowledge regarding preventive services.  Those least likely to 
access vaccination as a means of prevention (poor, less educated) are the same people at highest 
risk of morbidity and mortality associated with HPV.  Evidence supports women seeking pap 
smear screening have unmet information needs (Daley et al., 2008; Kwan et al., 2010; 
McCaffery & Irwig, 2006; Rosen et al., 2010).  These unmet educational needs provide evidence 
of a major gap in nursing practice that can be addressed through research.  This study was 
designed to have a direct impact on educational needs of women at high-risk for increased HPV 
morbidity and mortality.  The aim was to educate in order to change knowledge and beliefs about 
HPV, thus promoting behaviors toward increased utilization of HPV prevention (vaccination).   
Significance of the Study 
Contribution to Nursing Knowledge and Practice 
While nursing knowledge has supported a link between lack of HPV knowledge, 
increasing HPV stigma, and underutilization of HPV prevention, the best method of delivery of 
HPV information has yet to be identified (Bertram & Magnussen, 2008; Carpenter, 2010; Daley 
et al., 2010; Kahn et al., 2005, McCaffery & Irwig 2005, Perrin et al., 2006, Sandfort & Pleasant, 
2009).   Previous research suggests people can be either positively or negatively affected by the 
method of delivery and type of HPV information (McCaffery & Irwig, 2005; McCree, Sharpe, 
Brandt, & Robertson, 2006).  To date, no particular HPV educational program has been shown to 
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be most effective in increasing patient knowledge of HPV, decreasing associated stigma, and 
changing patient beliefs and behaviors toward HPV prevention.   
Understanding which educational interventions are most effective is important to nursing 
practice, because nurses have direct access to patients attending primary care clinics, and are 
often the first health care providers to provide health specific information for patients.  Nurses as 
patient educators need access to evidence based effective educational tools.  Identification of an 
effective educational program, with the potential for wide acceptance by nursing staff as a pre-
pap smear educational tool, is important for nursing practice.  Understanding the effectiveness of 
such a tool will add to nursing's knowledge and contribute to future interventions by the 
profession to decrease the morbidity and mortality associated with HPV.  
Potential Impact on Health and Quality of Life 
 HPV is associated with significant morbidity and mortality.  HPV morbidity is related to 
the chronic potential recurrence of genital warts, the psychological experience of stigma related 
to HPV diagnosis, and fear of cancer associated with HPV related cervical dysplasia.  While 
HPV mortality has decreased among developed countries utilizing secondary prevention, lives 
saved could be greater with increased awareness and acceptance of HPV primary prevention 
(vaccination).  Currently there is an underutilization of available HPV primary prevention 
services.  Identification of superior HPV prevention education programs to decrease morbidity 
and mortality from HPV is necessary for the continued health and quality of life of our 
population.  
Social Significance 
 Socially the video-based HPV educational intervention has the potential for changing 
normative views about HPV among the study population.  In addition, the evaluation of best 
11 
 
practice for HPV education delivery could positively impact health care delivery practices. 
Improved education regarding HPV has the potential to contribute to decreasing HPV morbidity 
and mortality, especially in the rural state of WV where risk factors for HPV and prevalence 
rates are relatively high.  Therefore, this study sought to provide evidence to support policy 
decisions regarding funding to support HPV educational programs that facilitate HPV primary 
prevention vaccination, as well as, informing policy decisions to support funding that would 
remove the barrier of cost associated with access to vaccination for this age group. 
Major Constituents of the Study 
Statement of Purpose 
The purpose of this research was to evaluate changes in knowledge, beliefs, and 
behaviors following an HPV educational intervention among rural women 18-26 years old.   It 
was hypothesized that video-based first account stories of persons diagnosed with HPV and clear 
messages about prevention and treatment measures are more powerful educational tools for 
increasing patients’ perceptions of susceptibility and severity of HPV than written information 
alone (Rosen et al., 2010; Waller, Marlow, & Wardle, 2007).  By increasing perceived 
susceptibility and severity of HPV among the study population, there will be increased 
knowledge of HPV, decreased HPV stigma, increased perceived benefits to prevention, and 
decreased perceived barriers to prevention, resulting in increased intention toward HPV 
vaccination uptake.   
The decision to use a video-based educational medium along with written material in the 
intervention group was made as a way to increase learner engagement in the material.   Based on 
previous literature, written material alone might not be sufficient to change health beliefs (Rosen 
et al., 2010; Waller et al., 2007).  Story telling has previously been used in health education of 
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patients as a means of increasing the patients’ engagement in the material being presented 
(Comas-Diaz, 2012).  By augmenting the written information with the addition of video-based 
stories the learner will be engaged both visually and auditorily with the information presented in 
a way that will increase learning.  In addition, the decision to use video-based first account 
stories from persons diagnosed with HPV was made on the basis that the information might be 
more meaningful when received from persons with similar backgrounds as the patients receiving 
the education.  This could be construed as using a form of “cultural brokerage” (the use of 
culturally competent strategies to reach patients) (Alexander, Uz, Hinton, Williams, & Jones, 
2008).  In this instance, patients were believed to be more open to hearing about the disease from 
women like themselves who have had the disease.      
Ultimately, the increased engagement in the educational material was designed to foster 
increased perceived susceptibility and severity of HPV among the study population.  In addition, 
there will be increased knowledge of HPV, decreased HPV stigma, increased perceived benefits 
to prevention, and decreased perceived barriers to prevention, resulting in increased HPV 
primary prevention (vaccination) utilization behaviors.   
Research Question 
1. How effective is a video-based HPV prevention education intervention compared to 
written HPV educational material at improving women's knowledge, beliefs, and 
behaviors regarding HPV prevention? 
 
Hypothesis:  The video-based HPV prevention education intervention will be superior to 
the written material at improving women’s knowledge, beliefs, and behaviors regarding 
HPV prevention. 
 
Sub-questions: 
i. How effective is a video-based HPV prevention education intervention 
compared to written HPV educational material at improving women’s 
knowledge of HPV? 
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Hypothesis: The video-based HPV prevention education intervention will 
be more effective than the written HPV educational material at improving 
women’s knowledge of HPV. 
 
ii. How effective is a video-based HPV prevention education intervention 
compared to written HPV educational material at improving health belief 
model (HBM) constructs (perceived susceptibility, perceived severity, 
perceived benefit, perceived barriers) regarding HPV prevention among 
women? 
 
Hypothesis:  The video-based HPV prevention education intervention will 
be more effective than written HPV educational material at improving 
HBM constructs (perceived susceptibility, perceived severity, perceived 
benefit, perceived barriers) regarding HPV prevention among women. 
 
iii. How effective is a video-based HPV prevention education intervention 
compared to written HPV educational material at improving women’s 
behaviors regarding HPV primary prevention? 
 
Hypothesis:  The video-based HPV prevention education intervention will 
be more effective than written HPV educational material at improving 
women’s behaviors regarding HPV primary prevention. 
 
iv. How effective is a video-based HPV prevention education intervention at 
decreasing women’s perceived stigma associated with HPV? 
 
Hypothesis:  The video-based HPV prevention education intervention will 
result in decreased perceived stigma among women in this study. 
Definition of Terms 
 There are four HBM constructs to define in this study; perceived susceptibility, perceived 
seriousness, perceived benefit, and perceived barrier.  Perceived susceptibility is the likelihood 
that participants will understand the prevalence of HPV and will believe themselves to be 
susceptible to the disease.  Perceived severity is the likelihood that participants will believe HPV 
to be personally life threatening if they contract the disease.  Perceived benefit is the net positive 
effect participants will believe the HPV vaccine will have on protecting them from HPV.  
Perceived barriers are any obstacles participants believe will impede their access to the HPV 
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vaccine.  Additionally, a fifth term, "cue to action", is defined as either an intrinsic or extrinsic 
motivator to change participants' health beliefs.  In this study, “cue to action” refers to the 
educational intervention. However, other “cues to action” are also assessed as part of the study 
instrument sub-scale titled cues to action.  Lastly, the term HPV behavior is defined as 
participants’ intentions toward acceptance of the HPV vaccine at follow-up. 
 Additional term definitions include, video based HPV prevention education intervention, 
defined as video first account stories of persons diagnosed with HPV and factual information 
about HPV; written HPV material, defined as a written paper educational handout; HPV 
knowledge, defined as awareness or understanding of HPV, that can be gained through personal 
experience or association; and perceived stigma, defined as a stereotypical designation based on 
a socially undesirable attribute. 
Method of Study 
 The method of study was a quasi-experimental intervention study using pre-test/post-test 
design with delayed intervention treatment administered to the control group at study 
completion.  Women who presented for care at several family planning clinic sites in southern 
WV were recruited. The clinics had similar patient demographics, and provided women’s health 
care services through the family planning program, WV Breast and Cervical Cancer Screening 
program (BCCSP), and private insurance.  Patients from half the clinics were assigned to the 
control group who received the written HPV educational material only, while the other half of 
the clinics were assigned to the intervention group and received the video-based oral educational 
intervention and written HPV educational material.  Care was taken to avoid spill over between 
clinics by separating the control and intervention clinic assignments geographically within the 
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region.  Additional participants were recruited on line. Online participants were randomized to 
either the intervention or control group. 
 After consent, both groups of women were given pre-tests (instrument is described in 
Chapter 3) to assess demographics, HPV knowledge, stigma, health belief model constructs, and 
behaviors toward HPV prevention.  Following pre-tests, all participants were given a written 
HPV educational handout.  The intervention participants also watched a short video, which 
contained a first account story of a woman diagnosed with HPV.  The video also provided a 
segment of factual HPV and HPV vaccine information.  Information in the DVD was specifically 
directed toward changing patient perceptions of the health belief model constructs.  All 
participants were then encouraged to get the HPV vaccine.  Patients requesting the vaccine who 
were uninsured or could not afford the vaccine were provided the Merck Patient Assistance 
Program Application to seek coverage for the vaccine.  At follow-up visits scheduled two month 
after the initial assessment, participants in both groups took a post-test measuring the same 
variables as the pre-test including a question regarding intention to get the HPV vaccine (but 
excluding demographics).  Chart audits were conducted at six months post-enrollment in the 
study to determine the extent that participants completed the HPV vaccine series. 
Theoretical Underpinnings 
 Rosenstock (1966) described the Health Belief Model (HBM) as a theoretical framework 
to understand why people adopted preventive health measures (Figure 1).  The model consists of 
four constructs (perceived susceptibility, perceived seriousness, perceived benefit, and perceived 
barriers) to predict how people will behave toward preventive health care (Carpenter, 2010).  
Assumptions of the model are: 1) the stronger people perceived susceptibility and perceived 
seriousness of illness, the stronger their behavior toward prevention, 2) the stronger their 
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perceived benefit and the weaker their perceived barrier, the stronger their behavior toward 
prevention (Carpenter, 2010).  Another component of the model is the "cue to action" prompting 
people to change their health beliefs.  "Cues to action" can be extrinsic (health education 
activities) or intrinsic (decreasing health status).  To date little is known about which cues to 
action are most pertinent to people's health beliefs (Carpenter, 2010).  Previous HPV studies 
used written educational material as the "cue to action" (Bynum et al., 2011; Gerend & 
Shepherd, 2007; Juraskova, Bari et al., 2011; Mishra, 2011).  In this study, the "cue to action" is 
a video-based first account of persons diagnosed with HPV and cervical cancer survivor stories, 
along with factual HPV and HPV vaccine information, designed to change participants perceived 
susceptibility, perceived seriousness, perceived benefit, and perceived barriers to prevention.  As 
written educational handouts alone will be administered to the control group, comparisons can be 
made about the most effective "cue to action" regarding HPV prevention following this study. 
 Strengths of the HBM include the substantial evidence in the literature demonstrating the 
model’s use among various populations and disease states (Cummings, Jette, & Rosenstock, 
1978).  While originally constructed as a way to predict a person’s desire to avoid disease, the 
model has also been used to evaluate general health motivations in the absence of disease, and 
even beliefs and behaviors associated with the sick-role (Becker & Maiman, 1975).  
Additionally, the model has demonstrated reliability in measuring health beliefs (Maiman et al., 
1977), and psychometric validity of Likert and multiple choice techniques for measuring the 
model constructs (Cummings et al., 1978).  Despite the different ways in which constructs have 
been operationalized in study questionnaires the model has remained predictive, which is a 
testament to the strength of the model variables (Becker & Maiman, 1975).  
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 Weaknesses of the model include having greater utility in prospective studies as opposed 
to retrospective study designs (Janz & Becker, 1984).  In addition, as a psychosocial model the 
HBM can only assess an individual’s behavior as the behavior relates to current attitudes and 
beliefs.  Janz and Becker also point out that the premise of the model is that health is valued by 
individuals and there are multiple cues to action.  The authors maintain that unless studies take 
into account cues to action and other moderator variables, like behaviors that are habitual rather 
than cognitive, and economic and environmental barriers to such action, then the model may not 
be as good at explaining and predicting behaviors.  Additional weaknesses of the model have 
been the tendency for studies to operationalize the model constructs in different ways.  While the 
model has remained predictive despite these variances, developing standardized tools to measure 
the model constructs so that comparisons could be made more easily across studies would be 
important (Janz & Becker).  Lastly, there is a need to assess the model’s predictive value over 
time, with the need for additional long-term studies utilizing the HBM (Becker & Maiman, 
1975). 
 Early research of the model suggests the perceived barriers construct is the most 
predictive of behaviors, and therefore should receive special attention when operationalizing the 
construct.  Aspects to consider when operationalizing the construct of perceived barriers are the 
social influences and self-efficacy toward behavior change, as both have been shown to be 
important components of this construct (Becker & Maiman, 1975; Janz & Becker, 1984).   While 
the model can be predictive when only one or two models constructs are assessed, the model has 
been found to be most predictive when the joint influence of the entire model constructs are 
assessed together (Becker & Maiman, 1975).   
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Summary 
 In summary, HPV is the most common STI in the US, and has serious health 
consequences for those infected.  The morbidity and mortality associated with the disease can be 
decreased with increasing utilization of available HPV prevention through vaccination.  
Addressing the most effective education ("cues to action") to facilitate HPV prevention uptake 
among the population is important to nursing practice.  This study evaluated the effectiveness of 
a video-based "cue to action" upon participant’s knowledge, beliefs, and intended behavior 
toward HPV prevention. 
 
Figure 1. 
Health Belief Model 
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Chapter 2 
This chapter will synthesize the existing literature evaluating changes in knowledge, 
beliefs, and behaviors associated with HPV.  Any studies addressing HPV knowledge, beliefs, 
and behaviors in relation to HPV participant vaccination are included in this review, with special 
attention given to those evaluating HPV educational interventions designed to increase 
participant vaccination rates.  Emphasis is placed on the relevance of findings to future research 
designed to change HPV knowledge, beliefs, and behaviors of women.  Conclusions were drawn 
to inform the design, population choice, and intervention type chosen for the proposed study.    
Literature Search Process 
A systematic search of health science databases (Academic Search Premier, Women's 
Health International, CINAHL, MEDLINE, and PubMED) was performed.  Keywords of HPV, 
knowledge, beliefs, behaviors, education, information, stigma, shame, prevention and 
intervention were used to identify the state of the science in current research surrounding HPV 
prevention behaviors.  A total of 4,906 articles were found on the initial search.  Limits were 
then placed for English language, scholarly peer reviewed research studies, interventions aimed 
at female participants’ ages 13-64 years old and published since 1999.  This year was selected as 
a starting point for this search because the most recent Cochrane Review (Shepherd, Frampton, 
& Harris, 2011) indicated there were no educational intervention studies reported in the literature 
prior to 1999.   
After limits were applied, a total of 570 abstracts were reviewed for any studies 
evaluating changes in participants’ HPV knowledge, beliefs, or behaviors.  Several studies were 
found evaluating HPV knowledge, beliefs, and behaviors, but relatively few studies (i.e. 
seventeen) included an educational intervention to promote HPV vaccination among women 
(Table 1).  Because of the paucity of educational intervention studies, the decision was made to 
20 
 
include any studies discussing HPV knowledge, beliefs, and behaviors in relation to HPV 
vaccination (Table 2 & 3).  The inclusion of these studies provides additional background for the 
proposed study constructs, with the discussion of educational intervention studies illuminating 
gaps in the intervention literature that are addressed in the current study (Table 1).   
While limits were set for studies of female gender, several recent studies were found to 
include men among the female population.  Studies containing both men and women were 
included in this review if the researchers specified results pertaining to women participants.  A 
total of 74 studies were synthesized to draw conclusions about HPV knowledge and beliefs, the 
educational needs of women, and the types of educational interventions found to be effective at 
increasing HPV prevention behavior, specifically vaccination.   
Literature Review 
Prior to Federal Drug Administration’s release of the HPV vaccine there were relatively 
few studies evaluating participants’ HPV knowledge, beliefs, and behaviors.  However, since the 
introduction of the HPV vaccination, greater emphasis has been placed on studying participants’ 
knowledge and beliefs surrounding HPV, HPV prevention intentions, and actual HPV prevention 
behaviors.  This review will describe the research related to knowledge, beliefs, and behaviors 
associated with HPV, including a discussion of the educational interventions that have been used 
to promote HPV vaccination among women. 
Knowledge 
Knowledge can be described as the awareness or understanding of something, that can be 
gained through personal experience or association (Merriam Webster’s Collegiate Dictionary, 
2004).  There have been several efforts to measure HPV knowledge in the last twelve years, with 
studies utilizing both qualitative and quantitative methods to describe levels of HPV knowledge 
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among participants.  The most common qualitative methods used have been phenomenology, 
content analysis, constant comparative analysis, and framework analysis with both individual 
interviews and focus groups.  Most qualitative studies have evaluated HPV knowledge among 
female participants, who ranged in age between 14-83 years old (Table 2), while a few have 
evaluated HPV knowledge among men and women (Bertram & Niederhauser, 2008; Friedman & 
Shepeard, 2007; Sandfort & Pleasant, 2009).   
Quantitative studies have included descriptive, correlational, experimental, and quasi-
experimental designs, and have measured HPV knowledge with a variety of measurement 
instruments, many of which were developed by the study authors to meet the purposes of the 
particular study.  While similar knowledge questions are used in all study instruments, none of 
the studies utilized the same instrument more than once among different populations as a way of 
increasing instrument psychometric data.  
Regardless of study methodology or population addressed, each study invariably 
identified deficiencies in HPV knowledge (Table 2 & Table 3).  The most frequent knowledge 
deficits identified are associated with modes of transmission, prevalence, relationship of HPV to 
cancer, and lack of knowledge regarding prevention methods.  While some study participants 
had heard of HPV, others reported never hearing of HPV.  This was true even for participants 
who had regular contact with health care providers.  For example, many studies showed women 
had good attendance for pap screenings, but still had a lack of HPV knowledge (Fry, Ferries-
Rowe, Learman, & Haas, 2010; Kahn et al., 2005; Waller et al., 2009; Warren, 2010).  
Continued lack of HPV knowledge among women with regular health care provider contact 
appears to be related to a lack of provision of HPV education by health care providers (Bayer et 
al., 2011).  Despite the deficiencies in HPV knowledge among those having regular contact with 
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health care providers, these participants were more knowledgeable than those not having regular 
health care provider access (Mills, Vanderpool, & Crosby, 2011).   
Significant consequences have been reported in the literature in relation to participant 
lack of HPV knowledge.  For instance, lack of HPV knowledge has been identified as negatively 
impacting HPV beliefs and intentions toward HPV prevention behaviors.  Participants with less 
HPV knowledge were reported to be more likely to believe HPV is a stigmatizing illness, related 
to promiscuous and morally corrupt behavior by those afflicted (Bertram & Magnussen 2008, 
Daley et al. 2008, Daley et al. 2010; Friedman & Shepeard 2007; Perrin et al., 2006).  In 
connection with this finding, participants who were subsequently diagnosed with HPV 
themselves were more likely to experience stigma, shame, and anxiety over the diagnosis (Kahn 
et al., 2005; Perrin et al., 2006).  Participants were also less likely to report intentions toward 
partner notification, and expressed a lack of social support related to internal and external 
experiences of stigma when disclosing their diagnosis to family and friends (Perrin et al., 2006).  
These negative perceptions of HPV as being a disease that only afflicts those who are sexually 
promiscuous can be corrected with increasing knowledge of HPV prevalence among the general 
population.  Subsequently, understanding the prevalence of HPV can also have a positive impact 
upon participants’ knowledge and beliefs toward HPV vaccination as a prevention measure.    
Beliefs 
Attainment of new health knowledge can inform health beliefs, which are described as 
the personal convictions that function to motivate an individual’s health behaviors (Mosby’s 
Medical Dictionary, 2008).  Health beliefs can be impacted by both internal and external forces 
and are likely to change over time as persons are exposed to new concepts regarding health and 
illness (Kidwell & Jewell, 2003).  Aside from perceived stigma associated with HPV, the most 
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commonly measured beliefs in the HPV literature were associated with HBM constructs of 
perceived susceptibility, perceived severity, perceived benefits, and perceived barriers.  
 To date perceived stigma associated with HPV has only been described in the qualitative 
literature.  HPV stigma beliefs are complex concepts with social and cultural dimensions, 
encompassing feelings of shame, guilt, and impropriety in relation to perceived acts of deviant 
social behavior (McCaffery & Irwig, 2005).  Perceived stigma in the qualitative literature 
appears to be associated with a lack of HPV knowledge.  Those participants with increased 
knowledge of HPV prevalence seemed to describe less perceived stigma associated with HPV, 
while those who only associated HPV with sexually transmitted disease information perceived 
more stigma associated with the disease (McCaffery & Irwig, 2005). 
Other qualitative studies also support this finding, having documented the perception of 
stigma associated with HPV among participants with low levels of factual HPV knowledge 
(Bertram & Magnussen, 2008; Brown et al., 2007; Daley et al., 2008; Daley et al., 2010; Kahn et 
al., 2005; McCree et al., 2006; Perrin et al., 2006).  Most found stigmatization was decreased 
with increasing knowledge of prevalence of the disease among the general population (Perrin et 
al., 2006; Friedman & Shepeard, 2007; Bertram & Magnussen, 2008; Daley et al., 2010).  There 
was also a strong preference among most study participants to receive HPV information from 
health care personnel in a caring atmosphere.  This was described as causing less perceived 
stigma associated with the disease among study participants (McCaffery & Irwig, 2005; McCree 
et al., 2006; Perrin et al., 2006; Brown et al., 2007; Friedman & Shepeard, 2007; Bertram & 
Magnussen, 2008).   
No quantitative studies have been identified that have yet measured perceived stigma in 
association with HPV.  Among the quantitative literature, the beliefs most commonly measured 
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were associated with the HBM constructs of perceived susceptibility, perceived severity, 
perceived benefits, and perceived barriers, with a few studies measuring beliefs associated with 
moral norms, social norms, behavior control, and attitudes.  These constructs were associated 
with the use of other less commonly used theoretical models (Theory of Reasoned Action, Social 
Cognitive Theory, Theory of Planned Behavior) (Table 3). 
Studies using the HBM have restricted measurement of health beliefs to include only part 
of the HBM constructs (Table 3).  Many studies only included perceived susceptibility and 
severity, which have been described as weaker than perceived benefits and barriers, and weaker 
still than the HBM as a whole in predicting changes in prevention behaviors (Carpenter, 2010; 
Harrison, Mullen, & Green, 1992).  Additionally, researchers have suggested that future HBM 
research include moderator variables (like “cues to action”) in addition to the four traditional 
model constructs (Carpenter, 2010).  Currently, only two HPV studies demonstrated the use of 
all four HBM constructs and the moderator variable of “cues to action” (Bynum et al., 2011; 
Juraskova, Bari et al., 2011).  While Carpenter’s meta-analysis suggest perceived susceptibility 
and severity are weaker health belief measures for predicting behavioral outcomes, some HPV 
studies utilizing perceived susceptibility and severity found them to be positive predictors of 
HPV intentions and behaviors (Table 3).   
Behaviors 
Behaviors are described as the actions manifested by persons in relation to some type of 
stimuli (Merriam-Webster’s Collegiate Dictionary, 2004).  Health behavior changes are related 
to changes in knowledge and beliefs associated with disease and disease prevention, and are 
often reflected in a person’s intentions toward behavior change.  However, intentions toward 
change alone are not entirely predictive of prevention behavior, therefore, whenever possible a 
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recommendation is to evaluate actual behavior rather than intentions toward behavior alone 
(Mills et al., 2011).  A weakness of many of the studies in this review was the fact that studies 
only measured HPV prevention intentions, with few studies actually measuring HPV prevention 
behaviors, and those who did assess behaviors did so through participant self-report, rather than 
more rigorous methods (chart review) (Table 2 & Table 3). 
In general, most of the reviewed HPV research studies supported some relationship 
between increasing HPV knowledge and prevention intentions and behaviors (Mills et al., 2011;  
Juraskova, Bari et al., 2011; Mock et al., 2007; Patel et al., 2012), however, one study 
demonstrated no link between intentions and behaviors following educational intervention 
(Juraskova, O'brien et al., 2011).  The researchers believed that even though intentions were high 
among participants, unidentified barriers to vaccination were possible moderators of actual 
vaccine behaviors.  Perceiving this to be true, Mills et al. (2011) removed the barrier of vaccine 
cost by providing vaccinations for free, and subsequently showed that intentions were related to 
behaviors when the barrier of cost was removed.  This is contrary to other studies, where no 
association was found between cost and behavior (Juraskova, Bari et al., 2011; Patel et al., 
2012).  As most studies did not assess perceived barriers, drawing conclusions is difficult 
regarding the impact perceived barriers may have on actual HPV prevention behaviors. 
In addition, aside from the barrier of cost, concerns over vaccine safety (Juraskova, Bari 
et al., 2011) and access to vaccination clinics might present real barriers to actual vaccine 
behaviors following education interventions (Mills et al., 2011).  Studies also show a connection 
between behaviors and moderators of vaccine barriers (Jurasokova, Bari et al., 2011; Mills et al., 
2011; Patel et al., 2012).  Examples of moderators of behavior include prevention 
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recommendation by health care providers, prevention education interventions, and financial 
support for prevention access.   
Most studies were among urban populations, with few targeting low-income 
disadvantaged rural populations who are disproportionately impacted by HPV and cervical 
cancer.  The universally low levels of HPV knowledge highlights the need for more intervention 
research aimed at increasing women’s knowledge of HPV and HPV vaccination.  A gap exists in 
the literature for assessing the efficacy of different types of theoretically grounded HPV 
educational material on women’s HPV knowledge and prevention intentions.   
Theoretical Frameworks Used 
There is a lack of theoretical grounding among the HPV literature reviewed.  In fact, few 
(17out of 69) studies utilized a theoretical framework as part of the study design.  Of the 
theoretical frameworks utilized, the HBM (10) was the most frequently cited in the HPV 
literature (Table 2 & Table 3).  Of the studies using the HBM, only four evaluated the 
effectiveness of an educational intervention in changing women’s health beliefs toward HPV 
prevention (Gerend & Shepherd, 2007; Gottvall, Tyden, Hodlund, & Larsson, 2010; Juraskova, 
Bari et al., 2011; Marlow, Waller, & Wardle, 2009).  Three of the four evaluated a connection 
between changing health beliefs and prevention “intentions”, and one theoretically grounded 
study evaluated connections between changing health beliefs and actual HPV prevention 
behaviors (Juraskova, Bari et al., 2011).   
Educational Interventions as “Cues to Action” 
There were a total of twenty-five educational intervention studies to promote HPV 
prevention behaviors found in the HPV literature.  Among these, three addressed an educational 
intervention toward adolescents, with another eleven studies specifically targeting women (Table 
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1).  Another six studies were found addressing college students, including both men and women 
(included in Table 1).  Studies specifically directing educational intervention programs toward 
women alone included women ages 14 and older, with most studies targeting women 18-26 years 
old.  Types of educational interventions used were written paper fact sheets or brochures (8), 
web delivered fact sheets (4), vaccine information videos (2), DVD of written power point 
information (1), face-to-face (5), and face-to-face augmented with written material (5).  One of 
the face-to-face interventions was indirectly related to increasing women's knowledge by 
educating the physicians at the gynecology clinic regarding the importance of educating women 
at the time of their annual appointment regarding pap testing.  While the educational intervention 
was targeted at physicians, the outcome measures of pap smear knowledge were assessed via the 
women attending the clinic (Fry et al., 2010).  Another face-to-face/media augmented 
educational intervention utilized peer lay educators to deliver the content (Mock et al., 2007).  
Most educational intervention studies relied on immediate post-test measures as follow-up of 
knowledge retention and changes in health beliefs.  Only three studies utilized a longer follow-up 
period to assess changes in HPV knowledge, beliefs, and behaviors.  One of these utilized a one 
month follow-up (Doherty & Low, 2008), and two utilized a six-month follow-up (Juraskova, 
Bari et al., 2011; Patel et al., 2012). 
While the majority of studies showed that educational interventions can increase 
prevention intentions (Crosby, Rager, Hanson, & Ribes, 2008; Fry et al., 2010; Juraskova, Bari 
et al., 2011; Kahn et al., 2005; Kwan et al., 2010; Mock et al., 2007; Papa, Moore-Simas, 
Reynolds, & Melnitsky, 2009), one study showed no change in prevention intentions after 
receiving the educational intervention (Patel et al., 2012), and another study showed less 
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participant self-intention to get vaccinated, but higher intentions to get the vaccine for their 
children following an educational intervention (Ferris, Waller, Owen, & Smith, 2007).   
While all studies measuring HPV knowledge showed an increase post-intervention in 
knowledge scores, some studies noted knowledge increases were not sufficient following written 
educational interventions alone (Rosen et al., 2010; Waller et al., 2007).  Few studies have 
evaluated the long-term gains in HPV knowledge and beliefs following an educational 
intervention, and the subsequent impact on changes in HPV prevention behaviors (Doherty & 
Low, 2008; Juraskova, Bari et al., 2011; Patel et al., 2012). 
Gaps in the Literature for Future Research 
Information from health care providers is cited in the literature as trustworthy and 
preferred by women (Bertram & Magnussen, 2008; Brown et al., 2007; Friedman & Shepeard, 
2007; McCree et al., 2006; Perrin et al., 2006), and regular contact with health care personnel 
during annual pap testing is a good opportunity to increase knowledge and decrease adverse 
emotional responses to subsequent diagnosis of HPV (Waller et al. 2009).  However, researchers 
have shown that women are often not afforded educational information about HPV nor the 
purpose of pap testing during routine annual well-woman exams with clinicians (Cermak et al., 
2010; Waller et al., 2009).  Reasons for this are complex and might involve clinician lack of 
awareness of patient information needs, lack of adequate educational tools, and lack of clinician 
time to provide adequate oral review of HPV and pap information.  To address these needs, the 
current study tested the effectiveness of an educational packet designed for administration during 
well-woman exams.  The educational packet included both a video delivered oral presentation 
and written information.  Based on the findings, the educational packet could afford clinicians 
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with an effective, time-saving tool to address the educational needs of their female patients who 
present for health care visits. 
As a result of this review, educational initiatives not based on theoretical principles may 
not be as effective at changing health beliefs toward prevention as those with a strong theoretical 
basis.  In addition, using a strong theoretical framework provides guidance for measurement 
outcomes that might be compared across studies in the future.  Having uniform, theoretically 
grounded intervention tools and outcome measures will contribute to nursing knowledge by 
generating research that is suitable for comparative effectiveness studies in the future.  Currently, 
there are no comparative effectiveness studies evaluating HPV educational interventions across 
patient populations.    
Only one HPV educational intervention study exists evaluating all HBM constructs to 
predict participant health beliefs and behaviors (Juraskova, Bari, et al. 2011).  Results of this 
study were promising, and included all model constructs in outcome measures.  However, the 
authors failed to design the actual educational intervention materials around the model 
constructs.  Therefore, the educational intervention may not have adequately impacted behavior 
change outcomes, making it difficult to show a direct cause and effect connection between the 
educational intervention offered and the outcomes measured. 
To address this lack, the current study proposed to develop a novel educational packet 
including video first account stories of persons diagnosed with HPV and written HPV 
educational material, which can easily be administered to patients at the time of well-woman 
exam visits.  The proposed educational packet will be based on theoretical principles of the HBM 
intended to positively influence participant health beliefs toward HPV prevention behaviors 
(specifically vaccination).  Outcome measures of the study will include HPV knowledge, beliefs, 
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and behaviors.  To assess the effectiveness of the educational packet on behaviors, efforts were 
taken to remove barriers that might prevent access to HPV vaccination.  
Summary 
 The literature demonstrates a lack of HPV knowledge and transmission of evidence based 
HPV information among the general population.  This lack of knowledge has adverse 
psychological and physical consequences for those at risk of contracting HPV, as at risk persons 
with lower HPV knowledge are less likely to utilize available primary prevention HPV 
vaccination services.  The proposed educational program will address participant HPV 
knowledge and beliefs in an effort to increase participant HPV prevention behaviors. 
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Table 1:  Educational intervention studies among adult women (number of studies = 17) 
Author Design Theoretical 
Underpinnings 
Intervention Type Measures Findings 
Chang et al. 
2013 
Quantitative 
Quasi-
Experimental 
 
Immediate post-
test follow-up 
None Face-to-Face lecture 
based educational 
seminar 
• HPV Knowledge 
• Vaccine intention 
• Low pre-intervention HPV knowledge 
• Knowledge increased post-intervention 
• Increased intention toward vaccination post-test 
Kester, 
Shed-Steele, 
Dotson-
Roberts, 
Smith, & 
Zimet 
 
 2013 
Quantitative 
 
Quasi 
Experimental 
 
Immediate post-
test of 
intervention 
group  
None Face-to-Face 10 minute 
group education session 
for intervention group 
only 
• HPV Knowledge 
• Vaccine Intention 
• Vaccine History 
• 62% of the seventy four individuals whose health care provider 
mentioned HPV vaccine had received the vaccine, whereas only 3% 
initiated vaccination without health care provider recommendation. 
• Intervention group had higher HPV knowledge scores 
• 38% had already had the HPV vaccine with 19% completion of the 
series. 
• Of those not already having the vaccine, the intervention group was 
more likely to have intentions toward vaccination (86%) than the 
control group (57%) (OR=2.09;95%CI = 1.02-9.36; p<0.05) 
Vanderpool 
et al.  
2013 
Quantitative 
Quasi 
Experimental 
Theory of Planned 
Behavior (TBP) 
and Information 
motivation 
behavioral skills 
model (IMB) 
Framework 
13 minute Video 
developed based on 
IMD Framework to 
promote completion of 
3 dose series 
• HPV attitudes 
• Subjective norms 
• Perceived behavioral 
control 
• Vaccine intentions 
• Vaccine behaviors 
• Increased intention for series completion predicted increased behavior 
for series completion 
Krawczyk et 
al. 2012 
Quantitative 
Experimental 
 
 Immediate post-
test follow-up 
HBM 3 groups: 
• Written HPV 
information 
• Video HPV 
information 
• Control 
• Vaccine Intention 
• HPV  and vaccine 
knowledge and awareness 
• Pre-intervention scores modest and intention to vaccination low 
• Both written and video group had higher knowledge than control group 
at pre and post intervention testing 
• Both written and video group had increased intentions to vaccinate 
post-test than did controls 
• No difference between type of educational material 
Patel et al. 
2012 
Quantitative 
 
Experimental 
 
6 month follow-
up 
 
 
TPB Fact Sheet and mailed 
Vaccination Reminder 
Card to Intervention 
Group 
• HPV Knowledge 
• Vaccine Intentions 
• Vaccine Behaviors 
• Baseline intentions to get vaccinated = 41% 
• Baseline no intentions to get vaccinated = 31.3% 
• Reasons for intentions to get vaccinated: worry over CC (65.7%), worry 
over genital warts (48.6%), physician recommendation (40%) 
• Reasons for no intentions to get vaccinated: safety concerns (48.8%), 
side effects (48.8%), cost (41.3%), long-term consequences (40.0%), 
not being at risk for HPV (28.8%) 
• HPV knowledge not correlated with vaccine intentions 
• Intervention was associated with vaccine behavior (5.5% had 1 dose of 
vaccine at 6 month follow-up) 
• Intentions associated with behavior (those with intentions to vaccine 
more likely to get vaccinated) 
• Cost and sexual risk taking not associated with intentions but not 
behavior 
Gerend & 
Shepherd. 
2011 
Quantitative 
 
Quasi-
Experimental 
None Vaccine Video • HPV Knowledge 
• Health Beliefs (perceived 
barriers) 
• Vaccine Attitudes 
• Low initial HPV knowledge despite most hearing of HPV before 
• Gain frame or Loss Frame video had no effect on intentions to get 
vaccinated 
• 27% had intentions to get vaccinated post-intervention 
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Immediate Post-
Test and 2 month 
Follow-up 
• Vaccine Intentions • 30% had no intentions 
• 44% undecided 
• Perceived barriers to vaccine = safety (26%), cost (17%), fear of shots 
(11%), no need (9%), and no access (6%) 
• Safety and low need were mentioned more often among non-intenders, 
other barriers mentioned more often among intenders 
Juraskova, 
Bari et al. 
2011 
Quantitative 
 
Experimental 
 
6 Month Follow-
up 
HBM  2 educational fact 
sheets 
 
Leaflet 1: Cervical    
      Cancer (CC)  
      information 
Leaflet 2: CC and  
      Genital Wart (GW)  
      information 
 
(delivered via 
computer) 
 
• HPV Knowledge 
• Perceived Severity 
• Perceived Susceptibility 
• Perceived Barriers 
• Perceived Benefits 
• Cues to Action 
• Vaccine Intentions 
• Vaccine Behaviors 
• ↓ HPV Knowledge pre-test [only 55% had heard of HPV, no group 
differences in pre-test knowledge (x21=1.12; p<0.05)] 
• Intentions ↑ post-intervention (n=73, 37% had received the vaccine 
post-intervention, and 76% reported sought information with intention 
to receive vaccine)  
• Intentions to get vaccine predictor of behavior to get vaccine post-
intervention (odds ratio [OR], 2.07; p=0.23; 95% confidence interval 
[CI], 1.11-3.89) 
• Intentions to get vaccine predictor of information seeking behavior 
post-intervention 
• CC+GW group (44%) more likely to get vaccine than CC only group 
(32%) 
• Perceived barriers and Perceived benefits were the greatest predictors of 
vaccine intentions (p<0.05) 
• Barriers = side effect concerns, access, pain, cost, multiple injections 
• Note: vaccine provided free to this population, but cost was cited as 
barrier if they would have to pay for it 
• Measured Actual Behaviors at 2 month follow up 
Juraskova, 
O’brien et 
al. 
 
2011 
Quantitative 
Experimental 
 
2 month follow-
up 
TPB and moral 
norm constructs 
2 different Fact Sheets 
• One on HPV, 
cervical cancer 
• One on HPV, 
cervical cancer, 
genital warts 
 
(delivered via 
computer) 
• Attitudes 
• Normative Beliefs 
• Perceived Behavior 
Control 
• Intention 
• Moral Norms 
• Behavior 
• Intentions, perceived behavior control, and moral norms were predictors 
of behavior (could be used to classify 67.1% of cases (x2=12.475; 
p=0.029) 
• Model (TPB) predicted 54% of variance in intention to get vaccination 
(R2=0.54 F3,155=61.580, p< 0.001) 
• Intention predicted 9.6% of variance in behavior (x2=7.355; p=0.007) 
Mills et al. 
2011 
Quantitative 
 
Experimental 
None Brochure 
Free Vaccine Voucher 
• Sexual Behaviors 
• Vaccine Behaviors 
• Focus was on removing barrier of cost for vaccine to determine 
likelihood of vaccination 
• Clinic participants more likely than college participants to get 
vaccinated (measured vaccine behavior through voucher receipts for 
shots given) 
• Clinic population using condoms or oral contraceptive were more likely 
to get vaccinated (p=0.0009) and (p=0.010) respectively 
• College women using IUD were more likely to get vaccinated (p=0.30) 
• Those having previous pap test more likely to get vaccinated (p=0.005) 
• Those with no doctor contact in last 12 months less likely to get 
vaccination (p=0.036) 
• Those with hx of abnormal pap were less likely to get vaccination 
(p=0.001) 
• Those participating in mutual masturbation less likely to get vaccination 
(p=0.006) 
Stock, Quantitative None Fact Sheet • HPV Knowledge • Intervention ↑ knowledge, and perceived risk to HPV [F(1,236)=31.62, 
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Peterson, 
Houlihan, & 
Walsh 
 
2012 
 
Experimental 
• Oral Sex Willingness 
• Risk Perception 
• HPV concern 
• Vaccine Intentions 
p<.001 (d=0.78; Ms=0.69 vs. 0.49] 
• Intervention ↓ intention to oral sex among women [F(1,130)=6.47, 
p>.02 (d=0.50)] 
• Men expressed ↑ likelihood to get vaccination after intervention (more 
so than women) [F(1,176)=16.85, p<.001 (d=0.71; Ms= 5.49 vs. 4.36)] 
Warren 
 
2010 
Quantitative 
 
Quasi-
Experimental 
 
2 month post-test 
None Face-to-Face with 
written on HPV 
• HPV Knowledge • ↑ knowledge post-intervention 
• ↓ HPV knowledge at pre-test 
 
Yanikkerem, 
Piyan, 
Kavlak, & 
Karadeniz 
2010 
 
Quantitative 
 
Quasi-
Experimental 
 
None Face-to-face • Sexual behavior 
• HPV knowledge and 
awareness 
• Vaccine Attitudes 
• Vaccine Intentions 
• ↓ HPV knowledge pre-intervention (mean pre-test score was 11.6 (SD 
1.76, range 10-20) 
• ↑ knowledge post-intervention (mean post-test score was 18.8 (SD 1.52, 
range 11-20) (p< 0.001) 
• ↑ positive attitude toward vaccine after intervention (62.4% wanted to 
be vaccinated post intervention) 
Marlow et 
al. 
2009 
Quasi- 
Experimental 
HBM Educational fact sheet • Vaccine Intentions 
• Vaccine Attitudes 
• Beliefs (benefits/barriers) 
• ↑perceived susceptibility = ↑ acceptability of vaccine (p<0.001) 
• ↑perceived benefit = ↑ acceptability of vaccine (p<0.001) 
• ↑ barriers (worry about side effects, afraid of needles) = ↓ acceptability 
of vaccine (p<0.001) 
• Benefits and barriers = strongest predictors of acceptability 
• Culture & religion explained 6% of variance on vaccine acceptability, 
but was not significant (F(6,301)=1.43; < the critical value of 2.13 for 
p=0.05) 
• White, higher socioeconomic had ↑ acceptability over ethnically 
diverse, lower socioeconomic participants (94% vs. 86% OR=2.38, CI: 
1.13-5.05) 
Doherty & 
Low 
2008 
Quantitative 
 
Experimental 
None Fact Sheet 
(delivered via web) 
• HPV Knowledge and 
Attitudes 
• Women had higher knowledge (M=5.03, SD=1.77) vs. Men (M=3.75, 
SD = 2.23; t(117)=-3.35, p<0.05), women (M=12.74, SD=1.61; 
t(117)=-4.02, p<.05) had higher positive attitudes toward vaccine than 
men (M=11.45, SD=1.87), women (M=18.31, SD=3.58)  had higher 
perceived susceptibility to infection on pre-test than men  (M= 15.92, 
SD=2.78; (t(117)=-4.1,p<0.05)  
• ↑ positive attitudes to vaccine post-test for intervention group 
((F(1,116)=3.1, p=0.08) 
• ↑ perceived risk to HPV post-test for intervention group 
(F(1,116)=26.1, p<0.001) 
• ↑ knowledge of HPV post-test for intervention group (F1,116)=71.4, 
p<0.0001) 
• Knowledge maintained at 1 month follow-up 
• Intervention group = clinical improvement, but not significant 
improvement on condom use at one month follow-up (N=78) 
(intervention group M=61.19% vs. control M=49.64%) on self-report of 
condom use post intervention (F(1,15)=0.79, p=0.38) 
Ferris et al. 
2007 
Quantitative 
 
Quasi-
Experimental 
None Pamphlet • HPV Knowledge 
• Vaccine Attitudes 
• Attitudes toward getting self- vaccinated ↓ after intervention (59% pre-
intervention vs. 50.2% post-intervention) (when removing neutral 
response option from analysis this was not as large and increased to 
57% post-intervention)[main reason for not wanting vaccine post-
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Immediate Post-
Test Follow-up 
intervention was report of not being at risk] 
• Attitudes toward getting daughter vaccinated ↑ after intervention 
(65.8% post-intervention, p=0.015, Bowker test of symmetry) 
• Biggest reason for not wanting vaccine for self was monogamy and low 
perceived need (29% and 15% respectively) 
• Attitudes for those undecided on pre-test were more positive after 
intervention 
Gerend et al. 
2007 
Semi-structured 
Interview 
 
Correlational 
HBM Face-to-Face education • Sexual behavior 
• Vaccine Intentions 
• Beliefs (benefits/barriers) 
• Anxiety 
• Approach-Avoidance 
Motivation 
• Intentions to get vaccine generally high (mean = 5.40, SD=0.96) 
• ↑intentions correlated with ↑susceptibility, perceived safety, perceived 
effectiveness, and physician recommendation, and hx of previous HIV 
testing  (F[5,45]=14.169, p<0.001) 
Lambert 
2001 
Quasi-
Experimental 
None Face-to-face education • HPV Knowledge • Lower HPV knowledge pre-test (45% answered correctly pre-test vs. 
79% correctly post-test) 
• PA students’ knowledge > psychology students 
• Knowledge = between gender 
• ↑HPV knowledge at 3 month follow-up 
• Physician assistant (PA) students’ knowledge still > psychology 
students 
• Psychology students had > overall improvement in knowledge (32% to 
70%) vs. PA students’ knowledge increase (60% to 89%) 
↑ = increased, ↓ = decreased  
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Table 2:  
Qualitative HPV knowledge, beliefs, and behaviors studies  
 
Adolescent 
Hilton & Smith 
2011 
United Kingdom 
 
 
N = 87 
 
Female 
 
Ages: 12-18 years 
 
Purposive Sample 
   • 78 were vaccinated against HPV at time of study 
• ↓ HPV knowledge of transmission 
• ½ knew HPV caused CC 
• Although most were vaccinated, they didn’t really 
understand what the vaccine protected against – 
stating mothers made the decision to vaccinate 
• Only ½ aware of pap test for CC 
Scarinci, Barces-
Palacio, & 
Partridge 
 
2007 
Birmingham & 
Anniston Alabama 
N = 28 Latina  
N = 17 Afr. Amer.   
 
Female 
 
Cross-sectional of  
Latina Immigrants 
and African 
American Women 
Qualitative 
 
Focus Groups 
None Brief HPV information 
provided after initial 
discussion of STI 
knowledge 
• Lack of knowledge re: STI transmission among 
Latina; AA women more knowledgeable 
• Most had never heard of HPV 
• After HPV information: AA felt all women at risk, 
whereas Latina felt only those with risk factors 
presented in presentation 
• Both groups willing to accept HPV vaccine 
• Skeptical about vaccine effectiveness, side effects, 
cost 
• Latina had fewer vaccine concerns than AA 
Racktoo & 
Coverdale 
2009 
UK  
Female 
 
Age: 12-13 years 
Qualitative 
Focus Groups 
Framework Analysis 
None None • ↓ HPV knowledge 
• Barrier = fear of vaccine, pain from shot, concern 
over side effects 
• + attitude toward acceptance of vaccine despite 
vaccine concerns  
• Preference for education materials (face-to-face or 
video augmented by written) 
College Students 
Sandfort & 
Pleasant 
2009 
Urban N = 1500  
male and female 
health professions 
college students 
Quantitative   • ↑knowledge overall of HPV 
• ↑knowledge = ↓stigma associated with disease 
• Males = ↑stigma and ↓knowledgeable than females 
• 75% knew HPV was STD, info source TV, friends, 
school, internet 
• Preferred info. source = health care professional 
and internet 
Women 
Author Setting Population Study Design Theory Intervention Findings 
Rosenthal, Dyson, 
Pitts, & Garland 
2012 
Australia 
 
Diverse population 
from women’s health 
and educational 
institutions in the 
country 
 
N = 34 
 
Female 
 
Age: 22-77 yo 
Qualitative 
 
Focus Group 
 
 
None None • Overall knowledge of vaccines assessed with most 
being positive toward vaccines in general 
• More controversy over HPV vaccine in particular 
because of negative association with STI 
• Information needs before getting vaccine included 
more info on side effects, effectiveness, and 
whether pap test were still needed 
• In general women said that if information 
presented the vaccine was safe, effective and was 
doctor recommended they would get the vaccine 
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and give it to their children 
• Nurses in the study felt it was important to educate 
patient more and noted they often have more time 
for this than physicians 
• Nurses also expressed some lack of information re: 
vaccine…needed more info on how long it would 
last, should women who are sexually active still get 
the vaccine, etc. 
Francis et al. 
2011 
South Africa 
 
Clinic 
N = 24 
 
Female 
 
Age: 18-44 years 
Qualitative 
 
Focus Groups 
None None • ↓HPV and CC knowledge 
• Barriers to vaccine (access, concern over side 
effects) 
Short et al. 
2010 
University based 
gynecologic clinic 
N= 38 
 
Female 
 
Age:  27-55 yo 
Mean age 40 yo 
Qualitative 
 
Framework Analysis 
None None • Many had heard of the vaccine, but HPV 
knowledge facts were not always accurate 
• Women felt all women should have access to the 
vaccine 
• Women felt reasons for vaccine were previous 
sexual exposure or future exposure if not in a 
monogamous relationship 
• Barrier to vaccine was cost, access, concern over 
side effects, negative opinions of others, and lack 
of endorsement by physician 
• Women did not see vaccine status as affecting their 
pap smear screening behavior 
Waller et al. 
2009 
Nationally 
representative of 
England, Scotland, 
Wales 
N = 1081  
women 25-64 year   
Quantitative   • ↓ awareness of HPV prior to study, ↓ knowledge 
HPV cancer link 
• large number reported regular pap screening, 
regular screening = less shame/worry than 
rare/never screened  
• Knowledge of HPV as STD =  ↑ anticipated shame 
• General HPV Education on prevalence = ↓shame 
• Women with college education reported less 
shame/worry than those with less formal education 
Daley et al. 
2008 
2010 
Urban 
 
clinic 
N = 52 (qualitative 
phase) N = 154 
(quantitative phase) 
women 18-45 years  
Mixed methods None None • ↑HPV knowledge overall, ↓understanding high-
grade vs. low grade HPV, transmission, effect on 
fertility 
• Internet common source for info 
• Dx = stigma, fear, anxiety, self-blame, 
powerlessness, anger, 
• ↑knowledge = ↑ power/control over Dx 
Bertram & 
Magnussen 
2008 
Urban N = 10 
women 18-35 years  
with Dx abn. pap in 
last 5 years 
Qualitative 
 
Phenomenology 
None None • ↑Stigma associated with STD nature of HPV 
• ↓Knowledge of HPV, misinformation, 
misunderstanding common 
• Like internet info for privacy, but too much STD 
info, hard to find HPV specific info, prefer health 
care provider for info 
Bertram & 
Niederhauser 
Urban N = 492, cross-
sectional, both male 
Quantitative   • Female with ↑ risk and those with Hx abn. pap had 
↑ knowledge 
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2008 and female • ↓knowledge overall, ↓knowledge among male 
population 
Brown et al. 
2007 
Urban N = 20  
women,  25-83 years  
Qualitative None Face-to-Face 
Brief information re: 
new HPV pap test as 
opposed to old pap test 
• ↑stigma associated with sexual transmission of 
HPV 
• + attitude toward HPV testing 
• lacked awareness of HPV overall 
• Education improved resulted in positive attitude 
toward HPV testing 
 
Friedman & 
Shepeard 
2007 
Nationally 
representative of US 
N = 314 
35 Focus groups 
adults age 25-45 
years old  
Qualitative None None • ↓knowledge overall of HPV, women more 
knowledgeable than men 
• Stigma associated with STD nature of disease 
Waller et al.  
2007 
Urban N = 909 women Quantitative 
 
  • ↑stigma and shame in those who knew HPV was a 
STD 
• knowledge of prevalence = ↓stigma, shame, and 
anxiety 
• Written ed. material did not translated into 
adequate knowledge of HPV, Need more research 
communicating HPV information 
McCaffery & Irwig 
 
2005 
Rural  N=44 
Women 19-63 years  
Dx with High Risk 
HPV within the last 
year, 68% African 
American 
Qualitative   • Health care provider most trusted source of 
information and preferred source overall 
• Some prefer privacy of written material (brochures 
in doctors office), Lack trust/preference for TV, 
magazine ads, internet 
• Prefer easily understandable information, ↓ 
preference for large amounts to sort through 
• All expressed need for more HPV/abnormal pap 
information overall 
McCree et al. 
2006 
South Carolina 
 
Clinics 
 
Rural 
Predominantly poor 
and largely African 
American population  
N = 50 
 
Female 
 
Ages: 19-63 years 
Qualitative 
 
Focus groups 
 
Constant comparison 
analysis 
 
Purposive sample 
(HPV positive) 
None None • Written information felt to be adequate, but some 
said brochures contained too much information to 
be clearly understood 
• Video was felt to be a positive means of 
information delivery, preferred free video from 
trusted source…downside was no ability to interact 
with live person 
• Most preferred method of information delivery was 
from health care worker in face-to-face setting 
• Most felt TV and radio were too commercialized to 
be trusted 
• Access to internet hindered preference for this 
media type 
• ***Although all women dx with abnormal pap and 
HPV as identified by clinic, only half reported 
hearing of HPV 
Perrin et al. 
2006 
Urban N = 52 
women 18-44 years  
recently Dx with 
HPV 
Qualitative 
 
Content Analysis 
None None • ↓ HPV knowledge overall 
• Dx of HPV = feelings of stigma, powerlessness, 
fear, and anger 
• Disclosure limited due to fear of stigma, when 
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75% white, 9.6% 
black, 11.5% 
hispanic, 3.8% asian 
disclosing emphasized cancer risk rather than STD 
association 
• ↑knowledge of prevalence = normalizing = ↓ 
negative emotions 
McCaffery et al. 
2005 
Urban N = 19 
Women 
Qualitative   • ↓ HPV knowledge overall 
• Knowledge of prevalence = ↓ stigma, ↓ distress 
• Follow up only for abnormal results = 
↑psychological distress, Prefer routine follow up to 
receive pap results, gives opportunity for dialogue 
with health care provider, and avoids singling out 
HPV + patients 
• Health care provider best source of information, 
internet sources increased confusion and stigma as 
HPV info is lumped with other STD's 
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Table 3: 
Quantitative HPV knowledge, beliefs, and behavior studies 
ADOLESCENT 
Author Setting Population Study Design Theory Intervention Findings 
Merzouk et al.  
2011 
Rural 
 
WV High 
Schools 
N = 626 
Male & Female 
Age: 15-16 yo 
Prospective  
Quantitative 
 
Experimental 
None DVD of power point • ↑ knowledge of condoms 
• ↑ overall HPV knowledge in intervention group (p > 0.05), but both groups 
had good knowledge prior to intervention (82% knew HPV related to CC) 
• Lack of knowledge re: smoking connection  
Brabin et al. 
2010 
Manchester 
England 
N= 2817 pre-test 
N= 814 post-test 
 
Female 
 
Age: 12-13 yo 
Cross-sectional 
Quantitative 
 
Quasi-
Experimental 
Elaboration 
Likelihood 
Model 
Film • Intervention ↑ intention to get vaccinated 
• HPV factual recall assessed 6 months after viewing film was limited (only 
34% recalled what film was about, only 60% answered fact questions 
correctly, 18% answered incorrectly) 
• N=29 recalled seriousness of HPV/CC at 6 months 
• ↓ knowledge of condoms for protection 
• Film ↑ perceived seriousness of HPV (short-term) and ↓ fear of vaccine 
Gottvall et al. 
2010 
Sweden 
 
High school 
N = 276 
Male & Female 
Age: 16 yo 
Prospective 
Quantitative 
 
Quasi-
Experimental 
HBM Face-to-Face with 
Website/Folder 
provided 
• Baseline low HPV knowledge for all students,  
• Intervention ↑ HPV knowledge 
• Intervention did not change attitudes toward vaccine 
• Positive attitudes to pap testing and condom use pre- and post-test 
• Student preference for face-to-face rather than website or folder 
Wang, Simoni, 
& Wu 
2006 
WV High 
Schools 
N = 159 
Female 
Ages: 14-20 
Purposive 
Sample 
Quantitative 
Survey 
Descriptive – 
Correlational 
Theory of 
Reasoned 
Action 
(TRA) 
None • ↓ HPV knowledge 
• Sexually active teens more knowledgeable about using condoms to prevent 
HPV 
• Teens in single parent homes more knowledgeable 
COLLEGE STUDENTS 
Author Setting Population Study Design Theory Intervention Findings 
Bynum et al. 
2011 
Historically 
black colleges 
N = 575 
 
Male and Female 
 
Ages:  18-26 
years 
Cross-sectional 
Quantitative 
 
Descriptive- 
Correlational 
HBM None • 75% had heard of HPV (females more than males) 
• Females more knowledgeable than males 
• Males scored lower on perceived severity, benefits, cues to action and 
higher on perceived barriers than females 
• No gender difference in perceived susceptibility 
• 71% had heard of the HPV vaccine 
• Females preferred HPV education from health provider, whereas males 
preferred television or internet 
Gerend & 
Shepherd 
2011 
Florida State 
University 
N = 739 
Female 
Ages:  18-26 
years 
Quantitative 
 
Descriptive -
Correlational 
None None • Only 3% had not heard of HPV, most knew it was related to CC 
• ↓ knowledge related to genital warts and transient nature of HPV 
• Mean knowledge scores 4.9 out of 10 
• Correlates of ↑ knowledge (↑age, sexual activity, non-conservative, 
previous STD testing) 
Gerend, 
Shepherd, & 
Shepherd 
2011 
Southeastern 
 
University 
N = 1612 
 
Female 
 
Age: 18-26 yo 
Quantitative 
 
Quasi-
Experimental 
None Vaccine Video • Gain frame or Loss Frame video had no effect on intentions to get 
vaccinated 
• 27% had intentions to get vaccinated post-intervention, 30% had no 
intentions, 44% undecided 
• Perceived barriers to vaccine = safety (26%), cost (17%), fear of shots 
(11%), no need (9%), and no access (6%) 
• Safety and low need were mentioned more often among non-intenders, 
other barriers mentioned more often among intenders 
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 Stock, 
Peterson, 
Houlihan, & 
Walsh 
 
2012 
 
 
College 
N = 238 
Male & Female 
Age: 18-35 yo 
Cross-sectional 
Quantitative 
 
Experimental 
None Fact Sheet • Intervention ↑ knowledge, and perceived risk to HPV 
• Intervention ↓ intention to oral sex  
• Men expressed ↑ likelihood to get vaccination after intervention (more so 
than women) 
Vogtmann et al. 
2011 
 
 
Mexico 
 
College 
N = 1109 
Male and Female 
Age: 17- 26 
years 
Cross-sectional 
Mexican 
American 
Quantitative 
 
Descriptive – 
Correlational 
None None • Those more likely to have heard of HPV = older, female, science students, 
higher socioeconomic background, having health insurance, and being 
sexually experienced 
• Low HPV knowledge overall 
Polik & Hardie 
2010 
Delaware 
Lesbian 
Community 
groups 
N = 96 
Female 
Age: > 18 years  
Convenience 
Sample 
Quantitative 
 
Descriptive – 
Correlational 
None None • 30% lacked knowledge of HPV transmission among female – female 
sexual relations 
• Openness with health care provider about lesbian status = ↓ knowledge of 
HPV transmission 
•  
Yanikkerem et 
al. 
2010 
Turkey 
 
University 
N = 553 
Male & Female 
Age: 18-32 yo 
Cross-Sectional 
Quantitative 
 
Quasi-
Experimental 
None Face-to-face • ↓ HPV knowledge pre-intervention 
• ↑ knowledge post-intervention (p< 0.05) 
• ↑ positive attitude toward vaccine after intervention 
 
Allen et al. 
2009 
New England 
 
University 
N = 1,401 
Female 
Ages:  > 18 years 
Quantitative 
 
Descriptive - 
correlational 
Transtheoret
ical Model, 
TRA, Social 
Cognitive 
theory, 
HBM 
None • Most had heard of HPV and the vaccine 
• Those in preparation and action had the highest HPV knowledge scores 
• Perceived severity highest among those decided against vaccine 
• Perceived benefits highest among those in preparation and action stages 
• Those in action stage had lowest perceived barriers 
• Social norms higher among preparation and action stage participants 
• All but perceived susceptibility were associated with stage of readiness to 
get vaccinated 
•  
Caron, Kispert, 
& McGrath 
2009 
University N = 361 
Female 
Age: 18-34 years 
Cross-sectional 
Quantitative 
 
Descriptive - 
Correlational 
None None • Most had heard of HPV and the HPV vaccine (85%) 
• + attitude to vaccine 
Elit, Trim, 
Mohan, Nastos, 
& Harnish 
2009 
University N = 203 
Male and Female 
Men = 57 
Women = 146 
Ages:  mean age 
19.7 years 
Undergraduate 
Quantitative 
 
Descriptive 
None None • ↓HPV knowledge (did not differ between men and women) 
• Internet and family doctor most preferred source of sexual health 
information 
• Women more likely than men to have heard of HPV vaccine 
• Only 32.6% of women who knew about HPV vaccine expressed interest in 
getting vaccine 
Marlow et al. 
2009 
United 
Kingdom 
 
College 
N = 365 
 
Female 
 
Age: 16-19 yo 
 
Cross-Sectional 
Quantitative 
 
Quasi 
Experimental 
HBM Fact Sheet • ↓ HPV knowledge pre-intervention 
• ↑perceived susceptibility = ↑ acceptability of vaccine 
• Barriers to vaccine = worry about side effects, afraid of needles,  
• ↑perceived benefit = ↑ acceptability of vaccine 
• ↑ barriers = ↓ acceptability of vaccine 
• Benefits and barriers = strongest predictors of acceptability 
• Culture & religion did not have an effect on vaccine acceptability 
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• White, higher socioeconomic had ↑ acceptability over ethnically diverse, 
lower socioeconomic participants 
Doherty & Low 
2008 
 
College 
N = 119 
 
Male & Female 
 
Age: N/A 
 
Prospective 
Quantitative 
 
Experimental 
None Fact Sheet 
(delivered via web) 
• Women ↑ knowledge, positive attitudes toward vaccine, perceived 
susceptibility to infection on pre-test than men 
• ↑ positive attitudes to vaccine post-test 
• ↑ perceived risk to HPV post-test 
• ↑ knowledge of HPV post-test 
• Knowledge maintained at 1 month follow-up 
• Intervention group = clinical improvement, but not significant 
improvement on condom use at one month follow-up 
Gerend & 
Magloire 
2008 
Florida 
University 
N = 124 
 
Male and Female 
 
Ages: 18-26 
years 
Quantitative 
 
Descriptive –
Correlational 
None None • 78% had heard of HPV 
• Women more knowledgeable than men (94% vs. 62%) 
• Most had high knowledge scores 
• Low perceived risk of HPV 
• 64% interested in learning more about HPV 
• 4 women had received HPV vaccine 
• Of 60 women not previously vaccinated 65% were interested in getting the 
vaccine 
Lambert 
2001 
New York 
 
College 
N = 60 
 
Male & Female 
 
Age: > 18 yo 
Prospective 
Quantitative 
 
Quasi-
Experimental 
None Face-to-Face • ↓HPV knowledge pre-test 
• PA students knowledge > psychology students 
• Knowledge = between gender 
• ↑HPV knowledge at 3 month follow-up 
• PA students knowledge still > psychology students 
• Psychology students had > overall improvement in knowledge 
WOMEN 
Author Setting Population Study Design Theory Intervention Findings 
Chang et al. 
2013 
  Quantitative 
Quasi-
Experimental 
Immediate post-
test follow-up 
None Face-to-Face lecture 
based educational 
seminar 
• Low pre-intervention HPV knowledge 
• Knowledge increased post-intervention 
• Increased intention toward vaccination post-test 
Kester et al. 
2013 
  Quantitative 
Quasi 
Experimental 
 
Immediate post-
test of 
intervention 
group 
None Face-to-Face 10 
minute group 
education session for 
intervention group 
only 
• 62% of the seventy four individuals whose health care provider mentioned 
HPV vaccine had received the vaccine, whereas only 3% initiated 
vaccination without health care provider recommendation. 
• Intervention group had higher HPV knowledge scores 
• 38% had already had the HPV vaccine with 19% completion of the series. 
• Of those not already having the vaccine, the intervention group was more 
likely to have intentions toward vaccination(86%) than the control group 
(57%) (OR=2.09;95%CI = 1.02-9.36; p<0.05) 
Vanderpool et 
al.  
2013 
  Quantitative 
Quasi 
Experimental 
TBP and 
IMB 
Framework 
13 minute Video 
developed based on 
IMD Framework to 
promote completion 
of 3 dose series 
• Increased intention for series completion predicted increased behavior for 
series completion 
Krawczyk et al. 
2012 
  Quantitative 
Experimental 
 
 Immediate 
HBM 3 groups: 
• Written HPV 
information 
• Video HPV 
• Pre-intervention scores modest and intention to vaccination low 
• Both written and video group had higher knowledge than control group at 
pre and post intervention testing 
• Both written and video group had increased intentions to vaccinate post-
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post-test 
follow-up 
information 
Control 
test than did controls 
• No difference between type of educational material 
Patel et al. 
2012 
University 
Clinic 
N = 256 
 
Female 
 
Age: > 18 yo 
Quantitative 
 
Experimental 
 
 
TPB Fact Sheet • Baseline intentions to get vaccinated = 41% 
• Baseline no intentions to get vaccinated = 31.3% 
• Reasons for intentions to get vaccinated: worry over CC (65.7%), worry 
over genital warts (48.6%), physician recommendation (40%) 
• Reasons for no intentions to get vaccinated: safety concerns (48.8%), side 
effects (48.8%), cost (41.3%), long-term consequences (40.0%), not being 
at risk for HPV (28.8%) 
• HPV knowledge not correlated with vaccine intentions 
• Intervention was associated with vaccine behavior (5.5% had 1 dose of 
vaccine at 6 month follow-up)*** chart review of vaccine uptake 
• Intentions associated with behavior (those with intentions to vaccine more 
likely to get vaccinated) 
• Cost and sexual risk taking not associated with intentions but not behavior 
Bayer et al. 
2011 
Peru 
 
Clinics 
N = 185 
Female 
Age: 18-67 years 
Purposive Non-
probabilistic 
sample 
Quantitative 
 
 
 
 
 
HBM None • Only 1 in 5 gave CC information 
• Few 2.2% gave HPV information 
• Only 31% gave literature 
• Only 11.9% gave pap smear information 
• Amount of Ed. Given influenced by length of visit 
• Nurses more likely to educate than physicians 
Bendik et al. 
2011 
Southeastern  
University 
N = 1,975 
 
Female 
 
Age: 18-24 
Quantitative 
 
Correlational 
None None • ↓ HPV knowledge (transmission, prevalence, seriousness) 
• Perceived importance of HPV, severity of HPV, severity of CC, perceived 
likelihood of getting CC, age at sexual debut, # of sexual partners, age, 
HPV knowledge were all associated with getting the vaccine 
• Among unvaccinated students, intentions to get vaccine were influenced by 
doctor recommendation to get it (35.4%), being able to pay for it (19.4%), 
parents encourage it (16.4%), becoming sexually active (14.0%), having 
more sexual partners (9.6%). 
Juraskova, Bari 
et al. 
2011 
Australia 
 
University 
N = 159 
 
Female 
 
Age: < 26 yo 
Quantitaive 
 
Experimental 
HBM 2 different Fact 
Sheets 
 
Leaflet 1: Cervical 
Cancer (CC) 
information 
Leaflet 2: CC and 
Genital Warts (GW) 
information 
• ↓ HPV Knowledge pre-test 
• Intentions ↑ post-intervention 
• Intentions to get vaccine predictor of behavior to get vaccine post-
intervention 
• Intentions to get vaccine predictor of information seeking behavior post-
intervention 
• CC+GW group (44%) more likely to get vaccine than CC only group 
(32%) 
• Perceived barriers and Perceived benefits = predictors of vaccine intentions 
• Barriers = side effect concerns, access, pain, cost, multiple injections 
• Note: vaccine provided free to this population, but cost was cited as barrier 
if they would have to pay for it 
• Measured Actual Behaviors at 2 month follow up 
Juraskova, 
O’brien et al. 
2011 
Australia 
 
University 
N = 159 
 
Female 
 
Age < 26 yo 
Quantitative 
 
Experimental 
TPB and 
moral norm 
constructs 
Fact Sheets 
(delivered via 
computer) 
• Intentions, perceived behavior control, and moral norms not predictors of 
behavior 
• Model (TPB) predicted 54% of variance in intention to get vaccination 
• Intention only predicted 9.6% of variance in behavior 
• Gap between intentions and behavior 
Mills et al. Kentucky N = Quantitative None Brochure • Focus was on removing barrier of cost for vaccine to determine likelihood 
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2011  
Clinic and 
College 
 
Female 
 
Age:  18-26 yo 
 
Experimental 
of vaccination 
• Clinic participants more likely than college participants to get 
vaccinated*** measured vaccine behavior through voucher receipts for 
shots given 
• Clinic population using condoms or oral contraceptive were more likely to 
get vaccinated 
• College women using IUD were more likely to get vaccinated 
• Those having previous pap test more likely to get vaccinated 
• Those with no doctor contact in last 12 months less likely to get 
vaccination 
• Those with hx of abnormal pap were less likely to get vaccination 
• Those participating in mutual masturbation less likely to get vaccination 
Royer & Falk 
2011 
4  Urban 
Clinics and one 
Midwestern 
University 
classroom 
N = 302 
 
Female 
 
Ages: 18-24 
years 
Cross-sectional 
Quantitative 
 
Survey data 
 
Descriptive – 
correlational 
Common 
Sense Model 
None • Most believed HPV would negatively affect their health 
• Most felt HPV was a chronic illness 
• Most thought rate of HPV transmission was low 
• Felt HPV dx would cause them shame and embarrassment, and negatively 
impact relationships and willingness to disclose dx 
• Women likely to believe HPV would result in cancer and or cause outward 
symptoms 
• Women already dx with HPV knew more about it, knew it had fewer 
symptoms, and had fewer negative psychosocial beliefs than those not 
already dx 
Teitelman et al. 
2011 
Low-Income 
 
Urban 
N = 34 
 
Female 
 
Ages: 13-26 
Mixed-Method 
 
Descriptive-
Correlational 
TPB None • 53% intended to get vaccine 
• ↑Intentions affected by, younger age of sexual debut, unemployment, + 
tobacco use, + hx of STI 
• Model constructs of attitudes, norms, and behavioral control = predictors 
of vaccine  intention 
Wong 
2011 
Malaysia 
 
Rural 
N = 449 
 
Female 
 
Convenience 
sample 
Quantitative 
 
Descriptive - 
Correlational 
None None • ↓ HPV knowledge, awareness of vaccine, awareness cervical cancer 
screening and CC risk factors 
• 2/3 had intentions to vaccine even though they had never heard of it 
• ↑ knowledge of CC screening and CC risk factors = ↑intentions to vaccine 
• ↓ Intentions to vaccine = fear of safety, embarrassment over getting STI 
vaccine, perception of low risk for HPV 
• Overall need for more education of rural Malaysia women 
Cermak, 
Cottrell, & 
Murnan 
2010 
Cincinnati 
 
Social Service 
employees 
N = 109 
 
Female 
Ages: 18-65 
 
Quantitative 
 
Descriptive 
None None • 71.6% reported physician did not educate them on HPV 
• Only 13.8% reported HPV was discussed by physician 
• Most do not remember doctor recommending HPV vaccine (76.1%) 
• Women with higher education had more HPV knowledge than those with 
low education 
Fry et al. 
2010 
Urban 
 
Clinic 
N = 383 pre-test 
N = 130 post-test 
Quantitative 
 
Quasi-
Experimental 
None Face-to-Face 
education of 
physicians treating 
the women 
• ↑ knowledge of difference between pelvic exam and pap test post-
intervention 
• No difference in knowledge regarding recommended pap smear interval 
• ↑ Knowledge of what pap smear screens for post-intervention 
• Spanish speaking women ↑ pap knowledge over English speaking women 
Kwan et al. 
2010 
Hong Kong, 
China 
 
Clinic 
N = 294 
 
Female 
 
Quantitative 
 
Experimental 
None Fact Sheets 
• Message 1: low 
risk(lr)+hight 
risk (hr)HPV 
• ↓ HPV knowledge pre-test 
• ↑ intentions to pap smear pre-test 
• Message 1 = > stigma 
• Message 2 = Stigma > Message 3, < Message 1  
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Age:  > 18 yo • Message 2: 
hrHPV 
• Message 3:  
ds+hrHPV 
• (ds=de-
stigmatizing 
language) 
• Message 3 = < stigma 
• ↑ HPV knowledge post-intervention for all groups 
• ↑ post-intervention intentions to pap smear (higher than pre-test) 
Ilter et al. 
2010 
Clinic N = 525 
 
Female 
 
Ages: 19-53 
years 
 
 
Quantitative 
 
Descriptive 
 
Survey 
None None • 82% had heard of pap tests, but only 56% had heard of HPV 
• 51% had at least one pap test 
• Only 52% knew HPV was connected to CC 
• 77% had heard of HPV vaccine 
• 56% reported willingness to get HPV vaccine 
• Most reported recommendation from health providers as a reason to get 
vaccinated 
Luque et al. 
2010 
Central Florida 
& Southern 
Georgia 
Clinics serving 
latino migrant 
farm workers 
N = 80 
Female 
 
Age: 19-54 
 
Cross-sectional 
Mixed Methods 
Survey Design 
 
Descriptive 
None None • Lack of awareness re: prevention of cervical cancer 
• Barrier to vaccine was lack of information, cost, fear of safety, access 
Rosen et al. 
2010 
Canada 
 
Clinical Trial 
N = 495 
 
Female 
 
Age: 30-69 yo 
 
Cross-Sectional 
Quantitative  
 
Experimental 
None Pamphlets 
 
• Pamphlet 1= 
long form with 
more HPV info 
• Pamphlet 2= 
short form with 
less HPV info 
• Control 1= long 
form on general 
cancer 
prevention 
• Control 2 = 
short form on 
general cancer 
prevention 
• Both forms = ↑ uncertainty and anxiety, but after controlling for inherent 
uncertainty/anxiety traits only long form was found to ↑ uncertainty and 
anxiety 
• Authors conclude uncertainty with HPV is inherent and increasing factual 
information does not negate it 
Warren 
2010 
Northeastern 
Pennsylvania 
 
College 
N =  
 
Female 
 
Age:  18-23 yo 
Quantitative 
 
Quasi-
Experimental 
None Face-to-Face with 
written 
• ↑ knowledge post-intervention 
• ↓ HPV knowledge at pre-test 
 
Zimet, Weiss, 
Rosenthal, 
Good, & 
Vichnin 
 2010 
Large managed 
care database 
N = 1,375 
 
Female 
 
Ages: 19-26 
years 
 
Purposive (those 
Quantitative 
 
Descriptive 
None None • 93.5% agreed cervical cancer was a devastating disease and genital warts 
are embarrassing 90.0% 
• 73% reported being comfortable talking about sexual health with doctor 
• of the 185 in this study, 176 reported hearing about the HPV vaccine, but 
only 32.4% thought it was important to them 
• 30.1% reported discussing it with their doctor and receiving doctor 
recommendation to get the vaccine 
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not yet 
vaccinated 
against HPV) 
• While most felt they could obtain the vaccine few actually did, reasons for 
not getting vaccinated were marriage, monogamous 54.9%, others thought 
it was too new 35.4% or didn't have enough information 31.7%.  24.4% 
were concerned about safety and 14.6% were concerned about insurance 
covering it 
Cates et al. 
2009 
North Carolina 
Clinic 
Rural 
Predominantly 
black  
N = 138 
Female 
Ages: 18-84 
years 
Quantitative 
 
Descriptive – 
Correlational 
None None • Only 24% of black women had heard of HPV compared to 57% of white 
• Black women had ↓ knowledge, and were less likely to think HPV was a 
serious threat to health, and perceived themselves less likely to get CC 
• Only 20% of participants had heard of vaccine and did not differ among 
race 
Dursun, 
Altuntas, 
Kuscu, & 
Ayhan  
2009 
Turkey N = 1,434 
 
Female 
 
Age: 17-80 years 
Quantitative 
 
Descriptive 
  • < half knew of HPV 
• ↓ HPV awareness 
• + attitude toward accepting HPV vaccine 
Papa et al. 
2009 
Clinic N = 50 
 
Female 
 
Age: > 30 yo 
Quantitative 
 
Quasi-
Experimental 
None Face-to-Face with 
written 
• ↑ knowledge post-intervention 
• ↓ concern over positive HPV dx post-intervention (those with concern 
were related to cancer) 
• Positive attitude to pap testing with reflex test for HPV  
Pitts et al. 
2009 
Singapore N = 2,145 
 
Female 
Age:  18-49 
years 
Quantitative 
 
 
Descriptive – 
Correlational 
None None • ↓ awareness of HPV 
• ↓HPV knowledge  
• + attitude toward vaccine among those who knew of HPV 
Waller et al. 
2009 
England, 
Scotland, 
Wales 
N = 1081 
 
Female 
 
Age: 25-64 
 
Nationally 
Representative 
Quantitative  
 
Experimental 
None Fact Sheet  
(delivered via 
computer) 
• ↓ low number aware of HPV prior to study 
• large number reported regular pap screening 
• lack of knowledge of HPV cancer link 
• Knowledge of HPV as STD =  ↑ anticipated shame 
• Prior to knowledge of HPV as STD 90% disagreed with anticipated shame 
• No ↑shame with education on prevalence of HPV or general HPV 
education, and women with college education reported less shame/worry 
than those with less formal education 
• Regularly screened pap patients reported less shame/worry than rare/never 
screened women 
Crosby et al. 
2008 
Clinic N = 28 
 
Female 
 
Age: 17-23 yo 
Quantitative 
 
Quasi-
Experimental 
Precaution 
Adoption 
Process 
Model 
Face-to-Face or 
Phone 
• HPV + dx = ↑ intentions to pap test in future 
• HPV +  dx = ↓ smoking intentions in future 
• HPV + dx = ↑ intentions to get vaccine 
Fazekas et al. 
2008 
North Carolina 
 
Clinics 
 
Rural 
N = 146 
 
Female 
 
Age: > 18 yo 
Quantitative 
 
Correlational 
Implied -
Health Belief 
Model  
None • Few knew of HPV, low HPV knowledge 
• Younger = ↑ intentions toward vaccine 
• African American = ↓ intentions toward vaccine 
• Public clinics = ↑ intentions to vaccine over private OB/gyn clinics 
• Most said HPV vaccine would be most acceptable if it were free 
• ↑perceived likelihood of infection/CC, and ↑ perceived severity of 
HPV/CC = ↑intentions 
• ↑ belief in effectiveness = ↑ acceptability of vaccine 
• Cues to action and ↓ perceived barriers = ↑ acceptability of vaccine 
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• Women felt daughter more at risk than themselves and therefore more 
willing to pay for vaccine for daughters than for themselves 
Kahn et al. 
2008 
Cincinnati 
 
Clinic 
N = 409 
 
Female 
 
Age: 13-26 
Sexually 
experienced 
 
 
Quantitative 
 
Correlational 
 
 
TPB, social 
cognitive 
theory, HBM 
 
 
None • Low vaccine uptake at start of study with only 5% being vaccinated against 
HPV with one dose and only 0.2% receiving all 3 doses 
• 66% reported intentions to get vaccinated in next year 
• 68% were dx with HPV with 60% having high-risk types 
• ↓intentions to vaccine = lack of insurance, safety concerns, riskier sexual 
activity 
• ↑ intentions to vaccine = ↑ HPV knowledge, belief people in their life 
would approve of the vaccine, ↑ perceived severity of HPV, ↑ perceived 
benefits to vaccine,  
Ferris et al. 
2007 
Georgia & 
Texas 
 
Clinic 
N = 472 
 
Female 
 
Age: > 25 yo 
Quantitative 
 
Quasi-
Experimental 
None Pamphlet • Attitudes toward getting self- vaccinated ↓ after intervention 
• Attitudes toward getting daughter vaccinated ↑ after intervention 
• Biggest reason for not wanting vaccine for self was monogamy and low 
perceived need 
• Attitudes for those undecided on pre-test were more positive after 
intervention  
Gerend et al. 
2007 
North Florida 
 
Community 
clinics 
N= 58 
 
Female 
Age: 18-50 
Quantitative 
Semi-structured 
Interview 
Correlational 
HBM Face-to-Face • Intentions to get vaccine generally high 
• ↑intentions correlated with ↑susceptibility, perceived safety, perceived 
effectiveness, and physician recommendation, and history of previous HIV 
testing   
Mock et al. 
2007 
Santa Clara 
County 
 
Community 
 
 
N = 491 
(combined 
intervention 
group) 
N = 477 (media 
only group) 
 
Female 
 
Age: > 18 yo 
 
Prospective 
Vietnamese 
Americans 
Quantitative 
 
Experimental 
None Face-to-Face with 
mass media exposure 
vs. only mass media 
exposure  
• Good pap attendance prior to study 
• Combined education group sought pap more than mass media group during 
study 
• Both groups had ↑ intentions to get pap as result of intervention 
• Both groups had ↑ knowledge as result of interventions, but combined 
education group scored higher 
Waller et al. 
2007 
Urban 
 
London 
 
University 
N = 811 
 
Female 
 
Age: college age 
Quantitative 
 
Quasi-
Experimental 
None Written  
(delivered via 
internet) 
• ↑ stigma and shame in those who knew HPV was a STD 
• Knowledge of prevalence = ↓ stigma, shame, and anxiety 
• Written educational material did not translate into adequate knowledge of 
HPV 
• Need more research on best practices for communicating HPV information 
Giles & 
Garland 
2006 
Australia 
 
Clinics 
 
N = 90 
Female 
Age:  18-30 
years 
Quantitative 
 
Descriptive 
None None • Most had heard of HPV and knew it was an STD 
• Only 1/3 had heard of HPV vaccine 
• Lack of knowledge regarding transmission and relation to CC and pap 
testing 
Moreira, 
Oliveira, 
Neves, Karic, 
& Filho 
2006 
Brazil 
 
Clinic 
N = 204 
 
Female 
 
Age: 16-23 years 
Quantitative 
 
Descriptive 
None None • ↓ HPV knowledge 
• + HPV vaccine attitudes 
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Cross-sectional 
Kahn et al. 
2005 
Urban 
 
Clinic 
N = 100 
 
Female 
 
Age: 14-21 yo 
 
Purposive 
Quantitative 
 
Quasi-
Experimental 
None Face-to-Face with 
visual aids and 
written  
• Educational intervention ↑ HPV knowledge 
• Education and screening = ↑ feelings of empowerment, associated with 
doing something positive for their health 
• ↑ HPV knowledge = ↑ self-confidence and locus of control to treatment 
and prevention of HPV 
• + HPV result = ↑ distress and ↑ anticipated stigma 
• Educational intervention = ↑ intentions to safe sex practice 
• Most planned to tell partner of result, those not disclosing tended to be 
HPV positive 
• Reported reason for not disclosing was fear of stigma and feeling 
shameful, feared partner anger and rejection, feared perception by partner 
that they had been unfaithful 
Kahn et al. 
2003 
Cincinnati 
 
Community & 
clinical sites 
N = 52 
 
Female 
 
Age:  18-30 yo 
Mean 25 yo 
Quantitative 
 
 
TPB, Social 
Cognitive 
Theory, 
HBM 
None • Good knowledge of HPV among study population 
• + attitudes about receiving HPV vaccine,75% felt vaccine was safe 
• 62% felt it was very effective 
• Most had self-perceived risk of contracting HPV 
• ↑perceived severity of HPV/CC 
• 85% with ↑ intention to get vaccinated against HPV 
• Age, marital status, race/ethnicity, health insurance not associated with 
intentions toward vaccination 
• Knowledge and global belief in goodness of vaccination = ↑ intentions 
toward HPV vaccine 
• Personal beliefs not associated with intentions (susceptibility & severity) 
↑ = increased, ↓ = decreased, + = positive  
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Chapter 3 
 This chapter will discuss the research methods and design used for this study.  A 
discussion of human rights concerns is provided, along with an explanation of the sample 
selection criterion and data collection procedures.  Parametric and non-parametric analysis 
techniques are discussed, and attention is given to the methods used for establishing rigor in this 
study. 
Design 
 This study used a quasi-experimental, pre-test and post-test design, with delayed 
intervention treatment administered to the control group at study completion.  Participants were 
recruited both face-to-face and on-line.  Participants recruited face-to-face (n = 42, 22%) in this 
study were assigned based on clinic location to either the intervention or control group, while 
participants recruited on-line (n = 152, 78%) were randomized by the computer program to either 
the intervention or control group.  A quasi-experimental design was chosen over an experimental 
design.  The decision to assign face-to-face participants rather than randomize them, as was done 
with the online participants, was made due to the potential for participants and staff from the 
face-to-face enrollment sites to interact between clinics.  Some of the clinics are affiliated with 
the same organization and there was concern of spillover with randomization at these sites.  
However, because clinics are located in different counties, the decision was made to assign 
participants to intervention and control groups based on county.  Distance between the county 
clinic sites is quite far, thus decreasing the possibility of spillover from one county to another. 
 Four clinics were identified in two counties (Fayette & Greenbrier) of southern West 
Virginia.  The clinics are designated Federally Qualified Health Centers (FQHC), with the 
mission of caring for rural underserved and uninsured populations.  As FQHCs the clinics 
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administer similar federally funded programs for cervical cancer screening of women.  
Therefore, the participants in both the control and intervention groups who were recruited face-
to-face were from similar socioeconomic backgrounds, and utilized similar cervical cancer 
screening services at the facilities. 
 On-line recruitment was initiated after noting that many age eligible women in the clinics 
did not meet inclusion criteria for the study due to having received at least one HPV vaccine.  
Thus, the protocol was amended to expand recruitment to women in the workforce, general 
population, and university school setting.  Flyers advertising the study to these women directed 
them to an on-line enrollment portal through survey monkey.  Women who opted to participate 
in the study through this method were randomized to either the intervention or control group. 
Human Rights Considerations 
 The study was approved by West Virginia University’s Internal Review Board (IRB), and 
attention was given to the protection of human subjects in compliance with all IRB protocols.  
Written and verbal study information (Appendix A) were provided to prospective participants 
upon initial recruitment face-to-face, and written informed consent was provided to participants 
recruited online.  Face-to-face participants were initially informed by clinic staff that a research 
study was being conducted, and clinic staff provided the participant with written information 
about the study, later referring interested persons to the researcher for verbal information and 
written informed consent.  Online participants simply clicked a link provided in an information 
flyer and were directed to the informed consent for the study.  Information sheets detailed the 
purpose of the study, the required amount of time for participation in the study, risks and benefits 
of participation in the study, the fact that participation was voluntary, and researcher contact 
information should participants have further questions about the study.   
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The study questionnaire posed no more than minimal risk to participants, and likely 
benefitted participants by increasing awareness of HPV and HPV prevention measures.  
Additionally, the study intervention DVD and handout posed no more than minimal risk, instead 
conferring benefit of increased HPV knowledge, increased positive health beliefs toward HPV 
and HPV prevention, and increased willingness to accept the HPV vaccine for themselves and 
their adolescent children post-intervention.  Because the researcher believed the DVD and 
handout intervention would be more beneficial at increasing participants HPV knowledge and 
willingness to access prevention services, the researcher provided a delayed treatment protocol 
for control group participants, so equal benefit of the study intervention services was provided.  
 Because the geographic area for this research was rural and included areas where the 
researcher was a member of the community, there was the potential for the researcher to be 
known personally by some participants in the study.  To avoid the potential for coercion, the 
researcher avoided direct face-to-face contact with prospective study participants during initial 
recruitment.  The researcher relied on the clinic staff to distribute the study information sheet and 
to notify prospective participants of the availability of a study being conducted at the face-to-face 
recruitment sites.  Only after reading the information sheet and indicating to the clinic staff their 
willingness to participate, were participants referred to meet the researcher for enrollment in the 
study.  Coercion in the online setting was avoided by having online participants self-selected to 
the on-line survey after getting email and bulletin board notification of an available study. 
Sample Selection 
 A prospective cohort sampling design was used in this study, and included women 18-26 
years old presenting for health care at the designated clinics and self-selecting to participate 
online after receiving notification of the availability of the study.  Women were eligible for the 
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study if they met the age criteria, were English speaking, were non-pregnant, and had not 
received the HPV vaccine prior to study recruitment.  This age group was chosen because they 
are eligible for the HPV vaccine, and are above the age of consent for vaccination.  While 
females under 18 years are also eligible for the HPV vaccine, they must have parental consent to 
receive the vaccination.  Parental consent may not be obtainable in the family planning clinic 
setting because many females under 18 years may be presenting for pap testing without parental 
knowledge, and confidentiality concerns preclude acquiring parental consent for younger age 
groups in this setting.   
The selection of 18-26 year olds is significant for this study because many of this age 
group in West Virginia are under or uninsured and most do not qualify for traditional free 
vaccine programs (like the West Virginia Vaccines for Children (VFC) program).  Previous 
research has suggested that cost is a major barrier to HPV vaccine uptake (Mills et al., 2011).  
However, one study removed the barrier of cost and found that lack of knowledge and concern 
for vaccine safety were more significant barriers to vaccine uptake (Juraskova, Bari et al., 2011).  
This study will shed additional light on the actual barriers to vaccine uptake and the relationship 
of these barriers to knowledge surrounding HPV and HPV prevention among this population.  
Women who participated in the study were given a $5 gift card after completing the pre-
test and received a $10 gift card at the two month follow-up completion of the post-test 
questionnaire.  The remuneration functioned as an incentive to participate in the study, but could 
also address the barrier of cost for transportation to obtain vaccination services.  In addition, to 
address the barrier of cost for vaccination, the researcher worked with uninsured participants to 
access the Merck patient assistance program for free vaccine.  Forms for this program were 
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provided to those in need and clinic staff assisted uninsured participants wishing to become 
vaccinated as a result of participating in the study.   
The monetary incentive of $5 and $10 is believed to be sufficient to make participation in 
the study worthwhile, but is not excessive given the current price per gallon of gas in the United 
States economy.  In addition, efforts were made to ensure access to the HPV vaccine for all 
participants in the study regardless of health insurance coverage.  The attempt to remove the 
barrier of cost of the vaccine in this study was necessary to assess the true effects of the study’s 
educational intervention effectiveness on vaccination behaviors.   
Data Collection 
Data collection began upon approval of the study by West Virginia University’s Internal 
Review Board (IRB), and continued until adequate numbers were achieved.  Initial power 
analysis calculations based on a medium effect size, power of 0.80, and level of significance of 
0.05, indicates a sample size of 154 would be sufficient for this study if no participants were lost 
to follow-up.  The initial power calculation used was ten times the number of predictor variables 
(4 predictor variables) divided by the percentage of people expected to utilize vaccination in this 
study (26%), which is based on the previous percentages in a similar HPV vaccine study (Mills 
et al., 2011; Peduzzi, Concato, Kemper, Holford, & Feinstein, 1996).  To account for possible 
attrition of 20% (attrition number was derived from similar studies’ attrition rates) the decision 
was made to oversample, for a total sample size of 193.  Recruitment was cut off at 194 
participants completing the pre-test and 147 post-test.  The decision was made to cut off at this 
point after preliminary data analysis suggested the collection to 154 post-test would not have any 
significant bearing on the outcome variable. 
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Methods to Assure Rigor 
To maintain rigor in this study reliability of the study instrument was confirmed.  
Reliability refers to the consistency with which an item measures the same construct on two or 
more occasions (Polit & Hungler, 1999).  Reliability of the instrument measures were 
determined by assessing the internal consistency of the tools constructs.   
The instrument chosen for this study is based on the HBM and was previously used to 
assess HPV knowledge, beliefs, and behaviors among college students (Bynum et al., 2011).  
With permission from the instrument author (Appendix E), modifications were made to remove 
racial pride constructs from the instrument and to add additional belief construct questions 
pertinent to this study.  Previous instrument psychometric tests (Table 4) support the tool as an 
adequate instrument to measure research questions addressing the effectiveness of HPV 
prevention education (Reliability of perceived susceptibility, r=0.42; perceived severity, a=0.80; 
perceived benefit, N/A; perceived barriers, a= 0.58; cues to action, a=0.90)  (Bynum et al., 
2011).  However, the addition of questions to specific belief model constructs (perceived 
susceptibility, perceived benefits, and perceived barriers) increased the reliability of these 
measures in the current study (Table 5 & 6).   
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Table 4.  Original Health Belief Model Scales (Bynum, 2011) 
Scale Cronbach 
Alpha 
Question Set 
Perceived Susceptibility r = 0.42  It is extremely likely that I will get HPV in my 
lifetime. 
 My current behaviors put me at risk for HPV. 
Perceived Severity a = 0.80  HPV is a serious infection. 
 Cervical Cancer is a serious disease. 
 Cancer of the Penis is a serious disease. 
Perceived Benefits a = N/A  Getting the HPV vaccine could save my life. 
Perceived Barriers a = 0.58  I couldn’t afford to get the HPV vaccine. 
 I would not get the HPV vaccine because I am 
afraid of needles. 
 I don’t think vaccines work. 
Cues to Action a = 0.90  Knowing that HPV affects people like me would 
encourage me to get the HPV vaccine. 
 Knowing more about HPV would encourage me to 
get the HPV vaccine.  
 If my doctor recommended that I get the HPV 
vaccine then I would.  
 If my mother approved of the HPV vaccine then I 
would approve of it also.  
 If my grandmother approved of the HPV vaccine 
then I would approve of it also.  
 If my friends approved of the HPV vaccine then I 
would approve of it also.  
 
 
Table 5.  Reliability of health belief model constructs 
 
HBM Construct Original Instrument Modified Instrument 
Perceived Susceptibility r= 0.42 a= 0.75 
Perceived Severity a= 0.80 a= 0.67 
Perceived Benefits n/a a= 0.77 
Perceived Barriers a= 0.58 a= 0.80 
Cues to Action a= 0.90 a= 0.87 
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Table 6.  Modified Health Belief Model Scales (Current Study n=194) 
Scale Cronbach 
Alpha 
Question Set 
Perceived 
Stigma 
a = 0.78  Most people think that people with HPV should be ashamed of 
themselves. 
 Most people think that people with HPV are to blame for their 
problem. 
 Most people think that people with HPV are a danger to others. 
 Only people who are sexually promiscuous get HPV. 
Perceived 
Susceptibility 
a = 0.75  It is extremely likely that I will get HPV in my lifetime. 
 My current behaviors put me at risk for HPV. 
 HPV is a very common infection. 
 My risk of getting HPV is higher than most people’s risk. 
Perceived 
Severity 
a = 0.67  HPV is a serious infection. 
 Cervical Cancer is a serious disease. 
 Cancer of the Penis is a serious disease. 
 HPV can be life-threatening. 
 HPV is very likely to cause cervical cancer. 
Perceived 
Benefits 
a = 0.77  Getting the HPV vaccine could save my life. 
 Getting the HPV vaccine could protect me from getting certain 
types of HPV. 
 Getting the HPV vaccine will reduce the chance of me getting 
cervical cancer in the future. 
Perceived 
Barriers 
a = 0.80  I couldn’t afford to get the HPV vaccine. 
 I would not get the HPV vaccine because I am afraid of needles. 
 I don’t think vaccines work. 
 I have concerns about whether the HPV vaccine is safe. 
 I have concerns about whether the HPV vaccine is effective. 
 I have concerns about possible side effects of the HPV vaccine. 
Cues to 
Action 
a = 0.87  Knowing that HPV affects people like me would encourage me 
to get the HPV vaccine. 
 Knowing more about HPV would encourage me to get the HPV 
vaccine.  
 If my doctor recommended that I get the HPV vaccine then I 
would.  
 If my mother approved of the HPV vaccine then I would approve 
of it also.  
 If my grandmother approved of the HPV vaccine then I would 
approve of it also.  
 If my friends approved of the HPV vaccine then I would approve 
of it also.  
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 The modified instrument is comprised of five-items assessing vaccine acceptability (e.g. 
would you get a vaccine to prevent HPV infection? Response options: yes, no, don’t know).  
Twelve items assessing HPV knowledge and six-items assessing pap knowledge are assessed 
using response options of yes, no, don’t know, and are reverse scored so that correct responses 
are given a score of one and incorrect responses and don’t know responses are given a score of 
zero.  The instrument also includes four-items assessing HPV stigma beliefs, four-items 
assessing perceived susceptibility, four-items assessing perceived severity, six-items assessing 
perceived barriers, four-items assessing perceived benefits to HPV vaccination, and six-items 
assess cues to action toward HPV vaccination uptake.  Items assessing health beliefs are scored 
on a four-point Likert scale (1= strongly disagree to 4= strongly agree).  Other history and 
demographic information is assessed to include sexual history, race, age, relationship status, and 
education level (Appendix B). 
 The data collection process began following written informed consent of participants.  
After informed consent participants were given the pre-test questionnaire (Appendix B).  Then 
intervention group participants were given the HPV educational intervention materials to view, 
which consist of a short DVD video and HPV fact sheet.  The control group received only the 
HPV fact sheet (Appendix C).  Both groups were encouraged to get the HPV vaccination.  Two-
months after registration in the study, all participants received a post-test questionnaire via 
mail/email (with stamp addressed return envelope), telephone, or return appointment to the study 
site (Appendix D).  Six-months after enrollment in the study, chart review was conducted to 
assess whether participants completed the HPV vaccine series.  At the six-month interval control 
group participants were also given the delayed treatment protocol of the DVD and HPV fact 
sheet via the mail. 
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Data Analysis 
 Data were analyzed using Statistical Package for the Social Sciences (SPSS) program for 
analysis, and data were stored on the researchers password protected computer in a locked office.  
Data analysis began with an inspection of the data to identify any outliers or missing data that 
could affect analysis results.  Once identified, decisions were made on whether to exclude any 
outliers or missing data from the final analysis of results.  No outliers were identified needing 
exclusion from results, but missing data on some questions was noted and analyzed using list-
wise exclusion. 
Data analysis consisted of descriptive statistics of demographic data, such as, age, race, 
sexual orientation, relationship status, education level, smoking status, and use of hormonal 
contraceptives.  Assuming a normal distribution and random sampling, t-test were used to show 
differences between the intervention and control groups on HPV knowledge, pap knowledge, and 
HPV belief mean scores.  Assuming expected category counts of five or greater, Chi-square test 
were used to detect group differences on the categorical variables of HPV awareness, HPV 
vaccine awareness, HPV prevention behavior, and health information preferences.  Assuming 
homogeneity of variance, mixed within and between analysis of variance was used to assess the 
impact of knowledge and belief scores by group over time.  Lastly, logistic regression, using four 
predictors (HPV knowledge scores, HPV belief scale scores, group, and insurance) were used to 
predict willingness to accept the HPV vaccine.   
Summary 
 A review of the study methodological considerations has been provided with in-depth 
discussion of human protection considerations, sample selection, data collection and analysis, 
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and steps to assure methodological rigor.  Supporting documents are provided to illustrate 
materials used in this study (Appendix A, B, C, D).   
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CHAPTER 4 
This chapter presents results obtained following an educational intervention designed to 
change women’s HPV knowledge, beliefs, and behaviors.  Data analysis consisted of descriptive 
statistics of demographic data, such as, age, race, sexual orientation, relationship status, 
education level, smoking status, and use of hormonal contraceptives.  Paired samples t-tests were 
used to compare pre/post-test measures on HPV knowledge, pap knowledge, and HPV belief 
mean scores.  Mixed between-within subjects analysis of variance were conducted to show 
interactions between type of educational intervention and time on HPV knowledge, pap 
knowledge, and HPV belief scale scores.  Chi-square tests detect group differences on 
categorical variables of HPV awareness, HPV vaccine awareness, HPV prevention behavior, and 
health information preferences.  Lastly, logistic regression models, using four independent 
variables (HPV knowledge scores, HPV belief scale scores, group, and insurance) were 
developed to predict prevention behavior.   
Results 
Sample Description 
The mean age of respondents was 22 years of age (SD 2.4, range 18-26).  The majority of 
respondents classified themselves as white (90%) with the remaining classifying themselves as 
black (3%), Hispanic/Latino (2%), Asian (3%), American Indian (0.5%) or other mixed race 
(2%).  Regarding marital status, 46% were single, 43% were married and/or living with a 
partner, and 10% were in a relationship but not living with a partner.  Regarding education most 
reported having some college or an associate degree (47%), with 23% reporting either high 
school graduate or GED equivalent, and 19% reporting a bachelor’s degree, and 6% reporting a 
graduate or professional degree (Table 7).   
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The study assessed several risk factors related to cervical cancer (Table 8).  Several risk 
factors were noted among the population.  Twenty-one percent of respondents smoked and 56% 
reported using hormonal contraceptives, both of which are risk factors associated with cervical 
cancer.  Additionally, respondents reported early mean age of sexual debut (mean = 17 years, 
range 12-26 years, SD 2.4 years), and numerous lifetime sexual partners (mean = 5 partners, 
range 1-32 partners, SD 5 partners).  Also, increasing their risk of HPV transmission, the 
majority reported not using condoms with their last sexual intercourse (57%). 
About a third (34%) of the study participants had not yet had pap smear screening tests. 
Of the 34% who had not had pap testing, 46% were above the age of 21 years when regular pap 
testing is advised.  The remaining 54% of women who had not had pap testing were 21 years and 
younger, and for these women pap smear screening guidelines require pap testing not start until 
women are at least 21 years of age.  Among those who had pap smear testing (66%), almost a 
third (28%) of respondents reported having an abnormal pap test in the past, which may place 
them at high-risk for cervical cancer.  Among those with abnormal pap testing (10%), reported 
knowing the abnormal results were a result of being diagnosed with HPV.  
The sample was also assessed on insurance status.  Surprisingly a large number of the 
respondents reported having either private insurance or Medicaid (84%).  However, they still 
reported cost (41%) as the most frequent barrier to getting the HPV vaccine.  It was noted that 
those who marked cost as a barrier also frequently marked risks of shots (38%) as a barrier to 
vaccination.  Other barriers to vaccination reported at Time 1 were “not available” (14%),”no 
perceived need” (20%), and “other” (21%).   The reported barriers decreased slightly at Time 2 
with only 33% reporting cost, and risk of vaccines as a barrier at Time 2.  The number reporting 
non-availability of the vaccine also decreased to 10% and those citing no perceived need dropped 
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to 12%, and other 14% for the respondents as a whole (Figure 1).  Respondents reported “other” 
barriers for not accepting the vaccine as, “meant to do it and just haven’t done it, does not cover 
enough strains of HPV, not enough long-term research, at the end of the age bracket so feel it is 
not needed now, have already tested positive for HPV, risks of vaccines in general, just don’t 
want it, I’m gay so don’t need it, and just don’t want to go to the doctor”.  
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Table 7.  
 
Characteristics and demographics of participants (n = 194) 
 N (%) Minimum 
Maximum 
Mean (SD) 
 
Age 
 
194 (100) 
 
18-26 
 
22 (2.4) 
 
Race 
    White 
    African American/Black 
    Hispanic/Latino 
    Asian 
    American Indian/Alaskan Native 
    Other 
 
 
 
174(90) 
5(3) 
4(2) 
6(3) 
1(.5) 
4(2) 
  
 
Sexual Orientation 
    Heterosexual 
    Gay/Lesbian 
    Bisexual 
    Unsure 
 
 
168(88) 
4(2) 
15(8) 
4(2) 
  
 
Relationship Status 
    Single 
    Married 
    Living with Partner 
    Divorced/Separated 
    Other 
 
 
91(46) 
41(21) 
43(22) 
2(1) 
19(10) 
  
 
Education Level 
    Less than High School 
    High School Graduate or GED 
    Associate Degree or Some College 
    Bachelors Degree 
    Graduate/Professional Degree 
 
 
10(5) 
45(23) 
91(47) 
36(19) 
12(6) 
  
 
Insurance Status 
    Private Insurance 
    Medicaid 
    Clinic Program (Family Planning, Sliding Fee) 
    Out of Pocket (Private Pay) 
    None 
 
 
112(57) 
53(27) 
8(4) 
14(7) 
8(4) 
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Table 8.  Cervical cancer screening & risk factors  
 N (%) Minimum 
Maximum 
Mean (SD) 
Sexual Debut (age in years) 173  12-26 17 (2.4) 
 
Lifetime Number of Sexual Partners 
 
157 
 
1-32 
 
5 (4.6) 
Smoking Status 
    Yes 
    No 
 
42 (21) 
155 (79) 
  
 
Sexually Active 
    Yes 
    No 
 
 
173 (91) 
18 (9) 
  
 
Condom Use with Last Intercourse 
    Yes 
    No 
    Don’t know/not sure 
 
 
75 (42) 
100 (57) 
2 (1) 
  
 
Reason for Condom Use 
    Prevent Pregnancy 
    Prevent HIV 
    Prevent STI 
    Other 
 
 
129 (66) 
105 (53) 
94 (48) 
11 (6) 
  
 
Hormonal Contraceptive Use 
    Yes 
    No 
 
 
111 (56) 
86 (44) 
  
 
Ever Had Pap 
    Yes 
    No 
 
 
128 (66) 
65 (34) 
  
 
History Abnormal Pap 
    Yes 
    No 
    Don’t know/not sure 
 
 
38 (28) 
93 (69) 
4 (3) 
  
 
Diagnosed with HPV 
    Yes 
    No 
    Don’t know/not sure 
 
 
19 (10) 
167 (88) 
3 (2) 
  
 
Diagnosed with Sexually Transmitted Infection 
    Yes 
    No 
 
 
17 (9) 
177 (91) 
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Figure 2. 
 
 
HPV Awareness and Acceptance of the HPV Vaccine 
 Overall awareness of HPV and the HPV vaccine were assessed for both the control and 
intervention group at time 1 and time 2.  Chi-Square test for independence (with Yates 
Continuity Correction) showed no significant difference between the control and intervention 
groups on awareness of HPV at time 1, x2 (1, n = 193 ) = 0.000, p=0.985, phi = 0.015. While 
there was a statistically significant increase in awareness of HPV for both groups following the 
educational intervention [control group = x2 (1, n=82) = 13.23, p < 0.001; and intervention group 
= x2 (1, n=65) = 6.25, p = 0.012], there was no significant difference between the control and 
intervention groups on awareness of HPV at time 2 (with Yates Continuity Correction), x2 (1, n = 
147 ) = 1.40, p=0.238, phi = -0.135 (Table 9).  
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Table 9. 
Heard of HPV 
 Intervention Control Sig. 
Time 1 Yes No Yes No p=0.985 
 81% 19% 79% 21% 
Time 2 94% 6% 99% 1% p=0.238 
 p = 0.012 p < 0.001  
 
Nor was there a difference between groups on awareness of the HPV vaccine at time 1 (with 
Yates Continuity Correction), x2 (1, n = 188) = 0.115, p=.734, phi =  -0.039, or at time 2 (with 
Yates Continuity Correction), x2 (1, n = 148) =0 .000, p= 1.00, phi = -0.013.  However, there 
was a statistically significant increase in awareness of the HPV vaccine for both groups 
following the educational intervention [control group = x2 (1, n= 82) = 12.25, p < 0.001; and the 
intervention group = x2 (1, n=66) = 13.00, p < 0.001] (Table 10). 
Table 10. 
Heard of the HPV Vaccine 
 Intervention Control Sig. 
Time 1 Yes No Yes No p=0 .734 
 81% 19% 84% 16% 
Time 2 99% 1% 99% 1% p= 1.000 
 p < 0.001 p < 0.001  
 
Respondents were asked about their willingness to accept the HPV vaccine for 
themselves and their adolescent children before and after receiving the HPV educational 
intervention.  There was no difference between the groups on willingness to accept the vaccine 
for themselves at time 1 (with Pearson Chi-Square), x2 (2, n=194), = 0.777, p=0.678, phi = 
0.063; nor at time 2 (with Pearson Chi-Square), x2 (2, n=146) = 3.89, p=0.143, phi= 0.163.  
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Similarly, there was no difference between the groups in willingness to accept the vaccine for 
their adolescent daughters at time 1 (with Pearson Chi-Square), x2 (2, n=194) = 4.014, p=0.134, 
phi= 0.144, nor at time 2 (with Pearson Chi Square), x2, (2, n=147) = 2.25, p = 0.324, phi=0.124. 
Willingness to accept the vaccine for themselves and their adolescent children increased for both 
groups over time, and while not significant, the intervention group was slightly more likely to 
accept the vaccine for themselves and their adolescent daughters than the control group.  Groups 
did not significantly differ on willingness to accept the vaccine for their adolescent sons at time 
1(with Pearson Chi Square), x2, (2, n=194) = 2.131, p= 0.345, phi = 0.105.  However, groups 
significantly differed on willingness to accept the vaccine for adolescent sons at time 2 (Pearson 
Chi Square), x2, (2, n= 147)= 6.22, p=0.045, phi= 0.206 (Figure 2).   Participants in the 
intervention group were significantly more likely to accept the vaccine for their adolescent sons 
at time 2 than those in the control group.  
 
Figure 3. 
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Health Information Preferences 
 Participants gave information regarding preferences for receiving health information, 
sources of health information used most often, and sources of health information trusted most.  
Results are presented in Table 11.  Overall, participants reported the sources they most preferred 
for health information was their health care provider (83%) or the internet (66%), followed by 
pamphlets (50%), school health center (35%), television (31%), family (30%), friends (27%) and 
other (3%).  The sources most used by respondents for seeking health information were health 
care provider (72%) or the internet (72%), followed by family (26%), pamphlets (21%), school 
health center (20%), television (12%), friends (17%) and other (1%). Despite using other sources 
for health information, participants reported the source of health information most trusted was 
their health care provider (80%).   
Table 11.  Health information sources 
 Preference for 
Receiving Health 
Information 
Source Used The 
Most 
Source Trusted The 
Most 
 N (%) N (%) N (%) 
Health Care Provider 163(83) 141(72) 158(80) 
Pamphlets 98(50) 41(21) 6(3) 
Internet 120(66) 141(72) 16(9) 
TV 60(31) 23(12) 3(2) 
Family 59(30) 51(26) 11(6) 
Friends 54(27) 33(17) 4(2) 
School Health Center 68(35) 40(20) 4(2) 
Other 6(3) 2(1) 3(2) 
 
Knowledge and Belief Scale Scores 
 Pap knowledge was assessed with a six-item scale.  Percentage of correct responses to the 
questions are presented (Table 12) for both time periods. Independent t-test comparing pap 
knowledge based on previous pap testing experience is presented in Table 13.  Women who had 
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not previously had pap testing were significantly less knowledgeable than pap tested women at 
both time 1 and time 2.   
Paired sample t-test comparing pre/post-test measures (Table 14) showed overall a 
statistically significant increase in pap knowledge over time (p = <0.001).  Mixed between-
within subjects analysis of variance (Table 15) was conducted to assess the impact of the two 
educational interventions (written material alone vs. video with written material) on participants 
pap knowledge scores, across the two time periods.  There was no significant interaction between 
the type of educational intervention and time, Wilks Lambda = 0.99, F (1, 140), = 0.718, p = 
0.398, partial eta squared = 0.005.  The main effect for time was significant, Wilks Lambda = 
0.853, F(1, 140), = 24.16, p = <0.001, partial eta squared = 0.147, with both groups showing a 
significant increase in pap knowledge scores across time.  The main effect for group was not 
significant, F (1, 140) = 0.159, p = 0.691, partial eta squared = 0.001, suggesting no difference in 
the effectiveness of the two teaching approaches.   
 HPV knowledge was assessed with a twelve-item scale.  Percentage of correct responses 
to the questions are presented (Table 16) for both time periods. Paired sample t-test comparing 
pre/post-test measures (Table 14) showed overall a statistically significant increase in HPV 
knowledge over time (p = <0.001).  A mixed between-within subjects analysis of variance was 
conducted to assess the impact of the two educational interventions (written material alone vs. 
video with written material) on participants HPV knowledge scores, across two time periods 
(Table15).  There was no significant interaction between the type of educational intervention and 
time, Wilks Lambda = 0.99, F (1, 136), = 0.185, p =0.668, partial eta squared = 0.001.  The main 
effect for time was significant, Wilks Lambda = 0.838, F (1, 136), = 26.27, p = <0.001, partial 
eta squared = 0.162, with both groups showing a significant increase in HPV knowledge scores 
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across time.  The main effect for group was not significant, F (1, 136) = 0.344, p =0 .558, partial 
eta squared = 0.003, suggesting no difference in the effectiveness of the two teaching 
approaches.   
Table 12. Descriptive Statistics 
Pap smear knowledge questions  
 N (%) Correct 
Time 1 Time 2 
A pap smear is a test to find out if a woman is pregnant  162 (85)  129(88)  
All women should be getting pap smears by the time they are 21 years old 150(79)  130(88)  
A pap smear checks for changes in the cells of a woman’s uterus, also 
called the womb 
85(45)  68(46) 
A pap smear checks for changes in the cells of a woman’s cervix 161(84)  145(98)  
Getting regular pap smears is the best thing a woman can do to prevent 
cervical cancer 
141(74)  132(91)  
If a woman has a pap smear result that is not normal that usually means 
that she has cancer 
139(73)  114(77)  
 
Table 13. T-test 
Comparing pap knowledge based on previous exposure to pap testing 
Pap Knowledge 
Score 
Pap Testing 
 
Mean SD t df Sig. (2-tailed) 
 
Time 1 
No 3.31 2.09  
-5.451 
 
73.65 
 
<0.001 Yes 4.91 1.16 
 
 
Time 2 
      
No 4.50 1.17  
-3.689 
 
89.41 
 
<0.001 Yes 5.16 .814 
 
Table 14. Paired Sample T-Test 
Knowledge and belief scale scores over time 
 N Minimum 
Maximum 
Mean SD Sig. 
Pap 
Knowledge 
 
142 0 
6 
4.28 (Time 1) 
4.85 (Time 2) 
1.72 
1.08 
<0.001 
HPV 
Knowledge 
 
138 0 
12 
7.28 (Time 1) 
8.52 (Time 2) 
3.37 
2.43 
<0.001 
Belief Scale 
Scores 
116 0 
81 
47.95 (Time 1) 
49.66 (Time 2) 
8.03 
7.72 
0.007 
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Table 15.  Mixed Within and Between Analysis of Variance 
Impact of educational intervention 
 Control Intervention Wilkes Lambda 
N M SD N M SD 
Pap 
Knowledge 
       0.99, 
F(1,140)=0.718, 
p=0.398, partial eta 
squared = 0.005 
Pre-Test 78 4.29 1.81 64 4.28 1.61 
Post Test 78 4.76 1.12 64 4.95 1.03 
HPV 
Knowledge 
       0.99, 
F(1,136)=0.185, 
p=0.668, partial eta 
squared = 0.001 
Pre-Test 78 7.44 3.46 60 7.08 3.27 
Post Test 78 8.59 2.37 60 8.43 2.53 
Belief Scale 
Scores 
       0.99, F(1,114)= 
.163, p=0.687, 
partial eta squared = 
0.001 
Pre-Test 60 47.68 8.74 56 48.25 7.26 
Post Test 60 49.63 8.67 56 49.69 6.64 
 
Table 16.   
HPV knowledge questions 
 N (%) Correct 
Time 1 Time 2 
HPV can cause HIV/Aids 108(57) 81(55) 
You can always tell when someone has HPV 151(80) 122(84) 
HPV can cause abnormal pap smears/Pap test 149(79) 128(88) 
Only women get HPV 116(61) 106(73) 
HPV can cause herpes 79(42) 67(46) 
HPV can cause genital warts 79(42) 90(63) 
You can have HPV without knowing it 156(83) 137(94) 
HPV is a sexually transmitted infection (STI) or STD   134(71) 116(80) 
HPV can cause cervical cancer 150(79) 132(90) 
The HPV vaccine protects against all HPV infections   74(39) 75(52) 
Condoms are not 100% effective at preventing HPV   139(74) 121(82) 
HPV is spread by skin to skin contact 61(32) 70(48) 
 
HPV related health beliefs were assessed using belief subscale scores that were compiled 
for a total belief scale score.  The subscales consisted of perceived stigma, perceived 
susceptibility, perceived severity, perceived barriers, perceived benefits, and cues to action.  
Paired samples t-test comparing pre/post-test measures showed overall a significant increase in 
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total Health Belief Scale Scores over time (Table 14).  Additionally there was a significant 
increase in participant severity subscale scores over time (p = 0.001), and benefits subscale 
scores did not change significantly over time (p = 0.072).  There was no significant change in 
any of the other subscale scores over time, but there was a trend in the sample toward lower HPV 
related stigma beliefs, higher severity, susceptibility, and benefits beliefs, lower barriers beliefs, 
and increased beliefs in cues to action at time 2 (Table 17).   
 
 
 
 
Table 17. Paired Sample T-Test 
Belief sub-scale scores over time 
 N Mean SD Sig. 
 
Stigma Scale 
Scores 
 
139 
 
5.16 (Time 1) 
4.94 (Time 2) 
 
2.43 
2.13 
 
0.259 
 
Susceptibility 
Scale Scores 
 
135 
 
4.71 (Time 1) 
4.8 (Time 2) 
 
2.30 
2.22 
 
0.595 
 
Severity 
Scale Scores 
 
138 
 
9.01 (Time 1) 
9.49 (Time 2) 
 
1.69 
1.59 
 
0.001 
 
Barriers 
Scale Scores 
 
136 
 
7.73 (Time 1) 
7.45 (Time 2) 
 
3.65 
3.27 
 
0.204 
 
Benefits 
Scale Scores 
 
142 
 
6.09 (Time 1) 
6.30 (Time 2) 
 
1.51 
1.29 
 
0.072 
 
Cues to 
Action Scale 
Scores 
 
137 
 
10.73 (Time 1) 
11.17 (Time 2) 
 
3.67 
8.03 
 
0.158 
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Mixed between-within subjects analysis of variance was conducted on each subscale and 
the total belief scale scores to assess the impact of the two educational interventions (written 
material alone vs. video with written material) on participants’ scores, across two time periods.  
There was no difference between the groups detected.  The subscale results and interpretations 
are presented in (Table 18) and the subscale responses are presented in Table 19. 
In relation to the subscale of perceived stigma associated with HPV there was no 
significant interaction between the type of educational intervention and time, Wilks Lambda = 
0.99, F (1, 137), =0 .890, p =0.347, partial eta squared = 0.006.  The main effect for time was 
also not significant, Wilks Lambda =0.99, F (1, 137), = 1.051, p = 0.307, partial eta squared = 
0.008, with neither group showing a significant decrease in HPV related stigma beliefs across 
time.  The main effect for group was also not significant, F (1, 137) = 0.005, p = 0.942, partial 
eta squared =0.000, suggesting no difference in the effectiveness of the two teaching approaches 
on HPV related stigma beliefs.   
The subscale of perceived severity of HPV showed no significant interaction between the 
type of educational intervention and time, Wilks Lambda = 0.99, F (1, 136), = 0.188, p = 0.665, 
partial eta squared = 0.001.  However, the main effect for time was significant, Wilks Lambda = 
0.99, F (1, 136), = 10.72, p = 0.001, partial eta squared = 0.073, with both groups perceiving 
greater severity of HPV across time.  The main effect for group was not significant, F (1, 136) = 
0.884, p = 0.349, partial eta squared =0 .0060, suggesting no difference in the effectiveness of 
the two teaching approaches on changing participants perceived severity of HPV beliefs.   
The subscale of perceived benefits to HPV vaccination showed no significant interaction 
between the type of educational intervention and time, Wilks Lambda = 0.99, F (1, 140), = 
0.204, p = 0.652, partial eta squared = 0.001.  The main effect for time was also not significant, 
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Wilks Lambda = 0.97, F (1, 140), = 3.112, p = 0.08, partial eta squared = 0.022, with neither 
group showing a significant increase in perceived benefits to HPV vaccination across time.  The 
main effect for group was also not significant, F (1, 140) = 0.274, p = 0.602, partial eta squared = 
0.002, suggesting no difference in the effectiveness of the two teaching approaches on perceived 
benefits of HPV vaccination.   
Cues to action were also assessed and showed no significant interaction between the type 
of educational intervention and time, Wilks Lambda = 0.99, F (1, 135), = 0.176, p = 0.676, 
partial eta squared = 0.001.  The main effect for time was also not significant, Wilks Lambda = 
0.98, F (1, 135), = 2.098, p = 0.150, partial eta squared = 0.015, with neither group showing a 
significant increase in cues to action scores across time.  The main effect for group was also not 
significant, F (1, 135) = 1.358, p = 0.246, partial eta squared = 0.010, suggesting no difference in 
the effectiveness of the two teaching approaches on cues to action scores.  (Note: The cues to 
action sub-scale assessed in the study instrument were separate from the overall study “cue to 
action”, which was the educational intervention). 
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Table 18:  Mixed Within and Between Analysis of Variance 
Impact of educational intervention by belief subscales 
 Control Intervention Wilkes Lambda 
N M SD N M SD 
 
Stigma Scale 
Scores 
        
0.99, F (1, 137)=0.890, 
p=0.347, partial eta 
squared = 0.006 
Pre-Test 77 5.25 2.62 62 5.04 2.20 
Post Test 77 4.87 2.20 62 5.03 2.05 
 
Susceptibility 
Scale Scores 
        
0.99, F (1,133)= 0.968, 
p=0.327, partial eta 
squared =0.007 
Pre-Test 73 4.69 2.47 62 4.74 2.09 
Post Test 73 4.95 2.44 62 4.64 1.94 
 
Severity Scale 
Scores 
        
0.99, F (1,136)= 0.188, 
p=0.665, partial eta 
squared = 0.001 
Pre-Test 74 9.14 1.65 64 8.85 1.73 
Post Test 74 9.56 1.61 64 9.40 1.59 
 
Barriers Scale 
Scores 
        
0.99, F (1,134)= 1.00, 
p=0.847, partial eta 
squared = 0.000  
Pre-Test 72 7.59 3.89 64 7.89 3.38 
Post Test 72 7.27 3.80 64 7.65 2.57 
 
Benefits Scale 
Scores 
        
0.99, F (1,140)= 0.204, 
p= 0.652, partial eta 
squared = 0.001 
Pre-Test 77 6.11 1.63 65 6.06 1.37 
Post Test 77 6.37 1.30 65 6.21 1.29 
 
Cues to Action 
Scale Scores 
        
0.99, F (1,135)= 0.176, 
p= 0.676, partial eta 
squared = 0.001 
Pre-Test 75 10.50 3.96 62 11.01 3.30 
Post Test 75 10.82 3.57 62 11.59 3.78 
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Table 19. 
Belief subscale responses 
   
Stigma Beliefs N (%) Mean 
Score 
t 
value 
Sig. (2 
tailed) 
 Most people think that people with HPV should be ashamed of themselves 
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 31(17) 94(50 53(28) 9(5) 1.7817   
  Post-Test 30(21) 75(52) 36(25) 4(3) 1.0986 6.476 < 0.001 
     
 Most people think that people with HPV are to blame for their problem 
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 26(14) 75(40) 76(40) 11(6) 1.5793   
  Post-Test 23(16) 64(44) 53(36) 7(5) 1.7034 -1.587 0.115 
     
 Most people think that people with HPV are a danger to others    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 20(11) 57(31) 94(51) 14(8) 1.4085   
  Post-Test 17(12) 56(38) 64(44) 10(7) 1.5423 -1.785 0.076 
     
 Only people who are sexually promiscuous get HPV    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 57(30) 88(47) 38(20) 5(3) 2.0552   
  Post-Test 39(27) 75(50) 21(14) 13(9) 1.9517 1.768 0.079 
    
76 
 
 
Table 19 (cont). 
Belief subscale responses 
   
Susceptibility Beliefs N (%) Mean 
Score 
t 
value 
Sig. (2 
tailed) 
 It is extremely likely that I will get HPV in my lifetime    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 38(20) 96(52) 43(23) 9(5) 1.0845   
  Post-Test 35(24) 57(39) 43(30) 10(7) 1.1972 -1.562 0.121 
     
 My current behaviors put me at risk for HPV    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 76(41) 66(36) 39(21) 5(3) .8881   
  Post-Test 62(42) 58(40) 25(17) 2(1) .7762 1.593 0.113 
     
 HPV is a very common infection    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 1(.5) 57(31) 107(58) 21(11) 1.8392   
  Post-Test 0(0) 29(20) 97(67) 19(13) 1.9371 -1.961 0.052 
     
 My risk of getting HPV is higher than most people’s risk    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 64(34) 91(49) 28(15) 3(2) .8571   
  Post-Test 41(29) 85(60) 14(10) 2(1) .8429 .229 0.819 
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Table 19 (cont). 
Belief subscale responses 
   
Severity Beliefs N (%) Mean 
Score 
t 
value 
Sig. (2 
tailed) 
 HPV is a serious infection    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 2(1) 21(11) 116(63) 46(25) 2.2028   
  Post-Test 1(.7) 8(6) 80(55) 57(39) 2.3357 -2.322 0.022 
     
 Cervical cancer is a serious disease    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 0(0) 5(3) 63(34) 118(63) 2.6207   
  Post-Test 0(0) 0(0) 47(32) 100(68) 2.6828 -1.263 0.209 
     
 HPV can be life-threatening    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 2(1) 23(12) 110(60) 50(27) 2.1250   
  Post-Test 0(0) 11(8) 79(54) 57(39) 2.3125 -3.264 0.001 
     
 HPV is very likely to cause cervical cancer    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 0(0) 24(13) 124(67) 36(20) 2.0857   
  Post-Test 0(0) 16(11) 92(64) 36(25) 2.1500 -1.194 0.235 
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Table 19 (cont). 
Belief subscale responses 
   
Barrier Beliefs N (%) Mean 
Score 
t 
value 
Sig. (2 
tailed) 
 I cannot afford to get the HPV vaccine    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 47(26) 65(35) 56(30) 16(9) 1.8511   
  Post-Test 41(28) 66(45) 33(23) 6(4) 1.9574 -1.617 0.108 
     
 I would not get the HPV vaccine because I am afraid of needles    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 81(44) 56(30) 32(17) 17(9) 2.1736   
  Post-Test 66(45) 53(36) 20(14) 8(5) 2.2222 -.725 0.470 
     
 I do not think vaccines work.    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 70(38) 75(41) 27(15) 13(7) 2.1831   
  Post-Test 55(38) 79(55) 8(6) 3(2) 2.2887 -1.699 0.092 
     
 I have concerns about whether the HPV vaccine is safe.    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 22(12) 56(30) 73(40) 33(18) 1.3776   
  Post-Test 18(12) 49(33) 60(41) 20(14) 1.4406 -1.069 0.287 
     
  I have concerns about whether the HPV vaccine is effective.    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 19(10) 68(37) 81(44) 18(10) 1.4931   
  Post-Test 14(10) 51(35) 64(44) 18(12) 1.4028 1.529 0.129 
 I have concerns about possible side effects of the HPV vaccine.    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 14(8) 57(31) 85(46) 31(17) 1.2917   
  Post-Test 16(11) 37(25) 70(48) 23(16) 1.3056 -.226 0.822 
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Table 19 (cont). 
Belief subscale responses 
   
Benefits Beliefs N (%) Mean 
Score 
t 
value 
Sig. (2 
tailed) 
 Getting the HPV vaccine could save my life.    
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 8(4) 32(17) 120(65) 26(14) 1.8897   
  Post-Test 1(.7) 21(14) 100(68) 25(17) 2.0069 -2.205 0.029 
     
 Getting the HPV vaccine could protect me from getting certain types of HPV. 
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 0(0) 13(7) 130(70) 44(24) 2.1818   
  Post-Test 1(.5) 4(2) 112(77) 28(19) 2.1469 .728 0.468 
     
 Getting the HPV vaccine will reduce the chance of me getting cervical cancer in the future. 
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 1(.5) 28(15) 125(68) 31(17) 2.0350   
  Post-Test 1(.7) 10(7) 100(68) 36(25) 2.1538 -2.135 0.035 
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Table 19 (cont). 
Belief subscale responses 
   
Cues to Action N (%) Mean 
Score 
t 
value 
Sig. (2 
tailed) 
 Knowing that HPV affects people like me would encourage me to get the HPV vaccine. 
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 4(2) 36(20) 116(63) 29(16) 1.9241   
  Post-Test 2(1) 26(18) 93(63) 26(18) 1.9655 -.687 0.493 
     
 Knowing more about HPV would encourage me to get the HPV vaccine. 
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 6(3) 25(14) 112(61) 42(23) 2.0140   
  Post-Test 7(5) 21(14) 90(61) 29(20) 1.9720 .581 0.562 
     
 If my doctor recommended that I get the HPV vaccine then I would get it. 
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 4(2) 50(27) 91(49) 41(22) 1.9021   
  Post-Test 6(4) 35(24) 69(48) 35(24) 1.9091 -.111 0.912 
     
 If my mother approved of the HPV vaccine then I would approve of it also. 
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 13(7) 55(30) 88(47) 30(16) 1.7273   
  Post-Test 10(7) 40(27) 68(47) 28(19) 1.7692 -.638 0.524 
     
 If my grandmother approved of the HPV vaccine then I would approve of it also. 
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 16(9) 68(36) 77(41) 26(14) 1.6224   
  Post-Test 7(5) 45(31) 71(49) 22(15) 1.7343 -1.577 0.117 
 If my friends approved of the HPV vaccine then I would approve of it also. 
   Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
   
  Pre-Test 19(10) 73(39) 70(37) 25(13) 1.5764   
  Post-Test 10(7) 49(34) 62(43) 25(17) 1.6875 -1.593 0.113 
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Vaccine Uptake 
Logistic regression was originally proposed to assess the impact of a number of factors 
on the likelihood that respondents would become vaccinated against HPV during the study.  The 
model contained four independent variables (HPV knowledge scores, HPV belief scale scores, 
group, and insurance).  Due to low numbers of respondents actually getting vaccinated (N = 8) 
during the study period, logistic regression analysis could not be conducted for this outcome 
variable.  Vaccine status was verified for all but twelve (6%) participants using a three step 
approach (chart audit 42%, state immunization database 39%, and self-report 13%).  During chi 
square analysis there were equal numbers of participants in both the control (N = 4) and 
intervention (N = 4) group who received the HPV vaccine during the study period.  For this 
reason the outcome variable of interest in the logistic regression model was changed to look at 
intentions to accept the HPV vaccine.  Intentions to accept the HPV vaccine were determined 
based on yes/no response to the question, “If cost were not an issue would you accept the HPV 
vaccine for yourself?”. 
Using intention to accept the HPV vaccine as the outcome variable, logistic regression 
was performed with the same independent variables of HPV knowledge scores, HPV belief scale 
scores, group, and insurance.  The full model containing all predictors was highly significant, x2 
(4, N = 124) = 28.57, p=<0.001, indicating the model could distinguish between respondents 
who did and did not indicate intentions toward HPV vaccine.  The model as a whole explained 
between 21% (Cox and Snell R square) and 28% (Nagelkerke R. Squared) of the variance in 
intentions to accept the vaccine, and correctly classified 70% of cases with a sensitivity of 84% 
and specificity of 50%.  As shown in Table 20, only one of the independent variables made a 
unique statistically significant contribution to the model (Total Belief Scale Score) recording an 
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odds ratio of 1.142.  This indicated that respondents who had increased total belief scale scores 
were 1.142 time more likely to have intentions to accept the vaccine than those with lower belief 
scale scores. 
Table 20. 
 
Logistic regression predicting likelihood of intentions to accept the HPV vaccine 
 B S.E. Wald df p Odds 
Ratio 
95.0% C.I. 
for Odds Ratio 
       Lower Upper 
HPV Knowledge  
Scores 
 
-.094 .090 1.081 1 0.298 .91 .763 1.087 
Total Belief Scale 
Scores 
 
.133 .033 16.216 1 <0.001 1.142 1.070 1.218 
Group 
 
.725 .420 2.986 1 0.084 2.065 .907 4.699 
Insurance Status 
 
1.222 .644 3.606 1 0.058 3.395 .961 11.991 
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Chapter 5 
The purpose of this study was to evaluate the effectiveness of a video based HPV 
prevention education intervention compared to written HPV educational material at improving 
women’s knowledge, beliefs, and behaviors regarding HPV and HPV prevention.  The video-
based first account stories of persons diagnosed with HPV and clear messages about prevention 
and treatment measures was hypothesized to be a more powerful educational tool for increasing 
patients’ knowledge, beliefs, and behaviors regarding HPV and HPV prevention than written 
material alone.  Based on previous literature, written material alone might not be sufficient to 
change health beliefs (Rosen et al., 2010; Waller et al., 2007).  In addition, previous literature 
supported the use of storytelling for health education of patients as a way to increase patients’ 
engagement with the material being presented (Comas-Diaz, 2012).  By augmenting the written 
information with the addition of video-based stories, the learner would be engaged both visually 
and auditorily with the information presented in a way that would increase learning about HPV 
and HPV prevention. 
HPV has been a focus of health care research for many years with a great deal of new 
scientific knowledge generated since the release of the HPV vaccine in 2006.  However, despite 
the growing evidence to support a general lack of knowledge related to HPV among the world's 
population, there are still relatively few studies evaluating educational interventions to increase 
HPV knowledge.  This review showed that only seventeen HPV educational intervention studies 
have been conducted in the past 13 years among vaccine eligible adult women.  HPV educational 
intervention studies are needed to develop an evidence-based model that addresses specific 
population needs for HPV information.  Additionally, using a strong theoretical framework can 
provide guidance for measurement outcomes that might be compared across studies in the future.  
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Having uniform, theoretically grounded intervention tools and outcome measures will contribute 
to nursing knowledge by generating research that is suitable for comparative effectiveness 
studies in the future.  Currently, research has not provided evidence to support that a particular 
educational intervention is most effective at increasing participants’ knowledge, beliefs, and 
behaviors toward HPV prevention.  The purpose of this chapter is to discuss the findings of this 
study in relation to the current literature on the topic of HPV knowledge, beliefs and behaviors.  
Implications for nursing practice will be discussed along with suggestions for future research. 
Impact on Knowledge 
This study hypothesized that video-based first account stories of persons diagnosed with 
HPV and clear messages about prevention and treatment measures would be a more powerful 
educational tool for increasing participants’ pap and HPV knowledge than written information 
alone.  While it was observed that both pap and HPV knowledge significantly increased for both 
groups across time, there was no statistically significant difference between the groups based on 
type of educational information received.  This is similar to Krawczyk et al. (2012) who also 
compared written and video delivered HPV information.  Krawczyk et al. found that both groups 
scored similarly on HPV knowledge at pre-test and post-test.  Krawczyk et al. speculated the 
reason for this was that the information delivered was identical except for the mode of 
information delivery.  The researchers suggested that future studies might add music and images 
to trigger an emotional response in participants and target the video message to influence target 
audiences based on gender, culture, sexual experience, and age.  The current study incorporated 
some of these elements, specifically music, images, and cultural brokerage through first account 
stories of a cervical cancer survivor.  While findings from the current study were not statistically 
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significant, the video based educational group did have slightly higher knowledge scores than the 
written educational group.  
Upon enrollment in the study, women’s pap and HPV knowledge levels were low, even 
among participants who regularly had contact with health care personnel for pap screening.  This 
is consistent with the literature suggesting low pap and HPV knowledge exists among women 
who have regular contact with health care providers for pap screenings (Cermak et al., 2010; Fry 
et al., 2010; Kahn et al., 2005; Waller et al., 2009; Warren, 2010).  Findings from this study 
support that low pap and HPV knowledge is still a relevant problem today among women who 
regularly see health care providers for annual exams.  The fact that knowledge deficits persist 
despite increasing access to health care providers through the affordable care act is concerning 
and speaks to many unmet educational needs that could be influenced by changes in health care 
practices.   
Reasons for low knowledge despite regular health provider contact is unclear, but may be 
due to lack of time in the office for face-to-face education of women (Bayer et al., 2011), or 
could reflect a lack of HPV knowledge and self-efficacy among healthcare providers.  Further 
research into reasons for women’s unmet educational needs regarding HPV is warranted.  
Similarly, further research into healthcare providers’ lack of provision of HPV education is also 
warranted. 
Participants in this study were least knowledgeable regarding the fact transmission of 
HPV is via skin to skin contact rather than blood or body fluids.  The participants also did not 
understand that there were many types of HPV and that the vaccine only protects against some 
types of HPV.  Knowledge deficits were also related to signs and symptoms of HPV, with many 
participants believing HPV was the virus that caused herpes, HIV/AIDS, and many participants 
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did not understand the relationship between HPV and abnormal pap smears and cervical cancer.  
This is similar to the literature citing the most frequent knowledge deficits among women are 
associated with modes of transmission, prevalence, relationship of HPV to cancer, and lack of 
knowledge regarding prevention methods (Fry et al., 2010; Kahn et al., 2005; Waller et al., 2009; 
Warren, 2010).  These discrepancies in accurate HPV knowledge are concerning and suggest a 
greater need for accurate health information on HPV.  Future educational campaigns should 
stress factual HPV information related to the transmission and prevention of HPV.   
Additionally, 34% (n = 65) of age eligible women in this study population reported never 
having pap testing.  The subsequent pap and HPV knowledge scores among this group of study 
participants is significantly lower than the women who did attend for pap testing exams.  This 
reflects similar findings in the HPV literature regarding the connection between regular pap 
testing, HPV knowledge, and prevention behaviors (Mills et al., 2011).  The lack of participation 
in pap screening exams is concerning for this study group as they were noted to have several risk 
factors for HPV and cervical cancer (Table 6).  Their lack of participation in secondary 
prevention of HPV related cancer may be related to their overall lack of pap and HPV knowledge 
and is consistent with previous studies showing lack of knowledge is a real barrier to prevention 
seeking behaviors (Bynum et al., 2011; Juraskova, Obrien, et al., 2011).  Additionally, many 
women do not understand the purpose of pap testing is to prevent cervical cancer (Hawkins et al., 
2011; Panagopoulou et al., 2011; Vasconcelos et al., 2011).  In fact, women most often report 
other reasons (contraception, pelvic pain or symptoms) for attending clinics for pap smear 
testing, not related to HPV or cervical cancer screening (Bayer et al., 2011; Bertram & 
Magnussen, 2008; Daley et al. 2010; Friedman & Shepeard, 2007; Perrin et al., 2006; 
Vasconcelos et al., 2011).  Of major importance for future health initiatives is to educate young 
87 
 
 
women regarding the age they should start pap testing, the purpose of the pap test, and the 
importance of pap testing regardless of vaccine status. 
Impact on Health Beliefs 
Health Belief Model Constructs 
In addition to evaluating women’s knowledge of HPV this study sought to evaluate 
changes in women’s health beliefs regarding HPV and HPV prevention.  The video based HPV 
prevention education intervention was hypothesized to be more effective than written HPV 
educational material at improving health belief model constructs (perceived susceptibility, 
perceived severity, perceived benefits, perceived barriers, and cues to action) regarding HPV 
prevention among women.  The supposition was that as perceived susceptibility and severity 
increased, participants would perceive greater benefit and fewer barriers to vaccination, leading 
to increased uptake of primary prevention vaccination behaviors among the participants in the 
study. 
Findings showed no significant difference in the effectiveness of the two teaching 
approaches on changing participants’ health beliefs.  However, there was a significant increase in 
the Total Belief Model Scale Scores for both groups over time.  Additionally, there was a 
significant increase in perceived severity subscale scores for both groups over time, and while 
not significant there was a trend of positive changes in each subscale for both groups over time.  
In this study, both educational programs were equally effective at changing health beliefs related 
to HPV.  This is similar to findings by Juraskova, Bari, et al. (2011) who showed significant 
changes in perceived severity and perceived benefits following an educational intervention.  In 
their study, they also noted the subscales of perceived severity and perceived benefits were most 
predictive of vaccine behavior.  The researchers found that the cues to action subscales were 
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more likely than other belief subscales to be a significant predictor of positive attitudes toward 
HPV vaccine acceptance.  This is consistent with more recent studies of the Health Belief Model, 
which suggest the construct of “cues to action” is more predictive of health behaviors than other 
constructs in the model (Carpenter, 2010).  
Previous HPV studies have utilized the Health Belief Model as a theoretical framework 
to guide study interventions.  However, most studies have used only part of the model (ie. 
perceived susceptibility and severity) rather than the model as a whole, which may make the 
study outcomes less predictive (Carpenter, 2010; Harrison et al., 1992).  Carpenter (2010) 
suggested using the four traditional model constructs (susceptibility, severity, benefits, barriers) 
as a whole, and including moderator variables (like “cues to action”).  At the time of this study, 
there were only two HPV studies utilizing the model as a whole with “cues to action” (Bynum et 
al., 2011; Juraskova, Bari, et al., 2011).  The current study found that utilizing the model as a 
whole was most predictive of vaccine intentions.  Future HPV educational intervention studies 
should include the model in its entirety for maximum predictive value on outcome variables. 
HPV Stigma Beliefs 
 Lack of HPV knowledge is associated in the literature with increased stigma beliefs 
associated with HPV (Bertram & Magnussen, 2008; Daley et al., 2008; Daley et al., 2010; 
Lagro-Janssen & Schijf, 2002).  Stigma associated with HPV has implications for disease 
prevention in the future.  Studies have identified stigma associated with HPV as a barrier to 
prevention seeking behaviors, partner notification, and social support (Friedman & Shepeard, 
2007; Perrin et al., 2006).  Addressing the psychosocial stigma attached to HPV is important to 
facilitate successful prevention programs.   
89 
 
 
This study hypothesized a video based educational program using a cervical cancer 
survivors story would result in greater decreases in HPV related stigma beliefs in women than 
written material alone.  Findings from the study did not support the hypothesis that the video 
based educational program would be more effective than written information alone in changing 
women’s HPV stigma beliefs.  However, all of the women had higher rates of HPV stigma 
beliefs going into the study, which decreased for both groups over time.  Therefore, HPV related 
stigma beliefs are impacted by factual HPV information, and lower HPV related stigma can 
impact HPV prevention seeking behaviors by women (Friedman & Shepeard, 2007; Perrin et al., 
2006). 
Prevention 
Primary Prevention 
HPV vaccination rates are low among women 19-26 years old, with only 20.7% of 
women having received at least one dose of HPV (MMWR, February 3, 2012).  Several 
educational programs among women have sought to change this statistic.  While the majority of 
studies showed that educational interventions can increase prevention intentions (Crosby et al., 
2008; Fry et al., 2010; Juraskova, Bari et al., 2011; Kahn et al., 2005; Krawczyk et al, 2012; 
Kwah et al., 2010; Mock et al., 2007; Papa et al., 2009), one study showed no change in 
prevention intentions after receiving the educational intervention (Patel et al., 2012), and another 
study showed less participant self-intention to get vaccinated, but higher intentions to get the 
vaccine for their children following an educational intervention (Ferris et al., 2007).   
This study sought to evaluate the effectiveness of two types of educational program on 
vaccine behaviors.  However, actual vaccine behaviors could not be evaluated due to too few 
participants actually becoming vaccinated during the study period.  Subsequently, the 
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effectiveness of the two educational programs was evaluated based on ability to predict changes 
in attitudes toward vaccination for the participants themselves and their adolescent children.  
Findings showed both groups were more willing to accept the vaccine for themselves and their 
adolescent children post-intervention, but there was no statistically significant difference 
between the two groups on willingness to accept the vaccine for themselves’ or their adolescent 
daughters.  There was a statistically significant difference in the participants’ willingness to 
accept the vaccine for their adolescent sons over time, with the video based education group 
being more willing than the control group to accept the vaccine for their adolescent sons at time 
2.  To determine the cause of this difference the two educational programs were evaluated for 
differences in message content.  Evaluation showed the video based factual information 
regarding who is eligible to receive the HPV vaccine may have been more gender neutral than 
the written CDC fact sheet given to the control group.  The video message simply provided the 
ages for which the vaccine has FDA approval, which includes “all males and females 9-26 years 
of age can receive the HPV vaccine”.  The CDC hand out is more specific about different age 
groups and risk groups who should be vaccinated.  The CDC message reads “the vaccine is 
recommended for boys and girls ages 11 or 12 years, catch-up ages for boys are from 21-26 and 
the CDC recommends the vaccine for gay and bisexual men through age 26, and men and 
women through age 26 with an impaired immune system (including people living with 
HIV/AIDS)”  (CDC, February 23, 2015).  Possibly by including specific criteria for gay/bisexual 
men in the CDC handout participants were led to believe their son would not need the vaccine if 
he were not in this high-risk category.  Additionally, it is possible that different age ranges for 
recommended and catch-up schedules based on gender led some women in the study to perceive 
less need for the vaccine for their adolescent boys when in effect it is equally important to 
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vaccinate both genders against HPV in order to eradicate the infection from the population.  
Based on findings from this study, content review of parent handouts related to HPV and HPV 
vaccine information would be important.  Simplified recommendations to include the same age 
range for both genders irrespective of other risk factors with long-term eradication of HPV 
infection among the general population as a goal might be more effective in swaying parent 
decisions to vaccinate adolescent children.   
Secondary Prevention 
 There was a fairly large proportion of 18-26 years old women in this study who had not 
yet had a pap smear screening test (34%). This rate is higher than the national average of 22% 
for women (aged 18-65 years) who have not undergone pap testing (NCI, 2005).  It is difficult to 
make a direct comparison of this number however, because the sample for this study is much 
smaller and the age ranges are not equal.  
However, among those who had never had pap smear screening, 46% were above the age 
of 21 years when regular pap screening is advised.  It is not clear why these women were not 
getting regular pap smear screening, but lack of knowledge regarding the benefits of regular pap 
testing may be a factor.  It was observed that women naïve to pap testing had significantly lower 
pap knowledge scores at time 1 (M = 3.31, SD 2.09) than women who had pap testing prior to 
the study (M = 4.91, SD 1.16) t (73.65) = -5.45, p = .000 (two-tailed).  Even though non-pap 
testing women had their knowledge increased over time (M = 4.5, SD 1.17), it was still 
significantly lower than the pap testing group of women (M = 5.16, SD .81) at time 2, t (89.41) = 
-3.68, p = .000 (two-tailed).  Based on this data it is impossible to say whether age eligible 
screening participant lack of participation in pap screening is attributable to lack of knowledge 
regarding the need for screening or rather conversely their lack of knowledge is a result of no 
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exposure to pap screening.  What can be inferred is a large portion of age eligible women in this 
study are not getting the recommended screened for HPV and cervical cancer, and according to 
responses on age of sexual debut and lifetime number of sexual partners they are at high-risk for 
HPV transmission.  The findings in this study highlight a need for additional education among 
young women regarding the value of regular pap screening exams. 
Significance of the Study 
Contribution to Nursing Knowledge and Practice 
 Understanding women’s HPV knowledge, beliefs and behaviors has implications for 
nursing practice because the current national vaccine uptake rate among adult women is low at 
20%.  Studies among women have shown a connection between HPV knowledge and beliefs and 
vaccine uptake.  However, there are discrepancies in the literature regarding the most effective 
information and educational delivery format to meet this need.  This study sought to compare the 
effectiveness of two type of information delivery on changing women’s HPV knowledge, beliefs, 
and behaviors.  Several implications can be drawn from the study to inform practice.   
 First, nurses are often the first point of contact patients have for health care information, 
and according to respondents in this study health care providers are the most trusted source of 
health information.  However, this study demonstrated that women are not receiving adequate 
pap and HPV education despite having regular contact with health care providers for pap testing.  
It is unclear why they aren’t receiving education, but their lack of knowledge does have a direct 
impact on their willingness to accept the HPV vaccine for themselves and their adolescent 
children.  Both groups in this study were more willing to accept the vaccine for themselves and 
their adolescent children post-intervention.  Thus, increasing women’s knowledge of HPV and 
the HPV vaccine could in time have a positive influence on HPV vaccine rates. Additionally, by 
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providing gender neutral HPV educational information nurses may see greater willingness to 
accept HPV vaccination for adolescent boys.   
Nursing can also play an important role in women’s knowledge regarding pap screening 
exams.  Many participants in this study who were age eligible were not yet having recommended 
pap screening tests.  Nursing can influence this by reminding young women at every opportunity 
about recommended preventive health testing that should occur.  Also observed in this study is 
that even among women who were getting regular pap testing their pap and HPV knowledge was 
low.  Thus, it is important that nurses not assume that women attending regularly for pap testing 
already know all about the test, HPV, or other sexual health issues.  Nurses need to treat every 
health care visit as an opportunity to broaden a patient’s knowledge of health topics.  
Beyond understanding the importance of health prevention behaviors, nurses also play a 
role in removing barriers to health care.  In this study, the most common barriers to vaccination 
cited by participants were cost and fear of vaccines.  Nurses can play a critical role in removing 
these two barriers by helping patients locate local clinics where the vaccine is available for 
low/no cost.  Additionally, myths are pervasive in the public and through social media regarding 
the HPV vaccine that can falsely elevate peoples’ fear of the vaccine.  As such, dissemination of 
factual HPV information in places commonly viewed by the general public would be important 
for nurses to combat fears perpetuated by inaccurate information.  Nurses should consider 
dissemination of HPV vaccination facts and dispelling myths in popular and accessible media 
including magazines and online social media forums.  In this study, participants attending family 
planning clinics were more often getting the HPV information than women from the general 
population without access to regular health care.  Thus, nurses need to step outside of their 
traditional work environments to reach women with minimal exposure to the health care system.   
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In this study, women had many unmet pap and HPV knowledge needs, which provide 
evidence of a major gap in nursing practice.  Additional research among nursing/health care 
personnel is needed to determine their knowledge of HPV and their self-efficacy to educate 
patients regarding prevention.  
Potential Impact on Health and Quality of Life 
HPV is associated with significant morbidity and mortality.  HPV morbidity is related to 
the chronic potential recurrence of genital warts, the psychological experience of stigma related 
to HPV diagnosis, and fear of cancer associated with HPV related cervical dysplasia.  While 
HPV mortality has decreased among developed countries utilizing secondary prevention (pap 
testing), lives saved could be greater with increased awareness and acceptance of HPV primary 
prevention (vaccination).  Currently, there is an underutilization of available HPV primary 
prevention services.  This study supports both HPV primary and secondary prevention services 
are not being fully utilized by age eligible women, and many in the study were high-risk for HPV 
and its associated morbidity. 
 Participants in this study had several risk factors for HPV (young age of sexual debut, 
multiple partners, lack of condom use, etc.) and approximately 10% of participants in this study 
reported a previous diagnosis of HPV.  This has significant implications for health and quality of 
life for study participants as those diagnosed with HPV will have to undergo expensive and often 
physically and psychologically painful diagnostic and treatment procedures to prevent later 
development of cervical cancer.  Any effort we can make as a health care community to prevent 
morbidity associated with HPV infection is worthwhile.  
 Despite many participants having insurance coverage in this study, the most cited barriers 
to utilization of prevention services in this study was cost, availability, and fear of vaccines.  
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This finding suggest there may be social and health policy implications needing addressed in 
order to remove barriers to prevention services for adult women.  Health policy legislation that 
could expand HPV vaccine availability to private physician offices, pharmacies, and other 
potential sources of access to adult women would be important to consider. 
Vaccine Availability and Uptake 
Despite being age eligible for the HPV vaccine, none of the study participants had yet 
been vaccinated upon enrollment in this study.  A small number became vaccinated during the 
study (n = 8).  Respondents reported several potential reasons for lack of vaccination.  
Lack of availability of the vaccine for adult women is concerning.  Fourteen percent of 
respondents at time 1 versus 10% at time 2 reported non-availability of the vaccine as a barrier to 
getting vaccinated.  In this study, participants’ intentions toward accepting the vaccine increased 
after learning more about HPV and the HPV vaccine, however, their behaviors toward 
vaccination during the study protocol indicated that while they were more inclined to accept the 
vaccine, few actually got vaccinated.  Perhaps lack of vaccine availability is one reason for this 
finding.  This has implication for future policy that might mandate greater availability of the 
vaccine for adult populations.  First, policies might suggest expanded federal VFC funding for 
adult doses of the vaccine for those who are under or uninsured.  Additionally, policies could be 
implemented at the state and national level to require access for all insured patients to adult 
vaccines health departments around the nation.  Finally, health policy could be implemented to 
require the HPV vaccine for seventh grade entry along with other adolescent vaccines. This type 
of policy would eventually solve the problem of children reaching adulthood without receiving 
the HPV vaccine. 
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While the vaccine is available in every state and county in the nation, the vaccine may 
only be available at county health departments or clinics who subscribe to the Vaccines for 
Children funds.  Additionally, these programs stock primarily for adolescent populations and 
may not have a large supply of private pay stock for adults due to the expense of maintaining a 
private vaccine supple.  Many private physician offices opt not to stock vaccines due to the 
expense of maintaining the supply in low volume clinic settings.  
Additionally, even though 84% of the population reported having insurance coverage, 
nearly 41% of respondents at time one and 34% at time 2 noted cost was a barrier to getting 
vaccinated.  This finding reflects that while many more young people are being insured through 
the Affordable Care Act, there may be gaps in insurance coverage for vaccinations.  Many 
women in this age group may fall through the cracks for age eligibility for government 
sponsored Vaccine Programs, which could impact women’s ability to become vaccinated.  While 
this study promoted pharmaceutical company charity programs for uninsured women, not all 
clinics were willing to subscribe to these program as they require extra paperwork and up front 
expense prior to reimbursement. For these reasons most clinics contacted during the study chose 
to refer patients to local health departments for vaccine services. 
Another reason for lack of vaccine uptake may have been respondents’ lack of perceived 
need for the vaccine.  Based on comments by participants their lack of perceived need stemmed 
from many factors.  Some felt that because they were currently monogamous with a male partner 
or lesbian, the vaccine was not needed.  Additionally, many felt that because they were at the end 
of the age bracket for suggested vaccination, they were too late to begin HPV vaccination.  A 
few participants reported already being diagnosed with HPV as a reason not to get the vaccine.   
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Many of these statements reflect a lack of understanding regarding HPV and HPV 
vaccination.  Recommendations for vaccination are not made based on monogamy or lesbian 
sexual orientation, thus any woman up to the age of 26 years should consider getting the HPV 
vaccine.  Additionally, even if a woman is already 26 years old and will turn 27 before finishing 
the HPV vaccine series, she can still start the vaccine series.  The age cut off of 26 years is made 
based on what we know about HPV pathophysiology and epidemiology.  Based on 
pathophysiology and epidemiology of HPV it is felt the vaccine is most cost effective when 
given at younger ages.  There are no added safety concerns if a woman should finish her vaccine 
series after she turns 27 years old.  Finally, participants’ feeling they could not be vaccinated 
because they were already diagnosed with HPV is a misperception common among many people.  
In actuality previous diagnosis of any HPV strain does not confer immunity towards additional 
HPV strains (Wheeler, 2007).  Nor does clearing the virus confer immunity against reinfection 
with the same HPV type in the future.  Thus, all women regardless of previous diagnosis with 
HPV are encouraged to become vaccinated against available HPV strains in the vaccine.  
Overall, these statements reflect the lingering lack of knowledge many people have regarding 
HPV types, transmission, and the vaccine in general. 
Finally, many respondents had an inherent fear of risks of vaccines as a reason for 
avoiding HPV vaccine uptake.  This is troubling given there is a large body of scientific evidence 
suggesting the benefits of vaccines far outweigh the risks of vaccination.  In particular, the HPV 
vaccine has an excellent safety profile with the most common side effects being pain and 
irritation at the injection site (Wheeler, 2007; FDA, 2015).  
 Respondents’ concern for HPV vaccine safety suggests an ongoing need for continued 
education on the topic of HPV vaccine safety.  Future educational programs must include factual 
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information regarding HPV vaccine safety as a way to decrease perceived barriers to vaccine 
uptake among women.  Furthermore, nurses should be trained in delivering HPV information to 
young women and in promoting HPV vaccination. 
Suggestions for Future Research 
The current study represented a prospective quasi-experimental, pre-test/post-test design 
with delayed intervention treatment administered to the control group at study completion.  The 
study was done because there was a lack in the current HPV literature reflecting effective HPV 
educational material and approaches for young women.  Prior to this study there had only been 
two video delivered studies among women.  One of which measured knowledge and the other 
assessed behavior outcomes following the intervention.  This study was designed to evaluate the 
effectiveness of a video based educational program on women’s knowledge and behaviors in 
comparison to the standard of care of written material alone.   
This study found there was no difference in the effectiveness of the two types of 
educational material on HPV knowledge, however, both groups’ HPV knowledge and attitudes 
scores improved following the different types of interventions.  Also, the video-based education 
was significantly more effective at increasing women’s willingness to accept the HPV vaccine 
for their adolescent sons.  Therefore, future studies might build upon this by studying the video 
based educational program among a larger sample of mothers of adolescent sons to see if the 
same result is obtained and whether the video-based education might influence actual vaccine 
uptake among adolescent boys. 
This study also found that while women are attending for pap screening they still have 
low pap and HPV knowledge scores suggesting they are not having all their educational needs 
met at these health care visits.  Reasons for lack of educational information among women who 
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have contact with health care providers is unclear, but future research may uncover factors 
influencing the provision of HPV education to women in the clinic setting.  Additionally, future 
research should explore nurses/health care providers’ knowledge of HPV and their self-efficacy 
to educate patients on the topic.  Possibly nurses and health care providers in general have unmet 
HPV and HPV vaccine knowledge needs. 
Limitations 
The majority of this sample was Caucasian with little ethnic or racial diversity and most 
respondents were living in rural Appalachia.  Therefore, inferences cannot be made about 
women from other ethnicities, races, or geographic locations.   Another limitation of this study 
related to recruitment procedures.  Issues arose during face-to-face recruitment in clinic causing 
the researcher to amend the IRB protocol to expand recruitment to the workforce, internet, and 
university student email.   Self-selection to an on-line survey poses challenges for verification of 
participant inclusion/exclusion criteria.  However, of the 194 participants recruited in the study, 
only 12 were completely unverifiable for meeting inclusion criteria.  The additional 182 were 
verifiable for female gender, age, and vaccine status.  Also because participants self-selected for 
this study they may have some biases toward the topic, which would make their responses less 
representative of the population as a whole.     
Another limitation was the inclusion/exclusion criteria for this study were too strict.  
Several women in the clinic were age eligible for the study and wanted to participate, but had 
already had at least one HPV shot which excluded them from the study.   After moving the 
recruitment to the university student email more non-vaccinated women were found for the 
study.  Additional studies among university students evaluating why they are not as likely to 
have gotten the vaccine would be important.  Perhaps there is a need for greater awareness and 
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access to health care services like vaccination among this age group of women in the community 
and on campus. 
Many HPV studies have assessed the impact of HPV knowledge on increasing HPV 
vaccine intentions.  Few studies have assessed actual vaccine uptake behaviors.  This study 
included assessment of actual vaccine uptake.  However, few participants (control n = 4, 
intervention n= 4) received the HPV vaccine during the study.  The low numbers of actual 
vaccine uptake in this study prevented analysis of the impact HPV education might have on 
vaccine uptake.  Therefore, a limitation of this study was that conclusions could only be drawn 
regarding the impact of HPV education on intentions toward HPV vaccination rather than actual 
vaccine behaviors, which would have been preferred.  It is not completely clear why so few 
participants became vaccinated during this study, but perhaps identified barriers of cost, access, 
and fear of shots were factors.  Future studies should be designed to address these barriers in 
order to assess the impact education might have on actual vaccine behaviors.  
Finally, a limitation of this study was that the control group in this study might have 
actually received more education than is typical of standard of care.  While the researcher felt 
written information alone was probably more typical of standard of care, it may be that no 
education of any type is more typical of the standard of care. This finding is based on the 
evidence in this study showing that women who regularly attended clinics for pap test still have 
low levels of baseline knowledge.   
Conclusions 
In conclusion, there is a need for additional HPV research focusing on theoretically 
grounded educational interventions among differing populations at risk for HPV.  In particular 
there is a need for additional research to determine why women who have regular contact with 
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health care providers are still having unmet HPV knowledge needs.  A study among health care 
personnel related to this topic might provide valuable insight into this problem.  Additionally, 
more research needs to be conducted regarding the importance of gender bias in HPV vaccine 
recommendations.  This study indicates there was a statistically significant increase in women’s 
willingness to vaccinate adolescent sons following the video based educational program.  
Replication of this study among parents of adolescent children would be important as a way of 
informing our knowledge regarding adaptations needed on future CDC HPV literature.   
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Appendix A:  Information cover letter for participants 
Dear Participant,  
 
This letter is a request for you to take part in a research project to assess your knowledge, beliefs, 
and behaviors associated with HPV and HPV vaccination.  This project is being conducted by 
Crystal Sheaves, a doctoral student at West Virginia University School of Nursing. Crystal 
Sheaves will administer this research project under the supervision of her Dissertation Chair, Dr. 
Ilana Chertok. Your participation in this project is greatly appreciated and will take 
approximately 20 minutes (to fill out a short survey and receive HPV educational material).  
 
Your involvement in this project will be confidential, and no identifying information will be 
collected on the survey. All data will be reported in aggregate. You must be 18 -26 years old, 
have never received a HPV shot, and non-pregnant to participate. Your participation is 
completely voluntary, and you may discontinue at any time.  Your visit today at the doctor’s 
office will not be affected in any way if you choose not to participate in this study.   West 
Virginia University's Institutional Review Board acknowledgement of this project is on file.  
 
I hope that you will participate in this research project, as it could be beneficial in understanding 
the strength of the HPV knowledge, beliefs, and behaviors of women in West Virginia. Thank 
you very much for your time. Should you have any questions about this letter or the research 
project, please feel free to contact Crystal Sheaves at (304) 573-6963 or by e-mail at 
csheaves@hsc.wvu.edu. In addition, if you have questions or concerns regarding this study you 
may contact the West Virginia University Office of Research Compliance at 304-293-7073 ext. 
3. 
 
For more information on HPV, please visit the CDC website at: http://www.cdc.gov/hpv/ 
You are also encouraged to discuss any questions or concerns you may have about HPV with 
your medical provider.  In addition, a list of counseling services in your area is attached, if you 
should feel the need to discuss any concerns that arose after taking the survey.   
 
Thank you for your time and help with this project.  
 
Sincerely,  
 
 
 
Crystal Sheaves 
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Appendix B: Pre-test HPV knowledge, beliefs, and behaviors questionnaire 
         Survey: _______ 
HPV Knowledge, Beliefs, and Behaviors Questionnaire 
Please, read each question and put a check (√) beside your answer. If you do not want 
to answer a question, you can leave it blank. Only mark one response for each 
question, unless you are asked to “check all that apply.”  
 
Questions about You 
1. How old are you? ______ 
 
2. What is your race? 
 White 
 African American or Black 
 Hispanic or Latino 
 Asian 
 American Indian or Alaska Native 
 Native Hawaiian or Other Pacific Islander 
 Other race (Please specify)______________________ 
 
3. What best describes your sexual orientation? 
 Heterosexual  
 Gay/Lesbian  
 Bisexual  
 Unsure  
 
4. What is your current relationship status?  
 Single  
 Married 
 Living with Partner (i.e., boyfriend/girlfriend) 
 Divorced/Separated  
 Other (Please Specify)_______________________________ 
 
5.   What is your highest level of education? 
 Some high school 
 High school graduate or GED equivalent  
 Associates Degree or Some college 
 Bachelor’s degree or Associate’s degree 
 Graduate/professional degree (i.e., Masters, PhD, MD) 
 
6.  How do you pay for your health care appointments? (CHECK ONLY ONE) 
 Private insurance 
 Medicaid 
 Clinic program (BCCSP, Family Planning, Sliding Scale, etc.) 
 Out-of-Pocket (Private Pay) 
 None 
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7.   Do you smoke? 
 Yes 
 No 
Questions about Your Sexual History 
8. Have you ever had sexual intercourse? (Sexual intercourse includes vaginal, oral, 
or anal sex.)  
 Yes 
 No 
 
9. How old were you when you had sexual intercourse for the first time? ________  
 
10. During your lifetime, with how many people have you had sexual intercourse 
with? ________ 
 
11. The last time you had sexual intercourse, did you or your partner use a 
condom? 
 Yes 
 No 
 Don’t Know/Not Sure 
 
12. In general, do you use condoms to (CHECK ALL THAT APPLY): 
 Prevent pregnancy 
 Prevent sexually transmitted infections (STIs) (also called STDs) 
 Prevent HIV infection (the virus that causes AIDS) 
 other reason (Please specify)________________________________________ 
 
13.   Do you use hormonal contraceptives? (birth control pills, depo shot, or 
IUD) 
 Yes 
 No 
 
14. How many times have you been pregnant? 
 0 
 1 
 2 
 3 
 4 
 5 or more 
 
15. How many live births have you had? 
 0 
 1 
 2 
 3 
 4 
 5 or more 
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16. Have you ever had a Pap smear also known as a Pap test?  
 Yes 
 No 
 Don’t Know/Not Sure 
 
17. How long has it been since you had your last Pap smear? 
 Less than 12 months ago 
 2 years ago 
 3 years ago  
 4 years ago  
 5 years ago   
 5 or more years ago  
 Don’t Know/Not Sure  
 
18. Have you ever been told by a health care provider that your Pap smear result is 
“abnormal”?  
 Yes 
 No 
 Don’t Know/Not Sure 
 
19. Have you ever been told by a health care provider that you had a sexually 
transmitted infection or disease also called an STD or STI?  
 Yes 
 No 
 Don’t Know/Not Sure  
 
20. Have you ever been told by a health care provider that you have HPV? 
 Yes  
 No  
 Don’t Know/Not Sure 
 
21.    If Yes, did your health care provider tell you that you had a high-risk type of 
HPV? 
 Yes 
 No 
 Don’t Know/Not Sure  
 
22.    If Yes, did your health care provider tell you that you had a low-risk type of HPV? 
 Yes 
 No 
 Don’t Know/Not Sure  
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Questions about Your Sexual Health 
23. Please tell us how much you agree or disagree with the statements (from 
“strongly disagree” to “strongly agree”).  
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
a. It is difficult for me to find effective solutions for the sexual 
health problems that come my way. 
    
b. I’m generally able to accomplish my goals with regard to 
my sexual health needs.  
    
c. I succeed in things I do to improve my sexual health.      
d. I am directly responsible for my sexual health.     
 
Pap Smear Knowledge 
 
24. Please, respond to the following statements about HPV as TRUE, FALSE, or 
DON’T KNOW.  
(If you don’t know, check “DON’T KNOW.”)  
 True False Don’t 
Know 
a. A Pap smear is a test to find out if a woman is pregnant.    
b. All women should be getting Pap smears by the time they are 21 
years old. 
   
c. A Pap smear checks for changes in the cells of a woman’s uterus, 
also called the womb. 
   
d. A Pap smear checks for changes in the cells of a woman’s cervix.    
e. Getting regular Pap smears is the best thing a woman can do to 
prevent cervical cancer. 
   
f. If a woman has a Pap smear result that is not normal that usually 
means that she has cancer. 
   
 
 
HPV Knowledge and Awareness 
 
25. Have you ever heard of HPV? (HPV stands for human papillomavirus.) 
 Yes 
 No 
 
26.  Have you ever heard of the HPV vaccine? (also called the HPV shot or 
GARDASIL.) 
 Yes 
 No 
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27.   Please, respond to the following statements about HPV as TRUE, FALSE, or 
DON’T KNOW.  
(If you don’t know, check “DON’T KNOW.”)  
 True False Don’t Know 
a. HPV can cause HIV/AIDS.    
b. You can always tell when someone has HPV.    
c. HPV can cause abnormal Pap smears/ Pap tests.    
d. Only women get HPV.    
e. HPV can cause herpes.    
g. HPV can cause genital warts.    
h. You can have HPV without knowing it    
i. HPV is a sexually transmitted infection (STI) or STD.    
j. HPV can cause cervical cancer.    
k.    The HPV vaccine protects against all HPV infections?    
l.     Condoms are not 100% effective at preventing HPV?    
m.   HPV is spread by skin to skin contact?    
 
HPV Vaccine Acceptability 
 
28. If cost was not an issue, would you get the vaccine to prevent HPV 
infection? 
 Yes 
 No 
 Don’t Know/Not Sure 
 
29.  What are the barriers or reasons for not getting the HPV vaccine? (CHECK 
ALL THAT 
APPLY) 
 Cost 
 Not available 
 Risks with shots 
 No need 
 Other: __________________ 
 
30. Do you know where to go to get the HPV vaccine? 
 Yes 
 No 
 
31. If you have an 11-12 year-old daughter (or became the parent of one in the future), 
would you have her vaccinated against HPV? 
 Yes 
 No 
 Don’t Know/Not Sure  
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32. If you have an 11-12 year-old son (or became the parent of one in the 
future), would you have him vaccinated against HPV? 
 Yes 
 No 
 Don’t Know/Not Sure  
 
 
Attitudes, Beliefs, and Perceptions about HPV and HPV Vaccine 
 
33. This section asks about your beliefs and perceptions about HPV and the HPV 
vaccine.  Please tell us whether you agree or disagree with the following 
statements (from “strongly disagree” to “strongly agree”).  
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
a. Most people think that people with HPV should 
be ashamed of themselves 
 
 
 
 
 
 
 
 
b. Most people think that people with HPV are to 
blame for their problem 
 
 
 
 
 
 
 
 
c. Most people think that people with HPV are a 
danger to others 
 
 
 
 
 
 
 
 
d. Only people who are sexually promiscuous get 
HPV 
 
 
 
 
 
 
 
 
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Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
e. It is extremely likely that I will get HPV in my 
lifetime.  
 
 
 
 
 
 
 
 
 
f. My current behaviors put me at risk for HPV.  
 
 
 
 
 
 
 
 
g. HPV is a very common infection 
 
 
 
 
 
 
 
 
h. My risk of getting HPV is higher than most 
people’s risk 
 
 
 
 
 
 
 
 
 
 
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
 
i. HPV is a serious infection. 
 
 
 
 
 
 
 
 
 
j. Cervical cancer is a serious disease.  
 
 
 
 
 
 
 
 
k. HPV can be life-threatening     
l. HPV  is very likely to cause cervical cancer     
 
 
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
 
m. I cannot afford to get the HPV vaccine.  
 
 
 
 
 
 
 
 
n. I would not get the HPV vaccine because I am 
afraid of needles.  
 
 
 
 
 
 
 
 
 
o. I do not think vaccines work.  
 
 
 
 
 
 
 
 
p. I have concerns about whether the HPV vaccine 
is safe. 
 
 
 
 
 
 
 
 
q. I have concerns about whether the HPV vaccine 
is effective. 
 
 
 
 
 
 
 
 
r. I have concerns about possible side effects of the 
HPV vaccine. 
 
 
 
 
 
 
 
 
 
 
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
 
s. Getting the HPV vaccine could save my life. 
 
 
 
 
 
 
 
 
t. Getting the HPV vaccine could protect me from 
getting certain types of HPV. 
 
 
 
 
 
 
 
 
u. Getting the HPV vaccine will reduce the chance 
of me getting cervical cancer in the future. 
 
 
 
 
 
 
 
 
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Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
v. Knowing that HPV affects people like me would 
encourage me to get the HPV vaccine. 
 
 
 
 
 
 
 
 
w. Knowing more about HPV would encourage me 
to get the HPV vaccine.   
 
 
 
 
 
 
 
 
x. If my doctor recommended that I get the HPV 
vaccine then I would get it.  
 
 
 
 
 
 
 
 
y. If my mother approved of the HPV vaccine then I 
would approve of it also.  
 
 
 
 
 
 
 
 
z. If my grandmother approved of the HPV vaccine 
then I would approve of it also.  
 
 
 
 
 
 
 
 
aa. If my friends approved of the HPV vaccine then I 
would approve of it also.  
 
 
 
 
 
 
 
 
 
Questions about Your Health Information Sources 
34.     Have you ever attended an HPV-related event? 
 No 
 Yes  
 
35.      Have you ever seen the “Tell Someone”, “One Less”, or other television 
commercials about  
           the HPV vaccine also called the HPV shot or GARDASIL? 
 Yes 
 No 
 
36. If you wanted information on HPV, how would you like to receive this information? 
(CHECK ALL THAT APPLY) 
 Health care provider 
 Pamphlets 
 Internet websites  
 TV 
 Family 
 Friends  
 School Health Center  
 Other (Please specify)_______________________________________________ 
 
37. Which source of health information do you use the most? (CHECK ALL THAT 
APPLY) 
 Health care provider 
 Pamphlets 
 Internet websites 
 TV 
 Family 
 Friends  
 School Health Center  
 Other (Please specify)________________________________________________ 
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38. Which ONE source of health information do you trust the most? (CHECK ALL 
THAT APPLY) 
 Health care provider 
 Pamphlets 
 Internet websites 
 TV 
 Family 
 Friends  
 School Health Center  
 Other (Please specify) 
__________________________________________________ 
 
 
Thank you for filling out the survey!  
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Appendix C: Genital HPV infection – CDC fact sheet 
What is HPV? 
HPV is the most common sexually transmitted infection (STI). HPV is a different virus than HIV and HSV (herpes).  HPV is so 
common that nearly all sexually active men and women get it at some point in their lives. There are many different types of 
HPV. Some types can cause health problems including genital warts and cancers. But there are vaccines that can stop these 
health problems from happening. 
How is HPV spread? 
You can get HPV by having oral, vaginal, or anal sex with someone who has the virus. It is most commonly spread during 
vaginal or anal sex. HPV can be passed even when an infected person has no signs or symptoms. 
Anyone who is sexually active can get HPV, even if you have had sex with only one person. You also can develop symptoms 
years after you have sex with someone who is infected making it hard to know when you first became infected. 
Does HPV cause health problems? 
In most cases, HPV goes away on its own and does not cause any health problems. But when HPV does not go away, it can 
cause health problems like genital warts and cancer. 
Genital warts usually appear as a small bump or group of bumps in the genital area. They can be small or large, raised or 
flat, or shaped like a cauliflower. A healthcare provider can usually diagnose warts by looking at the genital area. 
Does HPV cause cancer? 
HPV can cause cervical and other cancers including cancer of the vulva, vagina, penis, or anus. It can also cause cancer in 
the back of the throat, including the base of the tongue and tonsils (called oropharyngeal cancer). 
Cancer often takes years, even decades, to develop after a person gets HPV. The types of HPV that can cause genital warts 
are not the same as the types of HPV that can cause cancers. 
There is no way to know which people who have HPV will develop cancer or other health problems. People with weak 
immune systems may be less able to fight off HPV and more likely to develop health problems from it, this includes people 
with HIV/AIDS. 
How can I avoid HPV and the health problems it can cause? 
You can do several things to lower your chances of getting HPV. 
Get vaccinated. HPV vaccines are safe and effective. They can protect males and females against diseases (including 
cancers) caused by HPV when given in the recommended age groups (see “Who should get vaccinated?” below). 
HPV vaccines are given in three shots over six months; it is important to get all three doses. 
Get screened for cervical cancer. Routine screening for women aged 21 to 65 years old can prevent cervical cancer. 
If you are sexually active 
• Use latex condoms the right way every time you have sex. This can lower your chances of getting HPV. But HPV can 
infect areas that are not covered by a condom - so condoms may not give full protection against getting HPV 
• Be in a mutually monogamous relationship – or have sex only with someone who only has sex with you. 
Who should get vaccinated? 
All boys and girls ages 11 or 12 years should get vaccinated. 
Catch-up vaccines are recommended for males through age 21 and for females through age 26, if they did not get 
vaccinated when they were younger. 
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The vaccine is also recommended for gay and bisexual men (or any man who has sex with a man) through age 26. It is also 
recommended for men and women with compromised immune systems (including people living with HIV/AIDS) through age 26, if 
they did not get fully vaccinated when they were younger. 
 
 
 
 
How do I know if I have HPV? 
There is no test to find out a person’s “HPV status.” Also, there is no approved HPV test 
to find HPV in the mouth or throat. 
There are HPV tests that can be used to screen for cervical cancer. These tests are 
recommended for screening only in women aged 30 years and older. They are not 
recommended to screen men, adolescents, or women under the age of 30 years. 
Most people with HPV do not know they are infected and never develop symptoms or 
health problems from it. Some people find out they have HPV when they get genital 
warts. Women may find out they have HPV when they get an abnormal Pap test result 
(during cervical cancer screening). Others may only find out once they’ve developed 
more serious problems from HPV, such as cancers. 
How common is HPV and the health problems caused by HPV? 
HPV (the virus): About 79 million Americans are currently infected with HPV. About 14 
million people become newly infected each year. HPV is so common that most sexually- 
active men and women will get at least one type of HPV at some point in their lives. 
Health problems related to HPV include genital warts and cervical cancer. 
Genital warts: About 360,000 people in the United States get genital warts each year. 
Cervical cancer: More than 11,000 women in the United States get cervical cancer each 
year. 
There are other conditions and cancers caused by HPV that occur in persons living in the 
United States. 
I’m pregnant. Will having HPV affect my pregnancy? 
If you are pregnant and have HPV, you can get genital warts or develop abnormal cell 
changes on your cervix. Abnormal cell changes can be found with routine cervical cancer 
screening. You should get routine cervical cancer screening even when you are pregnant. 
Can I be treated for HPV or health problems caused by HPV? 
There is no treatment for the virus itself. However, there are treatments for the health 
problems that HPV can cause: 
1. Genital warts can be treated by you or your physician. If left untreated, genital 
warts may go away, stay the same, or grow in size or number. 
2. Cervical precancer can be treated. Women who get routine Pap tests and follow 
up as needed can identify problems before cancer develops. Prevention is 
always better than treatment. For more information visit www.cancer.org. 
3. Other HPV-related cancers are also more treatable when diagnosed and treated 
early. For more information visit www.cancer.org. 
 
Where can I get more 
information? 
STD information 
http://www.cdc.gov/std/  
HPV Information 
http://www.cdc.gov/hpv/  
HPV Vaccination 
http://www.cdc.gov/vaccines/ 
vpd-vac/hpv/  
Cancer Information 
http://www.cdc.gov/cancer/  
Cervical Cancer Screening 
http://www.cdc.gov/cancer/ 
cervical/basic_info/screening. 
htm  
CDC’s National Breast and 
Cervical Cancer Early Detection 
Program 
http://www.cdc.gov/cancer/ 
nbccedp/  
CDC-INFO Contact Center 
1-800-CDC-INFO 
(1-800-232-4636) 
Contact www.cdc.gov/info  
CDC National Prevention 
Information Network (NPIN) 
https://npin.cdc.gov/disease/stds 
P.O. Box 6003 
Rockville, MD 20849-6003 
E-mail: npin-info@cdc.gov 
National HPV and Cervical Cancer 
Prevention Resource Center 
American Sexual Health Association 
(ASHA) 
http://www.ashasexualhealth.org/ 
stdsstis/hpv/ 
P.O. Box 13827 
Research Triangle Park, 
NC 27709-3827 
1-800-783-9877 
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Appendix D: Post-test HPV knowledge, beliefs, behaviors questionnaire 
I         Survey: _______ 
HPV Knowledge, Beliefs, and Behaviors Questionnaire 
 
Please, read each question and put a check (√) beside your answer. If you do not want 
to answer a question, you can leave it blank. Only mark one response for each 
question, unless you are asked to “check all that apply.”  
 
Pap Smear Knowledge 
 
24. Please, respond to the following statements about HPV as TRUE, FALSE, or 
DON’T KNOW.  
(If you don’t know, check “DON’T KNOW.”)  
 
 
 True False Don’t 
Know 
g. A Pap smear is a test to find out if a woman is pregnant.    
h. All women should be getting Pap smears by the time they are 21 
years old. 
   
i. A Pap smear checks for changes in the cells of a woman’s uterus, 
also called the womb. 
   
j. A Pap smear checks for changes in the cells of a woman’s cervix.    
k. Getting regular Pap smears is the best thing a woman can do to 
prevent cervical cancer. 
   
l. If a woman has a Pap smear result that is not normal that usually 
means that she has cancer. 
   
 
 
HPV Knowledge and Awareness 
 
25. Have you ever heard of HPV? (HPV stands for human papillomavirus.) 
 Yes 
 No 
 
26.  Have you ever heard of the HPV vaccine? (also called the HPV shot or 
GARDASIL.) 
 Yes 
 No 
27.   Please, respond to the following statements about HPV as TRUE, FALSE, or 
DON’T KNOW.  
(If you don’t know, check “DON’T KNOW.”)  
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 True False Don’t Know 
a. HPV can cause HIV/AIDS.    
c. You can always tell when someone has HPV.    
c. HPV can cause abnormal Pap smears/ Pap tests.    
d. Only women get HPV.    
e. HPV can cause herpes.    
g. HPV can cause genital warts.    
h. You can have HPV without knowing it    
i. HPV is a sexually transmitted infection (STI) or STD.    
j. HPV can cause cervical cancer.    
k.    The HPV vaccine protects against all HPV infections?    
l.     Condoms are not 100% effective at preventing HPV?    
m.   HPV is spread by skin to skin contact?    
 
HPV Vaccine Acceptability 
 
28. If cost was not an issue, would you get the vaccine to prevent HPV 
infection? 
 Yes 
 No 
 Don’t Know/Not Sure 
 
29.  What are the barriers or reasons for not getting the HPV vaccine? (CHECK 
ALL THAT 
APPLY) 
 Cost 
 Not available 
 Risks with shots 
 No need 
 Other: __________________ 
 
30. Do you know where to go to get the HPV vaccine? 
 Yes 
 No 
 
31. If you have an 11-12 year-old daughter (or became the parent of one in the future), 
would you have her vaccinated against HPV? 
 Yes 
 No 
 Don’t Know/Not Sure  
 
32. If you have an 11-12 year-old son (or became the parent of one in the 
future), would you have him vaccinated against HPV? 
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 Yes 
 No 
 Don’t Know/Not Sure  
 
Attitudes, Beliefs, and Perceptions about HPV and HPV Vaccine 
33. This section asks about your beliefs and perceptions about HPV and the HPV 
vaccine.  Please tell us whether you agree or disagree with the following 
statements (from “strongly disagree” to “strongly agree”).  
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
bb. Most people think that people with HPV should be 
ashamed of themselves 
 
 
 
 
 
 
 
 
cc. Most people think that people with HPV are to blame 
for their problem 
 
 
 
 
 
 
 
 
dd. Most people think that people with HPV are a danger 
to others 
 
 
 
 
 
 
 
 
ee. Only people who are sexually promiscuous get HPV 
 
 
 
 
 
 
 
 
 
 
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
ff. It is extremely likely that I will get HPV in my 
lifetime.  
 
 
 
 
 
 
 
 
 
gg. My current behaviors put me at risk for HPV.  
 
 
 
 
 
 
 
 
hh.  HPV is a very common infection 
 
 
 
 
 
 
 
 
ii. My risk of getting HPV is higher than most people’s 
risk 
 
 
 
 
 
 
 
 
 
 
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
 
jj. HPV is a serious infection. 
 
 
 
 
 
 
 
 
 
kk. Cervical cancer is a serious disease.  
 
 
 
 
 
 
 
 
ll. HPV can be life-threatening     
mm. HPV  is very likely to cause cervical cancer     
 
 
 
 
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
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nn. I cannot afford to get the HPV vaccine.  
 
 
 
 
 
 
 
 
oo. I would not get the HPV vaccine because I am 
afraid of needles.  
 
 
 
 
 
 
 
 
pp. I do not think vaccines work.  
 
 
 
 
 
 
 
 
qq. I have concerns about whether the HPV vaccine is 
safe. 
 
 
 
 
 
 
 
 
rr. I have concerns about whether the HPV vaccine is 
effective. 
 
 
 
 
 
 
 
 
ss. I have concerns about possible side effects of the 
HPV vaccine. 
 
 
 
 
 
 
 
 
 
 
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
 
tt. Getting the HPV vaccine could save my life. 
 
 
 
 
 
 
 
 
uu. Getting the HPV vaccine could protect me from 
getting certain types of HPV. 
 
 
 
 
 
 
 
 
vv. Getting the HPV vaccine will reduce the chance 
of me getting cervical cancer in the future. 
 
 
 
 
 
 
 
 
 
 
 
Strongly 
Disagree 
 
Disagree 
 
Agree 
Strongly 
Agree 
ww. Knowing that HPV affects people like me 
would encourage me to get the HPV vaccine. 
 
 
 
 
 
 
 
 
xx. Knowing more about HPV would encourage me 
to get the HPV vaccine.   
 
 
 
 
 
 
 
 
yy. If my doctor recommended that I get the HPV 
vaccine then I would get it.  
 
 
 
 
 
 
 
 
zz. If my mother approved of the HPV vaccine then I 
would approve of it also.  
 
 
 
 
 
 
 
 
aaa. If my grandmother approved of the HPV 
vaccine then I would approve of it also.  
 
 
 
 
 
 
 
 
bbb. If my friends approved of the HPV vaccine 
then I would approve of it also.  
 
 
 
 
 
 
 
 
 
 
Thank you for filling out the survey! 
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Appendix E:  
(Permission Dr. Bynum) 
 
 
From: Shalanda Bynum 
[Shalanda.Bynum@usuhs.mil] 
Sent: Tuesday, January 31, 
2012 8:35 AM 
To: Sheaves, Crystal 
Subject: Re: FW: Dr. 
Shalanda Bynum 
 
Hi Crystal, 
 
 
Please find attached the 52-
item survey as well as three 
publications with published 
reliability statistics for 
each construct and my 
student sample. Please let 
me know if I can be of 
further help. 
 
 
Best! sb 
----------------------------
----------------------------
-------------------- 
Shalanda A. Bynum, PhD, MPH 
Assistant Professor of 
Social & BehavioralSciences 
Department of Preventive 
Medicine & Biometrics 
E. Edward Hebert School of 
Medicine 
Uniformed Services 
University of the 
HealthSciences 
4301 Jones Bridge Road, 
Bethesda, MD 20814 
Tel : (301) 295-1585; Fax: 
(301) 295-1933 
E-mail: 
shalanda.bynum@usuhs.mi 
 
 
 
 
 
 
 
 
 
 
 
 
